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Abstract 
The development of a new class of phosphine-alkene and thio-phosphine-alkene ligands 
based on a chalcone ferrocene framework, represents the primary focus of this study. 
The synthesis and characterisation of novel ligands, ferrochalcone 32 and thio-
ferrochalcone 33, are described. The related alkene-phosphine ligands, the Lei ligand 17 
and novel thio-Lei ligand 46, are further detailed. 
Ferrochalcone, 32 Thio-ferrochalcone, 33  
The coordination chemistry of four ligands (17, 32, 33 and 46) with various transition 
metals (Pt, Pd, Cu, Rh and Au) has been investigated in a comprehensive spectroscopis 
study. Single crystal X-ray analysis has been conducted at suitable junctures within the 
project. A surprising finding was that some solution-state structures were found to be 
different when studied in the solid state. 
The AuI complexes-containing the ligands have been successfully used in 1,5-enyne 
cycloisomerisation reactions. In addition to the coordination chemistry of the novel 
ligand systems, some interesting findings emerged For example, AuI complex of Lei 
ligand 17 and monodbaPHOS 74 undergoes an interesting solid-state [2+2] 
intramolecular cycloaddition transformation, giving cycloadduct, 72 and 77. 
An interesting finding includes the presence of impurity in commercially available 
Pd(OAc)2. Cyclopalladation of papaverine was carried out using pure and impure 
Pd(OAc)2, which resulted in the identification of  novel Pd-dimer complex, 86. The 
result suggest that nitrite contaminants derive from impurities in Pd(OAc)2, and not 
from the oxidation of acetonitrile mediated by metallic Pd0, explain the formation of 
PdII-nitrito cyclopalladated products. Photocrystallographic metastable linkage 
isomerisation and complete conversion to an oxygen-bound nitrito complex 90 was also 
observed. 
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Chapter 1: Introduction 
 
A readily exploited characteristic of transition metal chemistry is its variation of 
oxidation states, which can be achieved with a wide variety of ligands and metal 
combinations. This allows the reactivity of a given transition metal complex to be tuned 
for use in, for example, catalytic processes or material applications. The steric and 
electronic factors of ligands have a profound influence upon the nature of the reactive 
metallic species and hence can affect the reactivity of the metal complex formed.1 
Changing the ligand can directly influence reaction efficiency and selectivity.2 The use 
of ligands with new geometries and electronic properties may result in the catalyst 
possessing increased stability, selectivity and catalytic activity. Furthermore, the 
electronic character of the ligand can be varied over a wide range to deliver different 
types of catalyst for specific applications.3 Other factors which affect reactivity are the 
inclusion of exogenous additives, e.g. solvent and salts etc.4 Each component of a given 
catalytic system offer a means of modification and the promise of new reactivity.  
 
The development of new carbon-carbon (C-C) and carbon-heteroatom (C-X) bond- 
forming reactions continues to be an essential goal in organic chemistry.5 Indeed, 
synthetic chemists are continuously looking for new methodologies for the synthesis of 
these compounds. The principal focus of this thesis is the design of novel ligands for 
potential use in homogenous catalysis. 
 
The metals of interest in the thesis include Pd, Pt, Rh, Au and Cu, which are widely 
used in organic synthesis.  These metals are classified as B (or soft) metals according to 
Pearson Hard-Soft Acid Base principle (HSAB)6 and therefore prefer to bind to soft 
bases, e.g. P and S; class A (hard) metals like H, Li, Na, K, Ca, Co, Fe etc. and prefer N 
and O donors. 
 
Traditional metal-catalysed cross-coupling reactions for example, Heck,7 Negishi,8 
Stille,9 Suzuki-Miyaura,10 and Sonogashira,11 are well-established methods for the 
construction of C-C bonds, and widely applied in the synthesis of complex molecules. 
Over the last few decades considerable large research effort has been placed on the 
design and synthesis of highly active transition metal catalysts.12 In obtaining the most 
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active catalysts, the design of ligands is of the utmost importance, as is the selected 
metal. Often, ligands are designed to promote the rate-limiting step, with the majority of 
studies focusing on the σ-donor ligands, e.g. phosphines and N-heterocyclic carbenes13 
(NHCs).  
1.1 Phosphine as ligands 
Phosphine ligands play a key role in transition metal-catalysed reactions.14,15 In 1857 
Hofmann described the first phosphorus-metal complex, namely triethylphosphine 
platinum trichloride.16  Since then phosphines (PR3) have become a traditional and 
versatile ligand class for transition metal-catalysed reactions, especially since the late 
1960’s. The ability to vary the electronic properties in a systematic fashion can 
significantly affect ligation properties in metal complexes. In the 1970s, Tolman 
quantified the dependence of the phosphine’s electronic properties on R by investigating 
the changes in the CO stretching frequency in [Ni(CO)3(PR3)] complexes. In this study 
one of the CO molecules was displaced from Ni(CO)4 with the organophosphine of 
interest, allowing the resulting shift in the CO stretching frequency to be assessed by IR 
spectroscopy.  More electron-rich R-groups increase the electron density on the 
phosphorus, which in turn increases the back-bonding to CO.  This lengthens the C-O 
bond resulting in a decrease in the stretching frequency and lowering of the CO bond 
order. 17 
With advancements in computational methods and theoretical approaches alternatives 
have been developed to measure the electronic parameters.18 Similarly, the steric 
parameters of an organophosphine ligand can likewise be varied over a large range, in 
some cases independent of their electronic properties. Accordingly, the coordination 
number, geometry and electron-richness of a metal centre, the thermodynamics and the 
kinetics of (i) associative, and (ii) dissociative equilibria (Scheme 1) can be tailored 
through appropriate choice of substituents on phosphorus.   
 
Associative-A (2 steps)
            MLnX   +   Y    MLnXY MLnY   +   X
Dissociative-D (2 steps)
             MLnX   +   Y MLn   +   X   +   Y MLnY   +   X
(i)
(ii)
 
Scheme 1: General schematic representation of ligand substitution reactions. 
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Tolman also quantified the steric effects of phosphines by analysing their cone angles.19 
A bulkier phosphine, e.g. one with a larger cone angle, tends to have a greater 
dissociation rate then a smaller phosphine (Figure 1).   
 
 
Figure 1: Steric parameters used for phosphines. 
The cone angle can also dictate the geometry of the metal complex. A comparison of 
cone angles of common phosphine ligands in degrees is given in Table 1. 
 
Table 1: Cone angles for some common monodentate phosphine ligands. 
Phosphine  ligand Angle (°) 
PH3 87 
P(CH3)3 118 
P(Ph)3 145 
P(t-Bu)3 182 
P(C6F5)3 184 
 
Phosphines are mainly regarded as σ-donors. The lone pair on phosphorus can donate 
electron density to a metal. Increasing the electron density on phosphorus through the 
use of electron-donating substituents (R) increases the strength of σ-donation. 
Phosphines can also act as π-acceptors, with the σ*-orbital of the P-R bonds playing the 
role of the acceptor. π-Bonding arises through the donation of electron density from the 
metal into an empty orbital of the ligand, which exhibits phosphorus 3p character 
(Figure 2).  
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P M
π-acceptor
σ* orbital
of PR3
occupied
d-orbital
MP
R
R
R
C O
σ-donation
σ orbital π* orbital
π-backdonation
empty metal
d- orbital
occupied
metal d-orbital  
 
Figure 2: Phosphines are good σ-donors and π-acceptors. 
Trialkylphosphines are weak π-acceptors, followed by triarylphosphines, then 
trialkoxyphosphites, with toxic PF3 being similar to CO in its bonding to metals.20 
Common phosphine ligands used in both commercial and research laboratories range 
from simple alkyl and aryl phosphines, e.g. PCy3 and PPh3, to more complex 
phosphines like those shown in Figure 3. 
 
BINAP, 1 S-Phos, 2
X-Phos, 3
Xantphos, 4
DPEPhos, 6FesulPHOS, 5
Fe
O
O
PPh2
PPh2
PCy2
OMeMeO i-Pri-Pr
i-Pr
PCy2
Me Me
PPh2PPh2
PPh2 PPh2
St-Bu
PR2
 
Figure 3: Commercially available phosphines. 
A brief look at the history of the Buchwald-Hartwig amination highlights the evolution 
of the ligands used.21 Initially, simple phosphines such as P(t-Bu)3 and P(o-Tol)3 were 
employed. These were then replaced by chelating bisphosphines such as BINAP 1, 
which is a well known bidentate ligand. This chiral compound is also widely used in 
asymmetric synthesis.  
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Buchwald later reported the synthesis and use of monodentate phosphines containing a 
biphenyl backbone. S-Phos 2 and X-Phos 3 are monodentate phosphines derived from 
biphenyl. They are also used in various cross-coupling reactions.22,23 Suzuki-Miyaura 
coupling reactions of aryl and heteroaryl halides with aryl-, heteroaryl-, and vinyl 
boronic acids proceed in very good to excellent yields using the S-Phos 2 ligand 
(Scheme 2). 
Pd cat (0.1-10 mol%)
            base
rt - 100 °C
n-butanol, S-Phos
 
Scheme 2: General scheme for Suzuki-Miyaura coupling using S-Phos. 
 
These ligands have also proved efficient in a number of C-C, and C-O bond forming 
reactions. Later work by van Leeuwan and co-workers resulted in the discovery of new 
bisphosphine ligands such as XantPHOS 4 and DPEPhos 6, which also showed high 
activity for coupling of aryl halides with a variety of amines.24    
 
1.2 Alkenyl (olefin) ligands 
 
The impact of alkenes as ligands in transition metal catalysis is a greatly underexploited 
area.25 Alkenes are ubiquitous whether they are introduced in the form of substrates, in 
the catalyst or as an additive. There are many examples of alkenes influencing the 
outcome of a reaction through increased activity, stability or selectivity as depicted 
below in Scheme 3.26    
Where R= Electron donating group (EDG)
           `R= Electron withdrawing group (EWG)
Cl-
(6 mol%) Ar= 2,6-i-PrPh
7
Ligand 7 [Pd2(7)3] 
       (3 mol% )
n-Bu4NBr (10 mol%)
 
Scheme 3: General scheme for Suzuki-Miyaura cross coupling reaction. 
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It has been found that the electron-withdrawing substituents like NO2 or CF3 deactivate 
the Pd0 catalyst species, whereas strongly electron-donating substituents such as OMe 
increase catalytic activity over that of unsubstituted dba (dibenzylideneacetone) ligands. 
Independent electron-rich σ-donor ligands could increase back-bonding from the d10 
palladium(0) centre to the π-acidic dba, thus strengthening this Pd0-alkene interaction 
and thereby reducing the overall concentration of the active Pd0Ln species. The 
incorporation of an electron-withdrawing substituent onto the dba ligand should further 
enhance this back-bonding. Conversely, the incorporation of electron-releasing 
substituents as part of dba ligand will destabilize back-bonding and thus increase the 
concentration of the active catalyst species. In C-C bond-forming cross-coupling 
methodology, alkene additives have been reported to increase reaction efficiency, 
improve selectivity and dictate new reaction mechanisms.27, 28 Kurosawa et al. reported 
that the stereochemical outcome of oxidative addition of Pd0 and Pt0 compounds to 
trans-5-methoxycarbonyl-2-cyclohexenylchloride 8 is altered by the presence of olefin 
additives (Scheme 4). 
[Pd (alkene)n]
8
syn anti
None
1,5-COD
Alkene 45 : 55
10 : 90
97 : 3
97 : 3
Cl
CO2CH3
CO2CH3CO2CH3
H3CO2C
CO2CH3
CN
NC
PdClPdCl
 
Scheme 4: Stereoselectivity of oxidative addition of alkene metal complexes. 
 
It has been observed that alkenes can be utilised in transition metal-mediated reactions 
in different ways. They can be part of the metal precursor source, for example, the 
dibenzylideneacetone (dba) in [Pd2(dba)3], or added as exogenous additives (e.g. as 
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shown in Scheme 4). They can be used as the “working” ligand or as an ancillary 
ligand, or they can form part of the substrate (e.g. in the Heck reaction). In a series of 
studies, van der Boom and co-workers showed that aryl halide substrates containing an 
alkene undergo η2-coordination to Pt0 before oxidative addition occurs (Scheme 5).29 
Pt0(PEt3)4
THF
-10-25°C
intramolecular
THF , 40-68 °C
R= OMe, H, CF3, CN, NO2
X= Br, I
 
Scheme 5: Kinetically-favoured alkene coordination, followed by oxidative addition. 
Alkenes have also been used efficiently in many Pd-based catalytic studies.30  It is 
known that electron-deficient alkenes can accelerate reductive elimination. They can 
also affect the product selectivity of many reactions, by interfering with 
carbopalladation, isomerisation and β-H elimination pathways.31 For example in 2007, 
Firmansjah and Fu reported an intramolecular Heck reaction, which showed a 
remarkable dba (alkene) effect.32  There are two possible products from the reaction 
given in Scheme 6: a) the cyclised product where intramolecular insertion of the alkene 
occurs before β-H elimination, and b) the diene product where β-H elimination is faster 
than alkene insertion (carbopalladation).  
 
Pd2(dba-4,4`-Z)3  (5 mol%)
 SIMes.HBF4  (20 mol%)
KOt-Bu (20 mol%)
 Cs2CO3 (1.1 eq.)
    CH3CN, 65 °C
Z= H
Z= OMe
44%
80%
50%
6%
(a) (b)
Ar
Ar
Br
Ar
+
 
Scheme 6: Intramolecular Heck reaction displaying a remarkable dba(alkene) effect. 
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Using the Pd0 precursor [Pd2(dba)3] the authors obtained almost equal quantities of the 
cyclised and 1,5-diene products, whereas the use of [Pd2(dba-4,4'-OMe)3] resulted in 
cyclisation becoming the dominant pathway.  It can be hypothesised that dba-4,4'-OMe 
ligand slows down β-H elimination before alkene insertion, by coordinating to the PdII 
oxidative addition species, thus removing the vacant site needed for β-H elimination.  
The dba-4,4'-OMe ligand is more electron-rich than dba-H, and so it likely interacts 
more strongly with PdII.   
 
1.3 Transition Metal-Alkene Complexes 
 
Transition metal complexes with alkenes have been known for nearly two hundred 
years. Zeise in 1827 for the first time prepared K[PtCl3(C2H4)].H2O (Zeise’s salt) by the 
dehydration of EtOH with K2[PtCl4].33,34 although its formula was not confirmed until 
1861 by Griess and Martius.35 Its structure was finally elucidated in the 1950’s and was 
proven to be representative of alkene coordination to a transition metal. 36 Bonding of 
the metal centre to both carbon atoms of ethene results in an increase in the length of the 
C-C bond, and bending of the C-H bond, which occurs away from the metal centre. This 
change in geometry is described by the model of Dewar, Chatt and Duncanson who 
proposed synergistic alkene-metal σ-donation and complementary metal-to-alkene π-
donation (Figure 4).37  
M M
σ−donation
d orbital
metal
π orbital
alkene
d orbital
metal
π∗ orbital
alkene
π−back-donation
 
Figure 4: Frontier  molecular orbitals illustrating the metal-alkene bonding interaction. 
 
The σ-donation occurs from the highest occupied molecular orbital (HOMO) of the 
alkene, the C=C π-electrons, to an empty orbital on the metal centre. Concurrent π-
back-donation occurs from an occupied metal d-orbital to the lowest unoccupied 
molecular orbital (LUMO) of the alkene, e.g. the vacant π*-orbital. This backbonding 
weakens and lengthens the C-C bond and simultaneously results in a partial 
rehybridization of the carbon centres. The strength of the metal-alkene bond, which in 
 9
turn relates to the length of the carbon-carbon bond, is dictated by the efficiency of π-
backbonding. 
 
A weakly π-basic metal such as PtII in Zeise’s salt, provides minimal backbonding, and 
the resulting carbon-carbon bond length (1.375 Å) which differs relatively little from 
that of free ethylene (1.337 Å). This complex is representative of a simple π-complex of 
the alkene and metal and is typical of alkene complexes from metals in high oxidation 
states. Conversely coordination of an electron-deficient alkene, with a strongly π-basic 
metal, maximizes backbonding, in some cases leading to metallopropane type 
structures, with complete re-hybridisation of the carbon atoms to sp3 (Figure 5). Most 
transition metal-alkene complexes lie between these two extremes.  
 
Mvs.
weakly π-basic metals
e.g. PtII, PdII
strongly π-basic metals
e.g. Pd0, Pt0, Ni0
M
 
Figure 5: Different binding modes of alkenes towards metals. 
The extent to which re-hybridisation occurs, and thus the degree of back-donation can 
be measured by the shift in the NMR signal of the alkene carbon atoms coordinated to 
the metal, ∆δ = (δcomplex - δfree ligand).  The stronger the back-donation, the lower the 
frequency of the resonance of the complexed carbon atom and the greater ∆δ.  One also 
expects a decrease in the C=C stretching frequencies in the infrared spectrum upon 
coordination to a late transition metal centre.38,39 However, compared to a carbonyl 
stretching bond in CO, the C=C stretching frequency is weak and overlaps with many 
other groups, e.g. organic carbonyls (amide) and aromatic groups. This makes it a less 
reliable indicator for the strength of back-donation.  
 
Alkene coordination to metals has been studied extensively. In most cases alkenes are 
found to be more labile than the “working” ligands, e.g. phosphines or NHCs.  The 
extent of lability is dependent on the strength of the metal-alkene bond (i.e. alkene type) 
and the other surrounding ligands.  Electron-rich alkenes will be more labile due to 
decreased back-donation, which will increase reactivity. A ligand that contains both 
substitutionally labile and inert groups may act in a hemilabile fashion. The term 
“hemilabile” was first coined by Jeffrey and Rauchfuss in 1979.40 The weakly-
coordinating group can stabilise vacant sites on a transition metal centre until it is 
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introduced to a substrate molecule. The presence of an inert group means that the ligand 
remains anchored to the transition metal centre. These characteristics have meant that 
hemilabile ligands have found numerous applications in homogenous catalysis.41 
 
1.4 Phosphino-alkene ligands 
 
Bidentate ligands of the phosphino-alkenyl type have shown considerable promise, due 
to the combination of two beneficial types of ligand into a single framework.  The 
phosphine component ensures strong binding to the transition metal, while the alkene 
provides both the opportunity to create a chiral environment in close proximity to the 
transition metal, as well as providing another way to vary the electronic properties of 
the catalyst. 
 
The first chelating phosphino-alkene ligand (9) was reported by Nyholm and co-
workers in 1964, followed soon after by a number of further variants (10, 11, and 12; 
Figure6).42 
n
n= 1-4
9
10
11
12
n= 1-3
n
P
PPh2PPh2
Ph2P
 
Figure 6: The ‘first’ phosphino-alkene ligands. 
Later work by others including Grutzmacher,43 Carreira,44 Hayashi,45 Widhalm,46 
Ellmann47 and Lei48 resulted in development of a new array of alkene phosphine 
ligands, as shown in Figure 7. 
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*
*= chiral centre
Widhalm, 13 Grutzmacher, 14 Ellman, 15
Hayashi, 16 Lei, 17
P
R
P
O
Ph2P
Ph
Ph
Ph
PPh2
Ph
PPh2
 
 
Figure 7: Second generation phosphino-alkenyl ligands. 
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1.4.1 Phosphino-alkene ligands in catalysis 
Phosphino-alkene ligands have been utilised in a wide range of Pd, Pt, Rh, Cu and Au-
catalysed reactions, as outlined below. For example, Shaw and co-workers developed a 
series of phosphorus-alkene bidentate ligands and used them effectively in Pd-catalysed 
Suzuki cross-coupling reactions (Scheme 5).49  
Pd(OAc)2 (5 mol%)
Ligand (10 mol%)
K3PO4, DMF
110 °C, 24 h
18 (a) 18 (b) 18 (c)
18 (a)= 26%
18 (b)= 85%
18 (c)=93%  
Scheme 5: A range of phosphine-alkene ligands used in the Suzuki reaction. 
They found that electron-deficient and sterically hindered alkenes bring about greater 
yields, increasing the stability of the Pd catalyst.  As complexes with only phosphine 
ligands catalyse cross-couplings, control reactions with the saturated ligand were carried 
out to see if the alkene was necessary.  A saturated version of ligand 19 gave poor 
yields, indicating that the alkene plays a crucial role in the catalytic cycle.   
 
Lei and co-workers carried out a series of experiments using phosphine/electron-
deficient alkene ligands and found that these ligands promoted reductive elimination. 
Chalcone-based phosphino-alkene ligand, 17 was used in the Negishi coupling of ethyl 
2-iodobenzoate with cyclohexylzinc chloride. It is generally known that in Negishi 
coupling that β-H elimination competes with reductive elimination.50 The saturated 
version of ligand e.g. 17-H2 leads to large amounts of ethyl benzoate 19 (b) being 
formed along with product 19 (a), whereas ligand 17 was found to be highly selective 
for 19 (a). It is assumed that the hemilabile alkene blocks the coordination sites needed 
for β-H elimination, reducing the electron density at PdII and hence accelerates the 
reductive elimination step (Scheme 6). There is also the potential for the alkene to 
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dissociate giving a three-coordinate PdII intermediate from which reductive elimination 
is facile.  
n-C12H25ZnCl
PdCl2(MeCN)2 (1 mol%)
17 or 17(H2) (1 mol%)
THF , rt
19 (a) 19 (b)
17
 
 
Scheme 6: Negishi cross-coupling employing a chalcone-based phosphine-alkene ligand. 
Pd-catalyzed asymmetric allylic substitutions provide a practical and efficient approach 
to construct the C-C, C-N and C-O bonds in an enantioselective fashion. An example 
reaction is shown in Scheme 7, namely chiral alkene-phosphine hybrid ligands 20a and 
20b which promote the formation of optically-active oxime ethers in high yields, with 
good to excellent enantioselectivities (Scheme 7).51 
20a: Ar= Ph
    b: Ar= 3,5-Me2C6H3
[PdCl(C3H5)]2 (3 mol% Pd)
(20a or b 3 mol%)
DIPEA, CH3CN
0°C, 2 h
54-99% yield
83-96% ee
R1
R2
N
OH
OAcAr
Ar
R1 R2
Ar Ar
O
N
PAr2
+
 
Scheme 7: Asymmetric allylic etherization of oxime using chiral ligand 20a-b. 
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In the same year the group of Du52 developed a similar version of the above ligand 21 
and successfully used it in the Pd-catalyzed enantioselective allylic alkylation of indoles 
and pyrroles (Scheme 8). 
Ar= Ph, R= H
21
[Pd(C3H5)Cl]2
rt , 11 h
Et3N , DCM
conv: 80%
ee: 85%
21
 
Scheme 8: Enantioselective allylic alkylation’s of indoles and pyrroles  employing a chiral 
phosphine-alkene ligand. 
Hayashi and co-workers reported the use of norbornene-based phosphine-olefin ligand 
16 in the Pd-catalyzed allylic alkylation of 1,3-diphenyl-2-propenyl acetate. The 
reaction proceeded in both high yield and enantiomeric excess (Scheme 9). 53 
 
(+)-16
Dimethyl malonate (3 eq.)
[Pd(C3H5)Cl]2 (3 mol% Pd]
16 (3 mol%)
KOAc (6 mol%)
BSA (3 eq.), CH2Cl2, rt, 14 h
87%, 96% ee  
Scheme 9: Pd-catalyzed allylic alkylation using a chiral phosphine-alkene ligand. 
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Grutzmacher and co-workers developed a phenyl-substituted phosphino-alkene ligand 
based on the tropp (5-phosphanyl-5H-dibenzo[a,d]cyclohaptene) framework 14, 
successfully using them in the Rh-catalyzed 1,4-conjugate addition of phenylboronic 
acid to 2-cyclohexenone providing the product in 85% yield and 95% ee (Scheme 10). 
 
[Rh(C2H4)2Cl]2 (1 mol%)
14
14, (1 mol%)
PhB(OH)2, KOH
Dioxane, H2O
>85%, 95% ee
O
Ph
Ph2P
Ph
O
 
Scheme 10: Rh-catalyzed 1,4-conjugate addition using a tropp phosphine-alkene ligand. 
Hayashi and co-workers successfully used a norbornene-based chiral alkene-phosphine 
ligand 16 in Rh-catalyzed 1,4-conjugate addition of aryl boronic acids to enones to give 
unsaturated ketones in high yield and enantiomeric excess (Scheme 11). 
Ph-B(OH)2
[Rh((+)-16)Cl]2, (5 mol%)
KOH (0.5 eq.)
1,4-dioxane:H2O (10:1)
50 °C, 3 h
91%, 72% ee
(+)-16
 
Scheme 11: Rh-catalyzed 1,4-conjugate addition of arylboronic acids to unsaturated 
ketones in the presence of a chiral phosphine-alkene ligand. 
The work reported by Widhalm and co-workers resulted in the development of a novel 
phosphino-alkene ligand based on bis(naphthyl)phosphepine ring 13. These ligands 
have been successfully used in the 1,4-conjugate addition of aryl boronic acids to a 
series of cyclic enones and enolates, resulting in the formation of products in excellent 
yield and enantioselectivity (Scheme 12). 
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13
Ph-B(OH)2
1,4-dioxane/KOH (aq)
[Rh-(C2H4)2Cl]2 , 13 (0.5 mol%)
AgBF4
72%, 90% ee
O
O
Ph
O
O
P Ph
Ph
 
Scheme 12: Rh-catalyzed 1,4-conjugate addition of aryl boronic acids to enoates using 
ligand 13. 
1.5 Other metal-catalysed reactions of interest to this project 
 
 
Hashmi, Toste, Echavarren, Hayashi and Haruta have fueled the advance of gold to the 
forefront of transition metal catalysis.54 The use of gold(I) and gold(III) complexes as 
efficient homogenous catalysts in a wide-range of organic transformations has been 
highlighted in the last few years.55 The popularity of these processes, which allow the 
formation of both C-C and C-X bonds, is largely due to the significant increase in the 
molecular complexity and impressive structural diversity they can obtained.56 
Phosphine-ligated gold(I) complexes are powerful C-C, C-N, and C-O bond-forming 
catalysts due to the ease with which they can activate unsaturated bonds, which 
facilitates unique rearrangements or reactions with appropriate nucleophiles.  
 
One good example is that reported by Yamamoto and co-workers, namely gold-
catalyzed intermolecular hydroamination of allenes.57 Treatment of allenes with 
morpholine in the presence of a cationic gold(I) catalyst in toluene at 80 °C gave the 
corresponding allylic amines in good to moderate yields (Scheme 13). 
10 mol% ClAuPPh3
10 mol% AgOTf
Toluene, 80 °C
64% yield  
Scheme 13: Gold-catalysed intermolecular hydroamination of allenes. 
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Shibata showed that a AuI catalyst mediates the cyclisation of 1,5-enynes leading to 
substituted naphthalenes (Scheme 14).58 
[AuCl(PPh3)] (1 mol%)
AgOTf (2 mol%)
DCM , rt
87% yield
(7:1)
22
23
24
 
Scheme 14: Gold-catalysed cyclisation of 1,5-enynes. 
Depending on the substitution pattern of the triple bond, a 5-exo-dig-type cyclisation 
can also proceed which is competitive with the 6-endo-type cycloisomerisation. The 
benzannulation of enyne 22 gave an 87% yield of a 7:1 mixture of the naphthalene 23 
and the corresponding indene 24. 
 
In 2011, Echavarren and co-workers carried out a series of experiments which resulted 
in the cyclopropanation of trans-stilbene with cycloheptatriene using a AuI complex 
(Scheme 15).59 AuI-catalyzed cyclisation of 1,n-enynes proceeds through intermediates 
that can be viewed as highly distorted AuI carbenes, which are then subsequently 
trapped by alkenes either intra- or intermolecularly in cyclopropanation reactions. 
DCE
SbF6-
R= tBu, `R=R"= iPr
25
100° C, 5 h
73% yield
25 (5 mol%)
`R
Au NCMe
`R
R"
P
R
R
Ph
PhPh
Ph
Ph
Ph
+
+
 
Scheme 15: Cyclopropanation of trans-stilbene with cycloheptatriene using a AuI complex. 
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Copper has also been used in catalytic reactions as both the main metal centre (e.g. 1,4-
conjugate addition to α,β-unsaturated carbonyl compounds,60 N-arylation,61 
hydroboration of styrenes62 and cyclopropanation reactions63) and as a co-catalyst (e.g. 
direct C-H functionalisation of arenes and heteroarenes64). A number of simple 
phosphino-alkenyl ligands have been coordinated to CuI centres and found to be 
effective catalysts. 
 
In 2009, Taillefer and co-workers used 4-phenyl-1,3-butadienylphosphine as a ligand 
for the Ullmann-type copper-catalyzed arylations of N- and O-nucleophiles (Scheme 
16).65   
X= I, Br
26
NuH
10% Cu [(CuI + 2(26)]
2 eq. Cs2CO3
CH3CN, 82° C  
 
Scheme 16: Copper-catalysed arylation of N and O nucleophiles using a phosphino-alkene 
ligand. 
Dorta and co-workers reported the use of phosphoramidate-based phosphino-alkene 
ligands in Cu-catalysis.66  These complexes were evaluated in a catalytic 1,4-conjugate 
addition of organoaluminum reagents to conjugated enones (Scheme 17).  The neutral 
CuI complexes did not catalyse the reaction; indeed, they stopped the reaction 
completely.  However, the cationic CuI complexes gave excellent yields, though only 
with moderate enantioselectivities. 
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*
27
X= I, BF4
2 mol% Cu 27
ClCH2CH2Cl
AlEt3, -25° C, 1 h
 
Scheme 17: Use of phosphoramidate-based phosphino-alkene ligands in Cu-catalysed conjugate 
addition reaction. 
Very recent work by the Fairlamb group has concerned the synthesis of a multidentate 
conformationally-flexible ligand based on the dibenzylidene acetone core structure and 
its use in catalytic alkene cyclopropanation (Scheme 18).67 It was observed that 
complex 28 and 29 effectively catalyses the cyclopropanation of styrene using ethyl 
diazoacetate at low catalyst loading. 
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29            91                                     30:70
Cu cat. (1 mol%)
Styrene, 60°C, 45 min
trans cis
2+ 2PF6-
28
29
Conversion Diastereomeric ratio
         (cis / trans)
28            85                                     32:68
S
S
Cu
Cu
Cl
O
Cl
S
Cu
S
O
S
Cu
S
O
CO2EtPhCO2EtPh
N2 CO2Et
PPh2
PPh2
PPh2
PPh2
OH2
H2O PPh2
Ph2P
+
 
Scheme 18: Use of dba-based phosphino-alkene ligands in Cu-catalysed cyclopropanation. 
Overall, it can be seen that phosphino-alkene ligands can be used in combination with 
an appropriate metal to provide active catalysts for a variety of transition metal-
mediated organic transformations.  In a number of cases, they have been shown to be 
more effective than either phosphines or alkene ligands alone, and have opened-up new 
avenues of chemistry. Other developments not mentioned above include the use of 
phosphino-alkene ligands as mechanistic probes in the Pauson-Khand reaction.68  
 
 
1.6 Ferrocene-based ligands  
 
The chemistry of ferrocene-containing compounds has received considerable attention 
over the years, which is associated with their utilization in organic synthesis, catalysis 
and material chemistry.69,70,71 Ferrocene-containing compounds possess properties such 
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as high thermal stability and reversible redox characteristics which make them quite 
effective for use in coordination chemistry. The functionalization of the 
cyclopentadienyl rings with various donor groups and subsequent ligation to metal 
centres are important topics of research in many fields that utilise the special properties 
of such species. 
 
Ferrocene or di(η5-cyclopentadienyl)iron(II) was accidently discovered by Peter L. 
Pauson and his graduate student Tom Kealy in 1951 when they attempted the reductive 
coupling of the Grignard reagent cyclopentadienyl magnesium bromide in the presence 
of ferric chloride.72 Ferrocene is a orange-coloured neutral, chemically-stable and a non-
toxic molecule.73 It is soluble in most of organic solvents but insoluble in water. It is 
stable to temperature as high as 400 °C. The structure of ferrocene 30 is depicted in 
Figure 8.                                           
30  
Figure 8: General structure of ferrocene. 
 
The iron atom in ferrocene is assigned to the +2 oxidation state. Each cyclopentadienyl 
(Cp) ring is allocated a single negative charge, bringing the number of π-electrons on 
each ring to six, and thus making them aromatic. These twelve electrons (six from each 
ring) are then shared with the metal via covalent bonding, which, when combined with 
the six d-electrons on Fe2+, results in a 18-electron, electronic configuration. The lack of 
individual bonds between the carbon atom of the Cp ring and the Fe2+ ion results in the 
Cp rings being able to freely rotate about the Cp-Fe-Cp axis. The carbon-carbon bond 
distances are 1.40 Å within the five membered rings, and the bond distances between 
the sandwiched iron and the carbons at the rings are 2.04 Å. The two cyclopentadienyl 
(Cp) rings of ferrocene may be orientated in two extremes of either an eclipsed (D5h) or 
staggered (D5d) conformation (Figure 9). The energy of rotation about the Fe-Cp axis is 
very small (~ 4 kJmol-1).  
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                                          Eclipsed (D5h)              Staggered (D5d)       
 
Figure 9: The different conformations of ferrocene. 
 
Ferrocene can be easily derivatised, and functionalised and oxidised to the ferrocenium 
salt as depicted in Figure 10. 
- -
[Ox]
[Red]
-e
  orange
Ferrocene
     18 e
 blue-green
Ferrocenium
        17 e  
Figure 10: Oxidation of ferrocene to ferrocenium ion. 
 
Oxidation of ferrocene gives a stable cation called a ferrocenium ion. Typical oxidising 
agents used are I2, conc. HNO3 and silver nitrate. Ferrocenium salts are sometimes used 
as oxidising agents, in part because the product ferrocene is fairly inert to other 
compounds and readily separated from the ionic products.74 The electrochemical 
property of ferrocene is based on the readiness and reversibility of the one-electron 
redox process. The ferrocene-ferrocenium cation system is considered as one of the 
most highly reversible redox systems. Ferrocenium ion is effectively used as a 
component in chemical sensors and as an internal standard for calibrating the redox 
potential in non-aqueous electrochemistry. Substituents on the cyclopentadienyl ligands 
alter the redox potential, for example electron-withdrawing groups such as carboxylic 
acid shift the potential in the anodic direction (i.e. they are made more positive), 
whereas electron-releasing groups such as a methyl group shift the potential in the 
cathodic direction (i.e. more negative). Hembre and McQueen recently reported the use 
of a redox-active ligand as an electron shuttle in a catalytic process.75 Catalysts formed 
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from these ligands may be inactive or sluggish in one oxidation state, but active 
following oxidation or reduction. Alternatively, they may show selectivities for specific 
transformations that depend upon the oxidation state of the complex. 
 
1.6.1 Pharmaceutically important ferrocene derivatives 
 
Studies on bioactive organometallic compounds represent a field of research with 
increasing importance. In the search for novel bioorganometallic molecules exhibiting 
anti-cancer activity,76,77 ferrocene represents a promising organometallic unit. One of 
the examples is ferrocifen 31, an activity-enhanced analog of the breast cancer drug 
tamoxifen (Figure 10).78 The development of synthetic routes to these challenging 
compounds has greatly diversified the types of compounds that can be accessed. 
31
 
Figure 10: Ferrocifen, an analog of the breast cancer drug tamoxifen. 
 
Many ferrocenyl compounds display interesting cytotoxic,79,80,81 anti-tumour, 82,83 
antimalarial,84 antifungal85 and DNA-cleavage activity.86 Medicinal applications of 
ferrocene include in vitro (antimicrobial), e.g. [Mn(FcCOO)2], and in vivo (cytotoxic), 
e.g. [Co(FcCOO)2], compounds which have been used to treat several diseases.87 
Ferrocene is found to have good stability and low toxicity on biological media. Also, 
the lipophilicity is good for delivery. Ferrocene metabolite ferrocenium ion possesses 
cytotoxic activity against tumors and is easily derivatised. Given below (Figure 11), are 
a few well known pharmaceutically important ferrocene derivatives.  
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Ferrocenyl-penicilin
Ferrocenyl-cephalopsorin
Ferroquine
Ferrocerone
 
S
N
N
O
H
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O
N
O
H
S
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NH
NCl
N
O
Fe
Fe
Fe Fe
ONa
CH2OCOMe
ONa
COONa.4H2O
 
Figure 11: Pharmaceutically important ferrocene derivatives. 
 
1.6.2 Ferrocenyl ligands in metal catalysis 
 
In 1995, Hayashi was the first one to synthesise chiral ferrocene ligands and later on use 
them in asymmetric catalysis.88 His work was followed by Kagan,89 Richards,90 Togni,91 
Santelli,92 Hou,93 Lemaire94 and Guiry,95 which resulted in the development of 
interesting chiral ferrocene ligands, as shown in Figure 12. 
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Mopf Josiphos
Fesulphos
Walphos
Fc-Phox
Pigiphos
 
Figure 12: Examples of chiral ferrocene ligands. 
 
A chiral, redox-active ligand is, in theory, capable of acting as a chiral auxiliary in an 
organic transformation, with subsequent decomplexation of the ligand upon 
electrochemical oxidation, thus facilitating a complete catalytic cycle. 
 
Ferrocenyl ligands have been successfully used in homogenous asymmetric hydrogenat- 
-ion of C=C and C=O bonds producing different kinds of chiral compounds on 
industrial scale,96 thus showing that ligands based on the ferrocene framework can be 
considered as privileged structures for these types of transformations (Schemes 19 and 
20).  
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R1= Ph, R2= NHPh, 98%, 98% ee
R1= Bu, R2= OMe, 93%, 99% ee
[Rh(cod)2Cl]2 (0.2 mol%)
Josiphos (0.41 mol%)
(Boc)2O (1.1 eq.)
H2 (90-100 psi), MeOH, 20 °C
Josiphos
PtBu2
PCy2
R2
O
H
NBoc
R1
R2R1
ONH2
Fe
 
Scheme 19: Josiphos/Rh-catalyzed asymmetric hydrogenation of unprotected enamines. 
A group of researchers at Merck have effectively used Josiphos for the asymmetric 
hydrogenation of enamines. 97 The reaction was met with the drawback of amine-
product inhibition and low-functional group compatibility, which was later improved by 
using Boc2O in the presence of methanol. Under these conditions the corresponding Boc 
carbamates were isolated in good yields and high enantioselectivities. 
 
[Ir(cod)Cl2] / I2
Fc-Phox
Toluene, H2, (600 psi), rt
95% conv.
  90% ee
S/C ratio 100
Fc-Phox
N
PPh2
t-Bu
N
O
N
H
Fe
 
Scheme 20: Fc-Phox/Ir-catalyzed asymmetric hydrogenation of 2-methylquinoline. 
In another study, Zhou and co-workers showed the usefulness of Fc-Phox as a P,N 
ligand in the Ir-catalyzed asymmetric hydrogenation of 2-methylquinoline. It was 
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observed that the reaction proceeds with a slight decrease of enantioselectivity at lower 
catalyst loading.98 
 
1.6.3 Ferrocenyl-chalcone compounds 
 
One of the most recent developments in organometallic chemistry is its interface with 
other sciences like biological science.99 In many of the reported examples, a phenyl 
group in an organic molecule with well-known biological activities has been replaced 
with an organometallic moiety in order to determine whether it can be made more 
effective (akin to ferrocifen, 31).  In this regard, the ferrocene derivatives have featured 
prominently due to their excellent stability in aqueous (when substituted with 
appropriate water solubilising group), aerobic media, the easy accessibility of a large 
variety of derivatives and favourable electrochemical properties.100 
 
Chalcones are a naturally-occurring class of compounds that belong to the flavonoid 
family. They are aromatic ketones with two aromatic groups bridged by an enone 
linkage (of general structure of Ar-COCH=CH-Ar'). They have been used in a wide 
range of applications covering bio-materials101 non-linear optical102 and electroactive 
fluorescent materials.103 The synthesis of chalcones is generally achieved by base-
catalyzed aldol condensation.104 Previous work in the Fairlamb group has shown that 
the hydroxy- and methoxy-chalcones display a wide range of biological properties and 
exert diverse pharmacological activities. Their work showed that the position of 
methoxy substituent on the two aromatic rings affect the anti-inflammatory action of 
different chalcones in relation to their ability to increase heme oxygenase-1 (HO-1) 
activity.105 
 
Ferrocenyl chalcones belong to the chalcone family in which one aromatic group (Ar or 
Ar') is substituted by the ferrocenyl group. Ferrocenyl chalcones have regularly been the 
subject of many interesting papers dealing with varied aspects of their chemistry106 or 
potential uses in different fields.107 Several well known examples of ferrocenyl 
chalcones are shown in Figure 13 overleaf. 
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Fc-Naph
Fc-Etcb2
Fc-Pyridinyl
Fc-3-chlorophenyl
Fc-furyl
O
O
O
N
CH2CH3
O
N
O
Cl
O
Fe
Fe Fe
Fe Fe
 
Figure 13: Selected examples of ferrocenyl chalcone compounds. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 29
1.7 Project Summary (aims and objectives) 
 
Chalcone-ferrocene ligands are potentially tuneable compounds.108 The use of a 
chalcone-ferrocene ligand framework could be helpful in understanding the interaction 
of enone-type ligands with transition metal centres. By varying the substituents on the 
aryl ring connected directly to the enone π-system of the chalcone, as well as the 
ferrocene ring, the electronic effects could be probed.  
 
The presence of both phosphine and alkene components enable the ligand target to 
posses hemilabile characteristics. The presence of a phosphine group enhances reactions 
such as oxidative addition. Whereas, an alkene can promote transmetallation and 
reductive elimination.109 These chalcone-based ferrocene ligands are relatively straight-
forward to synthesise. The synthesis of these ligands and the assessment of the 
reactivity of their respective transition metal complexes will be studied in this research 
project. 
 
Metal coordination behaviour of Lei ligand 17 will be further investigated (Figure 14), 
and compared with the chalcone-ferrocene ligands. Ligand 17 was reported during the 
first months in which the current project was started in York, exhibiting a similar 
structure as to that of ferrocene chalcone ligand class. Only a few metal complexes 
containing ligand 17 have been reported.110 
17
O
Ph2P  
Figure 14: Structure of the Lei ligand (17). 
Primary aims for this research project are to develop a diverse series of novel ligands 
based on the chalcone-ferrocene ligand framework, study their metal coordination 
chemistry and examine their applications in catalytic reactions. More specifically: 
 
• To design and develop a simple methodology for the synthesis of a 
series of novel chalcone ferrocene ligands e.g. β-(2'-diphenylphosphinophenyl)-
acrylferrocene 32, and β-(2'-diphenylthiophosphinophenyl)acrylferrocene 33. 
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32 33
 
 
• Study the coordination chemistry of 17, thio-Lei, 32 and 33 with a variety of late 
transition metals like Pt, Pd, Rh, Au and Cu (exemplar coordination modes are 
shown below) 
 
• To compare the ligiating ability of the new ferrocenyl ligands with Lei’s 
chalcone-phosphine ligand 17. 
 
• To explore the electrochemistry of the chalcone-ferrocene ligands and their 
metal complexes, with an emphasis on AuI metal complexes. 
 
• To use X-ray crystallography and NMR spectroscopic studies to characterise the 
novel alkene-phosphine and alkene thio-phosphine ligands, and their metal 
complexes. 
 
• To screen novel ligands and metal complexes in benchmark catalytic reactions, 
in comparison with some well known catalytic systems. Cycloisomerisation 
chemistry will be explored using AuI metal complexes.  
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Chapter 2: Synthesis of multidentate phosphino-alkene ligands 
2.1 Design of ferrocenyl, olefin (alkene)-phosphine ligands 
Alkene ligands can act as both σ-donors and π-acceptors.111 A considerable amount of 
work has been done on the synthesis of alkene and phosphine ligands and they can be 
effectively used as a transition metal catalyst for a variety of organic transformations (as 
detailed in Chapter 1).112 The aim of this chapter is to design a ligand having an alkene 
and phosphine moiety within the same core structure. Previous work by the Fairlamb 
group has been concerned with phosphine-alkenyl ligand containing a dibenzylidene 
acetone ligand backbone.113 Also, Professor Aiwen Lei from Wuhan university (China) 
designed a similar ligand having both an alkene and phosphine moiety.114 We have been 
interested in the design and development of a new class of phosphine-alkenyl ligand 
based on the chalcone-ferrocene backbone.115 Ferrocenyl chalcone belongs to a 
chalcone family in which one aromatic group (Ar or Ar') is substituted by an 
electrochemically-active ferrocenly group.116 By varying the substituents on an aryl ring 
connected directly to an enone π-system of the chalcone, as well as the ferrocene ring, 
the electronic properties of the alkenes can potentially be tuned.117  The substituents on 
phosphorus could also be potentially varied and tuned, depending on the electronic and 
steric properties desired.118 
Redox active switch

Alkene l igand↵
R group on Phosphorus
        can be tuned
 
Figure 1: Design rationale for a new multidentate phosphino-alkene ligand system. 
The initial target ligands for the project were 32, and 33, shown in Figure 2. 
 
32 33
 
 
Figure 2: Initial ligand targets 32 and 33 
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2.2 Synthesis of ligands 
Chalcones are a group of naturally-occurring compounds belonging to the flavonoid 
family and are present in a variety of plant species such as fruits, vegetables, spices, tea, 
and soy based foodstuff.119 Chalcones, or trans-1,3-diaryl-2-propen-1-ones, are 
consider-ed as the intermediate precursors to all flavonoid compounds. The synthesis of 
chalcones is generally achieved by base-catalyzed aldol condensation.120 Different 
approaches were considered in this regard, such as refluxing in an organic solvent,121 
the solvent-free solid-phase reaction,122 ultrasonication123 and microwave radiation.124 
The synthesis of β-biarylacryl ferrocene is relatively straight-forward and can be 
accomplished by a Claisen-Schmidt condensation. The Claisen-Schmidt reaction is the 
aldol condensation between an aromatic aldehyde and a ketone leading to carbon-
carbon bond formation, with loss of water affording a conjugated enone as the final 
product (Scheme 1). The Claisen-Schmidt reaction requires the use of a base as catalyst. 
 
-H2O
base
 
Scheme 1: Claisen-Schmidt condensation reaction. 
 
The most studied example of the Claisen-Schmidt condensation is the reaction of 
benzaldehyde with acetophenone to form chalcone (IUPAC naming – 1,3-
diarylpropenone) 34 (Scheme 12).125 
      
NaOH
34
EtOH/H2O
    25 °C
 
 
Scheme 2: A generic synthesis of a 1,3-diarylpropenone (chalcone). 
It was envisaged that the target phosphorus-containing chalcone ferrocene ligands could 
be accessed by base-mediated Claisen-Schmidt condensation of acetylferrocene 35 with 
a phosphine-substituted benzaldehyde (e.g. 39).126 Compounds 32 and 33 can be 
synthesised from commercially available acetylferrocene 35. Also, 35 could be 
synthesised from ferrocene 30, acetyl chloride and aluminium chloride in 
 33
dichloromethane. The reaction simply involves stirring at room temperature for 18 h 
(Scheme 13). 
          
84% yield
30 35
CH3COCl 
AlCl3, DCM
18 °C, 18 h
O
FeFe
 
Scheme 3: Acetylation of ferrocene. 
Ferrochalcone ligand 32 was obtained by reacting acetylferrocene 35 with 2-
(diphenylphosphino)benzaldehyde 39. Compound 39 could be synthesised simply from 
2-bromobenzaldehyde 36 via protection of the bromoaldehyde as the acetal 37. This 
was followed by halogen-lithium exchange and trapping with chlorodiphenylphosphine. 
Deprotection of the acetal affords aldehyde 39 as shown in Scheme 4. 
85% yield
36 37
39
38
HOCH2CH2OH
p-TsOH, Toluene
1). n-BuLi , THF, -78° C2). Ph2PCl, -78 to 22° C
cat. p-TsOH, acetone
reflux 8 hr
O
O
BrBr
O
O
CHO
PPh2
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Scheme 4: Synthesis of 2-(diphenylphosphino)benzaldehyde 39. 
Base-catalyzed Claisen-Schmidt condensation of 39 with acetyl ferrocene 35 afforded 
32 in a yield of 84% (Scheme 5).  
 34
32
84% yield
35
39
EtOH : H2O
NaOH
20° C, 18 h
 
Scheme 5: Synthesis of target ligand ferrochalcone ligand 32. 
NMR and IR spectroscopy, and mass spectrometry, were used to analyse the structure 
of the product. The 31P NMR spectrum of 32 in CDCl3 gave a single peak at δ -13.0 
confirming the formation and purity of ferrochalcone ligand 32. The 1H NMR spectrum 
showed that the α-H (alkene) appeared as a doublet (J = 15.5 Hz) with a chemical shift 
of δ 6.87, whereas the signal for β-H (alkene) appeared at ca. δ 8.43, spin-coupled with 
α-H. The signal at δ 4.06 corresponds to the five symmetrical protons of the ferrocene 
ring and those at δ 4.75 and δ 4.51 to the remaining four protons of the substituted 
ferrocene ring, with each peak corresponding to two protons. The remaining protons for 
the phenyl ring come in the range of ca. δ 6.8-7.8 as expected (Figure 3). The IR 
spectrum of 32 exhibited a strong band at 1653 cm-1, which belongs to ʋ (C=O). 
Another strong band is observed at 1584 cm-1, which is attributed to ʋ (C=C). The mass 
spectrum gave a molecular ion peak at m/z 523.3310, which corresponds to 
C31H25FePONa [MNa]+ confirming the synthesis of the target ligand 32. 
 
 
 
Figure 3: The 1H NMR spectrum for ligand 32 in CDCl3. 
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Two different routes were devised for the synthesis of the “R3P=S” compound 33. The 
first route involves the synthesis of 2-(diphenylthiophosphino)benzaldehyde 40, 
followed by its base-catalyzed Claisen-Schmidt condensation with acetyl ferrocene 35. 
The second route involves the direct reaction of 32 with sulphur flowers (S8) in THF. 2-
(Diphenylthiophosphino)benzaldehyde 40 was synthesised by reacting 39 with excess 
S8 in presence of THF to give 40 as shown in Scheme 6. 
 
S8, THF
40
81% yield39
overnight stirring
 
Scheme 6: Synthesis of 2-(diphenylthiophosphino)benzaldehyde 40. 
Thio-ferrochalcone ligand 33 was obtained by the reaction of acetylferrocene 35 with 40 
(Scheme 7).  
33 71% yield
EtOH : H2O
4035
NaOH
20° C, 18 h
 
Scheme 7: Synthesis of target ligand thio-ferrochalcone 33. 
The target ligand thio-variant of ferrochalcone 33 could be synthesized by direct 
treatment of 32 with sulphur flowers (S8). Overnight stirring at room temperature in 
THF gave the target ligand 33 in 83% yield (Scheme 8). 
33
S8 , THF
83% yield
32
overnight
 
 
Scheme 8: Synthesis of target ligand thio-ferrochalcone 33. 
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The IR spectrum of compound 33 exhibits a band at 1643 cm-1 which is assigned to ʋ 
(C=O), whereas the band at 1577 cm-1 corresponds to ʋ (C=C). In the mass spectrum we 
observe a peak at m/z 533.4247 which corresponds to the molecular ion peak 
(C31H26FePSO [MH]+) confirming the synthesis of target ligand 33. The 31P NMR 
spectrum of 33 in CD2Cl2 gave a single peak at δ 42.05 (confirming the formation and 
presence of single product). 
 
The 1H NMR spectrum of 33 in CD2Cl2 shows a signal at δ 8.25 which corresponds to 
β-H. The signal at δ 6.83 corresponds to α-H. All the proton signals in the range ca. δ 4-
5 ppm correspond to that of ferrocene, and those between ca. δ 7-8 ppm represent the 
phenyl protons (Figure 4). 
 
Figure 4: The 1H NMR spectrum for ligand 33 in CD2Cl2. 
 
Alternative ferrocene chalcone derivatives 41 could be synthesised which possess 
different phosphorus R-groups (Figure 5). Such compounds can be effectively used as 
useful precursors for the synthesis of new metallocene derivatives.127  
Where R= Cy, t-Bu, Adamantyl
41Fe
O PR2
 
 
Figure 5: Representative structure for different ferrocene chalcone derivatives. 
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A key intermediate that could potentially be involved in the synthesis of these chalcone 
ferrocene derivatives is β-(2'-bromophenyl)acryl ferrocene 42 (Figure 6). 
42
 
Figure 6: Structure of β-(2'-bromophenyl)aryl ferrocene 42. 
 
β-(2'-Bromophenyl)aryl ferrocene 42  can be prepared by a base-catalysed Claisen-
Schmidt condensation reaction of acetylferrocene 35 with bromobenzaldehyde 36 at 
ambient temperature overnight (Scheme 9). 
   
82% yield42
3635
EtOH : H2O
   (1:1, v/v)
NaOH
20° C, 18 h
 
 
Scheme 9: Synthesis of β-(2`-bromophenyl)aryl ferrocene, 42. 
By the time we were working on the synthesis of these chalcone-ferrocene ligands Lei 
and co-workers published the synthesis of a similar ligand having a chalcone backbone 
with two phenyl rings as shown below 17 (as detailed in the introduction section) 
(Figure 7). 
       17  
Figure 7: Structure of the Lei ligand, 17. 
 
 
The Lei ligand was synthesised by a two-step Wittig reaction. The first step involves the 
formation of the phosphorus ylide 43 by reaction of α-bromoacetophenone with 
triphenylphosphine. Whereas, in the second step the phosphorus ylide 43 reacts with 
39 giving the target ligand 17, as given in Scheme 10. 
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68% yield
76% yield
43
39 1743
PPh3
Toluene
reflux 72 hr
Toluene
Over night stirring
 
 
Scheme 10: Synthesis of Lei ligand, 17. 
The 31P NMR spectrum of 17 gave a single peak at δ -13.32 confirming the synthesis of 
the target ligand. MS analysis showed a molecular ion peak at [MH]+ 393.1405, 
corresponding to C27H22OP. We struggled in the beginning to reproduce the results by 
Lei (usually poor yields and side products were formed). An additional product – the 
phosphine oxide 44, was formed along with the target compound 17 (Figure 9).  
However, the reaction conditions were improved by carefully repeating the reaction 
under inert conditions, especially running column chromatography on silica gel under a 
nitrogen atmosphere. The Lei ligand was found to be air sensitive, with phosphine oxide 
contaminating the product in the solution-form. Another, side -product obtained was the 
reduced phosphine oxide-Lei ligand 45 as given in Figure 9. 
4544
 
Figure 9: Side-products formed in the synthesis of the Lei ligand 17. 
 
We also wished to prepare a novel thio-variant of the Lei ligand, 46. A two-step 
reaction was used. The first step involves the formation of a phosphorus ylide obtained 
by reacting triphenylphosphine with α-bromoacetophenone to give 43. A solution of α-
bromoacetophenone in toluene was added dropwise to a solution of triphenylphosphine 
in toluene. The reaction mixture was stirred overnight at room temperature. Work-up 
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gave the target product 43 in 68% yield, which was used in crude form.  In the final step 
the Wittig reaction of 40 with ylide 43 gave the product 46 in a good yield of 65%, 
following column chromatography on silica gel (Scheme 11). 
68% yield
65% yield
43
43
46
40
PPh3
Toluene
reflux 72 hr
Toluene
Over night stirring
 
Scheme 11: Synthesis of the thio-Lei ligand, 46. 
 
The 31P NMR spectrum for 46 in CD2Cl2 gave a single peak at δ 42.1 confirming the 
formation and purity of product. In the 1H NMR spectrum the signal at δ 8.23 
corresponds to β-H, and that at δ 7.08 corresponds to α-H. All the peaks in the range of 
ca. δ 7-8 ppm correspond to the phenyl protons. 
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2.3 Structure of the ligands 
 
    2.3.1 β-[2'-(diphenylphosphino)phenyl]acrylferrocene 32.  
 
Very fine red crystals of ferrochalcone ligand 32 were grown from dichloromethane and 
ether (2:3, v/v). The crystals were kept in solution and analysed by X-ray diffraction 
methods (XRD) to obtain a single crystal solid-state structure (Figure 10). 
 
 
Figure 10: X-ray crystal structure of ligand 32. 
 
Solvent and hydrogen atoms are removed for clarity. Thermal ellipsoids shown at 50%. Bond 
lengths (Ǻ):C(6)-C(7) = 1.466(3), C(7)-C(8) = 1.330(3), C(8)-C(9) = 1.487(3), C(9)-C(10) = 
1.472(3), C(9)-O(1) = 1.228(3), P(1)-O(2) = 1.387(8), P(1)-C(1) = 1.832(2), P(1)-
C(20) = 1.833(2), P(1)-C(26) = 1.828(2), Bond Angles (º):C(6)-C(7)-C(8) = 126.0(2), C(7)-
C(8)-C(9) = 120.2(2), C(8)-C(9)-C(10) = 117.12(19), O(1)-C(9)-C(10) = 121.3(2), O(1)-C(9)-
C(8) = 121.55(19), O(2)-P(1)-C(1) = 123.1(3), O(2)-P(1)-C(20) = 109.5(3), O(2)-P(1)-C(26) 
= 112.5(3), C(1)-P(1)-C(20) = 102.10(9), C(26)-P(1)-C(20) = 104.93(10), C(26)-P(1)-
C(1) = 102.79(10). 
 
 
X-ray diffraction studies showed crystal twinning and further analysis revealed these to 
be a combination of both 32 and 47 (Figure 11; phosphine oxide not shown), in a ratio 
of ca. 80: 20. The unsubstituted cyclopentadienyl ring (Cp) proved to be disordered, and 
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was thus subsequently modelled over two positions both having equal occupancy. The 
disordered Cp rings were constrained as regular pentagons.   
 
The ligand 32 was found to be sensitive to light and air in solution. The formation of the 
phosphine oxide of 32 was noted by 31P NMR spectroscopic analysis with a resonance δ 
29.74 ppm. 
47
 
Figure 11: Structure of 47. 
 
Various attempts to crystallise 32 without contamination by the phosphine oxide were 
unsuccessful. It was observed that the ligand itself is more sensitive in solution form 
than any metal complexes derived from it (see later). The C(7)-C(8) alkene double bond 
length is 1.330 Å, as expected for an alkene bond (1.334 Å for ethene).128 However, the 
C-C bond length for C(6)-C(7) is 1.466 Ǻ  andC(8)-C(9) 1.487 Ǻ higher than that for a 
free C=C bond, showing a single bond character for these bonds. The torsion angle for 
C7-C8-C9-O1 is 6.2º, exhibiting a synperiplanar conformation (cis-conformation) 
whereas the torsion angle for O1-C9-C10-C11 is -169.4º, exhibiting an antiperiplanar 
conformation (trans-conformation). The torsion angle values for O2-P1-C1-C6, O2-P1-
C26-C27 and O2-P1-C20-C21 are 17.1º, 38.3º and 71.1º, showing that the first set of 
atoms exhibit a synperiplanar conformation, whereas the other two sets of atoms exhibit 
a synclinal conformation (e.g. gauche or skew conformation). 
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 2.3.2 Thio-Lei ligand (C27H21OPS) 
 
The thio-Lei ligand, 46 was obtained as light yellow powder, which was found to be 
soluble in most organic solvents, e.g. dichloromethane, ethyl acetate and benzene. The 
product was crystallised from dichloromethane. Fine yellow crystals were obtained and 
analysed by X-ray diffraction (Figure 12). The C=C bond length for C(8)-C(9) is 1.332 
Ǻ whereas the bond length for C(7)-C(8) is 1.488 Ǻ, and for C(9)-C(10) 1.477 Ǻ. This 
indicates a double bond order for C(8)-C(9) and a single bond order for the other two 
bonds. The bond length for C(8)-C(9) is similar to an alkene double bond of 1.333 Ǻ.  
The bond length P(1)-S(1) is 1.956 Ǻ. The torsion angle value for O1-C7-C6-C1 is -
159.8º and for O1-C7-C8-C9 is 17.1º, showing that O1-C7-C6-C1 exhibits an 
antiperiplanar conformation, whereas O1-C7-C8-C9 exhibits a synperiplanar 
conformation. The torsion angle for S1-P1-C15-C10 is 62.66º (e.g. synclinal 
conformation), and for S1-P1-C22-C23 -125.69º (e.g. in an anticlinal conformation) and 
for S1-P1-C16-C17 is -147.85º (e.g. in an anticlinal conformation). 
 
 
Figure 12: X-ray crystal structure of thio-Lei ligand 46. 
Solvent and hydrogen atoms are removed for clarity. Thermal ellipsoids shown at 50%. Bond 
lengths (Ǻ): C(6)-C(7) = 1.497(3), C(7)-C(8) = 1.488(3), C(8)-C(9) = 1.332(3), C(9)-C(10) = 
1.477(3), C7-O1 = 1.222(3), P(1)-S(1) = 1.956(7), P(1)-C(15) = 1.821(2), P(1)-C(22) = 
1.816(2), P(1)-C(16) = 1.811(2), Bond Angles (º): C(8)-C(7)-C(6) = 117.20(18), C(9)-C(8)-C(7) 
= 122.42(19), C(10)-C(9)-C(8) = 124.15(19), C(11)-C(10)-C(9 )= 119.93(19), C(9)-C(10)-
C(15) = 121.95(18), S(1)-P(1)-C(15) = 113.45(7), S(1)-P(1)-C(22) = 110.60(7), S(1)-P(1)-C(16) 
= 115.27(7), C(15)-P(1)-C(22) = 107.77(9), C(15)-P(1)-C(16) = 103.71(9), C(16)-P(1)-C(22) = 
105.38(10). 
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A comparison of key bond lengths and torsion angles for ligands 32 and 46 are given in 
Table 1. 
 
Table 1: Comparison of the bond length and torsion angle between compound 46 and 47. 
Bonds 32 46 
C=O 1.228(3) 1.222(3) 
C=C 1.330(3) 1.332(3) 
C-C C(6)-C(7) = 1.466(3), 
 C(9)-C(10) = 1.477(3) 
C(7)-C(8) = 1.488(3),  
C(9)-C(10) = 1.477(3) 
P=O 1.387(8) -- 
P=S -- 1.956(7) 
Torsion angle (º) (º) 
C10-C9-C8-C7 -174.86 -179.2 
C9-C8-C7-C6 -178.95 -163.6 
 
 
2.4 Summary 
 
The target ligands ferrochalcone 32 and thio-ferrochalcone 33 have been synthesised in 
good yields by a Claisen-Schmidt condensation reaction. The thio-Lei ligand 46 has 
also been synthesized successfully. Side-products were noted in the synthesis of Lei 
ligand 17, which were not originally reported by Lei and co-workers. The XRD analysis 
of ferrochalcone 32 confirmed its structure, which was supported by the full 
spectroscopic analysis. The phosphorus ligand 32 is air sensitive and hence the structure 
obtained was a mixture with the corresponding phosphine oxide. With ligands (17, 32, 
33 and 46) in hand, it is now possible to assess the coordination chemistry of these 
ligands towards a variety of metals, e.g. Cu, Pt, Pd, Rh, Au etc. (see Chapter 3). 
 
2.5 Experimental 
 
2.5.1 General Information 
 
1H-NMR spectra were obtained in the solvent indicated using a JEOL EXC400 or JEOL 
ECS400 spectrometer (400MHz for 1H, 100 MHz for 13C and 162 MHz for 31P). 
Chemical shifts were referenced to the residual undeuterated solvent of the deuterated 
solvent used (CHCl3 δ = 7.26 and 77.16 and DCM δ = 5.31 and 53.80 for 1H and 13C 
NMR spectra, respectively). NMR spectra were processed using MestrNova software. 
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All 13C NMR spectra were obtained with 1H decoupling.  31P NMR spectra were 
externally referenced to H3PO4, and obtained with 1H decoupling.  For 13C NMR spectra 
the coupling constants are quoted to ±1 Hz.  For the 1H NMR spectra the resolution 
varies from ±0.15 to ±0.5 Hz; the coupling constants have been quoted to ±0.5 Hz in all 
cases for consistency.   
 
Melting points were recorded using a Stuart digital SMP3 machine. IR spectroscopy 
was undertaken using a Jasco/MIRacle FT/IR-4100typeA spectrometer with an ATR 
attachment on solid and liquid compounds; solution and KBr IR spectra were obtained 
on a Nicolet Avatar 370 FT-IR spectrometer.  The relative intensities of the peaks are 
denoted by (s) = strong, (m) = medium and (w) = weak, whilst (br) is used to describe 
broad peaks. MS spectra were measured using a Bruker Daltronics micrOTOF MS, 
Agilent series 1200LC with electrospray ionisation (ESI and APCI) or on a Thermo 
LCQ using electrospray ionisation, with <5 ppm error recorded for all HRMS samples. 
Mass spectral data is quoted as the m/z ratio along with the relative peak height in 
brackets (base peak = 100). Dry and degassed toluene, ether, DCM and hexane were 
obtained from a solvent system. Nitrogen gas was oxygen-free and was dried 
immediately prior to use by passage through a column containing sodium hydroxide 
pellets and silica gel. THF and benzene were dried over sodium-benzophenone ketyl 
and ethanol was dried and distilled from magnesium-iodine. Commercial chemicals 
were purchased from Sigma-Aldrich or Alfa Aesar. Elemental analysis was carried out 
on an Exeter Analytical CE-440 Elemental Analyser. All column chromatography was 
run on silica gel 60 using the solvent systems specified in the text.  The fraction of 
petroleum ether used was that boiling at 40-60 °C.   
 
Dry and degassed toluene, CH2Cl2 and hexane were obtained from a ‘Pure Solv’ MD-7 
solvent purification system.  THF and Et2O were either obtained from a ‘Pure Solv’ 
MD-7 solvent purification system and degassed by the freeze-pump-thaw method or 
purged with N2 under sonication, or dried over sodium-benzophenone ketyl and 
collected by distillation.  Benzene was dried over sodium-benzophenone ketyl, EtOH 
was dried and distilled from magnesium-iodine, and triethylamine was dried over KOH.  
All air sensitive procedures were carried out using Schlenk techniques.129  Nitrogen gas 
was oxygen-free and was dried immediately prior to use by passage through a column 
containing sodium hydroxide pellets and silica.  Room temperature is quoted as the 
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broadest range 13-25°C, but it was typically 18-20 °C.  Commercial chemicals were 
purchased from Sigma-Aldrich and Alfa Aesar and used directly unless stated in the 
text.  Brine refers to a saturated aqueous solution of NaCl.   
 
β-[2'-(Diphenylphosphino)phenyl]acrylferrocene (32) 
Acetyl ferrocene (0.51 g, 0.002 mol) was dissolved in ethanol (2 mL) and a solution of 
2-(diphenylphosphine)benzaldehyde 39 (0.43 g, 0.002 mol) in ethanol (1 mL) was 
added to above mixture with stirring. After that stirring was continued for 0.5 h a 
solution of ethanol (2 mL), H2O (2 mL) and NaOH (0.18 g) was added dropwise under 
stirring at room temperature. A red precipitate appeared after some time, which became 
difficult to stir. After two hours TLC analysis indicated completion of the reaction. The 
mixture was poured into H2O (25 mL) and neutralized to pH=7 with 2M HCl, cooled 
using ice, and then filtered. The solid was washed with water (10 × 3) and dried in 
vacuo. The crude product was recrystallized from chloroform to afford the final product 
as a light red crystalline solid (0.94 g, 84%). Mp 147-151 °C, Rf = 0.35 
(EtOAc:Pet.ether); 1H-NMR (400 MHz, CDCl3) δ 8.43 (dd, J = 15.8, 3.7 Hz, 1H), 7.85-
7.60 (m, 1H), 7.40 (d, J = 3.8 Hz, 2H), 7.46-7.28 (m, 10H), 7.01-6.91 (m, 1H), 6.87 (d, 
J = 15.5 Hz, 1H), 4.75 (s, 2H), 4.51 (s, 2H), 4.06 (s, 5H); 13C-NMR (100 MHz, CDCl3) 
δ 193.1, 140.5 (d, J = 22 Hz, 2C), 139.4 (d, J = 23 Hz, 2C), 138.3 (d, J = 11 Hz, 2C), 
138.2, 136.1 (d, J = 10 Hz, 2C), 134.1 (d, J = 20 Hz, 2C), 133.8, 129.1 (d, J = 9 Hz, 
2C), 128.7 (d, J = 7 Hz, 2C), 127.3 (d, J = 4 Hz, 2C), 126.3 (d, J = 4 Hz, 2C), 80.2, 72.7 
(2C), 70.2 (2C), 69.9 (5C); 31P-NMR (162 MHz, CDCl3) δ -13.0 (s, 1P);  HRMS 
[MNa]+: 523.3310 (Calcd. for C31H25FePONa  523.3410); IR υ cm-1  3052 (s), 1653 (s), 
1584 (s), 1457 (s), 1377 (s), 1199 (s), 1081 (s), 759 (s), 696 (s), 501 (s). 
 
Acetylferrocene (35) 
Ferrocene (0.093 g, 5 mmol) was added to a stirred suspension of acetyl chloride (0.40 
g, 5.1 mmol) and aluminium chloride (0.68 g, 5.1 mmol) in dichloromethane. The 
resulting mixture was stirred overnight at room temperature and then washed with water 
(25mL). The organic layer was passed through a plug of alumina which was then 
washed with chloroform (3 × 10 mL) until washing become colourless. It was then 
finally concentrated in vacuo to give the crude product, which was purified by column 
chromatography on silica gel to give the title compound as deep red crystals (0.96 g, 
84%). Mp 78-81 °C (lit. 81-86 °C)130; 1H-NMR (400 MHz, CDCl3) δ4.77 (t, J = 4 Hz, 
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2H), 4.50 (t, J = 4 Hz, 2H), 4.21 (s, 5H), 2.40 (s, 3H); 13C-NMR (100 MHz, CDCl3) δ 
202.2, 79.2, 72.5, 69.8, 68.1, 27.3; LRMS (EI) m/z 251(M+Na, 100), 229 (50), 186 (4), 
158 (2), 142 (5), 110 (3).; HRMS (ESI) m/z (MNa+): 251.013 (Calcd. for C12H12FeO  
251); IR υ cm-1  3096 (m), 1661 (s), 1653 (s), 1457 (s), 1375 (s), 1280 (s), 1103 (s), 
1005 (s), 827 (s). 
 
2-(o-Bromophenyl)-1,3-dioxolane (37) 
2-Bromobenzaldehyde (15.0 g, 0.08 mol), ethylene glycol (6.7 mL, 0.12 mol) and para-
toluenesulfonic acid (63 mg) were dissolved in toluene (100 ml) and refluxed, while the 
evolved water was collected in a Dean-Stark trap. After water was no longer evolved 
(ca. 24 h) the solution was allowed to cool to rt and washed with a saturated solution of 
NaHCO3 (60 mL), followed by a saturated solution of NaCl (20 mL).  The solution was 
dried over MgSO4, filtered, concentrated in vacuo and distilled at 100 °C, 0.5 mmHg, to 
give the title compound as a colourless oil (16.33 g, 89%). 1H NMR  (400 MHz, CDCl3) 
δ 7.59 (ddd, J = 15, 8, 1.5 Hz, 1H), 7.37-7.32 (m, 1H), 7.28-7.24 (m, 1H), 7.18 (dd, J = 
7.5, 3 Hz, 1H), 6.11 (s, 1H), 4.23-4.04 (m, 4H). 13C NMR  (100 MHz, CDCl3) δ 136.7, 
133.1, 130.7, 127.9, 127.5, 123.1, 102.6, 65.6. HRMS (ESI) m/z 228.9859 [MH]+ 
(calculated for C9H10BrO2 = 228.99); IR ν cm-1 2955 (w, br), 2886 (m, br), 1730 (w), 
1592 (w), 1571 (w), 1472 (w), 1443 (w), 1387 (m), 1270 (w), 1211 (m), 1124 (m), 1084 
(s, br), 1042 (m), 1021 (m), 969 (m), 941 (m), 754 (s). 
 
 
2-(o-Diphenylphosphinophenyl)-1,3-dioxolane (38) 
A solution of 2-(o-bromophenyl)-1,3-dioxolane (20.95 g, 91 mmol) in dry THF (200 
mL) was cooled to -78 °C and kept under an inert atmosphere of N2. n-BuLi in hexane 
(40 mL, 93 mmol, 1.3 eq.) was added by syringe pump at a rate of 40 cc/h.  The 
reaction was allowed to warm-up to 24 °C overnight, before the addition of water (240 
mL). The organic phase was extracted with Et2O (3 × 50 mL), dried over anhydrous 
Na2SO4, filtered and the solvent removed in vacuo. The resulting oily liquid was 
purified by crystallisation from hot ethanol and cooled to -25 °C, to afford the title 
compound as a waxy white solid (21.24 g, 70%). Mp 94-95 ºC; 1H NMR  (400 MHz, 
CDCl3) δ 7.74-7.65 (m, 1H), 7.41-7.35 (m, 1H), 7.32 (dd, J = 4.5, 2.0 Hz, 6H), 7.30-
7.23 (m, 5H), 6.95 (ddd, J = 8, 4.5, 1.2 Hz, 1H), 6.43 (d, J = 5.0 Hz, 1H), 4.13-4.19 (m, 
4H); 13C NMR (100MHz, CDCl3) δ 142.1 (d, J = 22 Hz), 137.1 (d, J = 10 Hz), 136.1 (d, 
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J = 19 Hz), 134.2 (d, J = 2 Hz), 134.1, 133.8, 129.4 (d, J = 18 Hz), 128.7, 128.6 (d, J = 
7 Hz), 126.6 (d, J = 6 Hz), 101.8, 65.5; 31P NMR (162 MHz, CDCl3) δ -15.86 (s); 
LRMS (ESI) m/z 291.1 [M-C2H4O]+ (100), 273.1 (26), 261.1 (3), 242.1 (5), 213.0 (8).  
 
2-(Diphenylphosphino)benzaldehyde (39) 
2-(o-Diphenylphosphinophenyl)-1,3-dioxolane (21.24 g, 64 mmol) and para-
toluenesulfonic acid (0.45 g) were dissolved in acetone (450 mL) and refluxed for 8 h.  
Whilst still warm, water (100 mL) was added and the volume reduced to ~125 mL by 
solvent evaporation. The resulting mixture was cooled to -25 °C overnight (freezer), and 
the precipitate filtered and dried in vacuo to afford the title compound as a bright yellow 
powder (15.88 g, 85%). Mp 114-117 °C; 1H NMR (400 MHz, CDCl3) δ 10.50 (d, J = 
5.5 Hz, 1H), 7.97 (dd, J = 10, 2.7 Hz, 1H), 7.57-7.42 (m, 2H), 7.39-7.32 (m, 10H), 7.00-
6.92 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 191.9 (d, J = 19 Hz), 141.4, 136.2 (d, J = 
9 Hz), 134.3, 134.1, 134.1, 133.8, 130.9 (d, J = 4 Hz), 129.3, 129.1, 128.9 (d, J = 7 Hz); 
31P NMR (162 MHz, CDCl3) δ -11.00 (s); HRMS (ESI) m/z [MH]+ 291.0944, 
(calculated for C19H16OP: 291.1016); IR ν cm-1 3057 (w, br), 2851 (w), 1696 (m), 1672 
(m), 1583 (w), 1432 (m), 1198 (m), 843 (m), 751 (s), 744 (s), 696 (s), 670 (s).  
 
 
2-(Diphenylthiophosphino)benzaldehyde (40) 
2-(Diphenylphosphino)benzaldehyde (1.48 g, 5 mmol) and S8 (1.31 g, 5 mmol) were 
stirred together in THF overnight. The resulting mixture was centrifuged (3000 rpm, 3 
min) to remove the solid sulfur, and the solvent removed in vacuo.  Purification by 
column chromatography on silica gel eluting with petroleum ether to remove the 
remaining sulfur, and then diethyl ether: pentane (1:4 to 3:7), afforded the title 
compound as a cream powder (1.31 g, 81%). Mp 136-137 °C; 1H NMR (400 MHz, 
CDCl3) δ 10.71 (s, 1H), 8.11 (ddd, J = 7.7, 4.0, 1.5 Hz, 1H), 7.84-7.78 (m, 4H), 7.65-
7.61 (m, 1H), 7.60-7.44 (m, 7H), 7.03 (ddd, J = 14.6, 7.5, 1.0 Hz, 1H); 13C NMR (400 
MHz, CDCl3) δ 190.3 (d, J = 8 Hz), 138.0 (d, J = 7 Hz), 137.9 (d, J = 79 Hz), 132.8 (d, 
J = 12 Hz), 132.7 (d, J = 10 Hz), 132.5 (d, J = 11 Hz), 132.3 (d, J = 3 Hz), 132.1 (d, J = 
3 Hz), 132.1 (d, J = 85 Hz), 129.9 (d, J = 9 Hz), 129.1 (d, J = 13 Hz); 31P NMR (162 
MHz, CDCl3) δ 40.75 (s); HRMS (ESI) m/z [MNa]+ 345.0478 (calculated for 
C19H15NaOPS: 345.0473); IR ν cm-1 1685 (s), 1580 (w), 1435 (m), 1199 (m), 1099 (s), 
822 (w), 749 (m), 711 (s), 691 (s), 640 (s), 633 (s), 613 (m). 
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β-[2'-(Diphenylthiophosphino)phenyl]acrylferrocene (33) 
Acetyl ferrocene 35 (0.51 g, 0.002 mol) was dissolved in ethanol (2 mL) and a solution 
of 2-(diphenylthiophosphino)benzaldehyde 40 (0.43 g, 0.002 mol) in ethanol (1 mL) 
was added to the above mixture with stirring. After stirring for 0.5 h (until solid was 
dissolved) a solution of ethanol (2 mL), H2O (2 mL) and NaOH (0.18 g) was added 
dropwise stirring at room temperature. A reddish precipitate appeared after some time 
which became difficult to stir. After two hours TLC analysis indicated the completion 
of the reaction. The mixture was poured into H2O (25 mL) and neutralized to pH=7 with 
2M HCl, cooled using ice, and then filtered. The solid was washed with water (3 × 10 
mL) and dried in vacuo. The crude product was recrystallized from chloroform to afford 
the final product as a light red crystalline solid (0.85g, 71%). Mp 163-165 °C; 1H-NMR 
(400 MHz, CD2Cl2) δ 8.25 (d, J=15.5 Hz, 1H), 7.94-7.75 (m, 5H), 7.61 (d, J = 7.5 Hz, 
1H), 7.54 (dd, J=7.0, 2.0 Hz, 2H), 7.50 (dd, J=7.5, 3.0 Hz, 3H), 7.48-7.47 (m, 1H), 7.35 
(t, J=8.0 Hz, 1H), 7.14 (ddd, J=14.7, 7.8, 1.0 Hz, 1H), 6.83 (d, J = 15.5 Hz, 1H), 4.78-
4.73 (m, 2H), 4.56-4.51 (m, 2H), 4.12 (m, 5H); 13C-NMR (100 MHz, CD2Cl2) δ 192.1, 
139.9 (2C), 133.7 (2C), 132.9 (2C), 132.4 (2C), 132.3 (2C), 129.3 (2C), 129.2 (2C), 
129.1 (2C), 126.2 (2C), 80.8, 73.2 (2C), 70.5 (2C), 70.1 (5C); 31P NMR (162 MHz, 
CD2Cl2) δ 42.05 (s); HRMS [MH]+: 533.4247  (Calcd. for (C31H26FePSO)  533.4167); 
IR υ cm-1  3089 (s), 1699 (s), 1643 (s), 1577 (s), 1448 (s), 1375 (s), 1244 (s), 1081 (s), 
1001 (s), 976 (s), 821 (s), 743 (s). 
 
 
2-Phenyl(triphenylphosphoranylidene)ethan-2-one (43) 
A solution of α-bromoacetophenone (2.0 g, 1 eq., 10 mmol) in toluene (8 mL) was 
added dropwise to a solution of triphenylphosphine (2.63 g, 1 eq., 10 mmol) in toluene 
(8 mL) under a N2 atmosphere. The mixture was stirred overnight and the resulting 
phosphonium salt was suspended in a mixture of water (100 mL) and methanol (100 
mL). After stirring for 1 h, aqueous NaOH (1 M) was added dropwise until pH 7 was 
reached. The mixture was then stirred vigorously for 1 h. The white phosphorane was 
filtered, washed with water (15 × 3) and dried in vacuo. Purification by recrystallisation 
from ethyl acetate afforded the title compound as an off-white solid (2.36 g, 68%). Mp 
185-186 °C; 1H NMR (400 MHz, CDCl3) δ 7.99-7.92 (m, 2H), 7.75-7.65 (m, 6H), 7.57-
7.50 (m, 3H), 7.50-7.44 (m, 6H), 7.36-7.30 (m, 3H), 4.46 (d, J = 24.5 Hz, 1H). 13C 
NMR (400 MHz, CDCl3)  δ 185.0 (d, J = 3 Hz), 141.3 (d, J = 15 Hz), 133.2 (d, J = 10 
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Hz), 132.1 (d, J = 3 Hz), 129.4, 129.0 (d, J = 12 Hz), 127.5, 127.2 (d, J = 91 Hz), 127.1, 
51.1 (d, J = 112 Hz); 31P NMR (162 MHz, CDCl3) δ 17.80 (s). HRMS (ESI) m/z [MH]+ 
381.1403 (calculated for C26H22OP: 381.1403). IR ν cm-1 1586 (m), 1511 (s), 1482 (m), 
1435 (s), 1385 (s), 1104 (s), 871 (m), 747 (m), 707 (s), 688 (s). 
 
Lei Ligand (17) 
2-(Diphenylphosphino)benzaldehyde (0.49 g, 1 eq., 1.55 mmol) and 2-
phenyl(triphenylphosphoranylidene)ethan-2-one (1.17 g, 3.1 mmol) were added to an 
oven-dried Schlenk flask charged with degassed toluene (10 mL) under a N2 
atmosphere.  The resulting mixture was heated to reflux for 24 h.  After the toluene was 
removed in vacuo, purification by column chromatography on silica gel eluting with 
ethyl acetate: petroleum ether (7:93) afforded the title compound as a cream solid (0.85 
g, 76%). Mp 91-94 °C (no reported Mp) 131; 1H NMR  (400 MHz, CDCl3) δ 8.35 (dd, J 
= 15.8, 4.5 Hz, 1H), 7.75-7.71 (m, 3H), 7.55-7.51 (m, 1H), 7.42-7.25 (m, 14H), 7.18 
(dd, J = 15.8, 1.0 Hz, 1H), 6.93 (ddd, J = 7.7, 4.5, 1.0 Hz, 1H). 13C NMR (100 MHz, 
CDCl3) δ 192.1, 143.7 (d, J = 25 Hz), 139.8 (d, J = 22 Hz), 138.5 (d, J = 16 Hz), 138.0, 
136.0 (d, J = 10 Hz), 134.2 (d, J = 20 Hz), 133.8, 132.6, 130.1, 129.3, 129.1, 128.8, 
128.7, 128. 7 (d, J = 24 Hz), 127.1 (d, J = 4 Hz), 125.7 (d, J = 4 Hz). 31P NMR  (162 
MHz, CDCl3) δ -13.32 (s); HRMS (ESI) m/z [MH]+ 393.1405 (calculated for C27H22OP: 
393.1403); IR ν cm-1 1667 (s), 1605 (s), 1432 (s), 1309 (m), 1214 (m), 1011 (m), 744 
(s), 694 (s). The 31P NMR peak for the (side product): δ 31.07 (s). 
 
Thio-Lei Ligand (46) 
2-(Diphenylthiophosphino)benzaldehyde (0.49 g, 1.55 mmol) and 2-
phenyl(triphenylphosphoranylidene)ethan-2-one (1.17 g,  3.11 mmol) were added to an 
oven-dried Schlenk flask charged with degassed toluene (10 mL) under a N2 
atmosphere.  The resulting mixture was heated to reflux for 24 h.  After the toluene was 
removed in vacuo, purification by column chromatography on silica gel eluting with 
ethyl acetate: petroleum ether (7:93) afforded the title compound as a cream solid (0.85 
g, 64.5%). Mp 110-113 °C (novel so no mp); 1H NMR  (400 MHz, CDCl3) δ 8.23 (d, J 
= 15.5, 1H), 7.82 (m, 1H), 7.78 (m, 2H), 7.73 (m, 2H), 7.68 (m, 2H), 7.53 (m, 1H), 7.47 
(m, 3H), 7.40 (m, 6H), 7.35(m, 1H), 7.15 (m, 1H), 7.08 (d, J = 14.4 Hz, 1H). 13C NMR 
(100 MHz, CDCl3) δ 191.9, 143.7 (d, J = 25 Hz), 138.9 (d, J = 22 Hz), 137.4 (d, J = 16 
Hz), 134.0, 133.2 (d, J = 10 Hz), 132.4 (d, J = 20 Hz), 132.3, 132.1, 131.8, 131.7, 129.3, 
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128.6, 128.6, 128. 4 (d, J = 24 Hz), 128.2 (d, J = 4 Hz), 126.2 (d, J = 3 Hz); 31P NMR  
(162 MHz, CDCl3) δ 42.1 (s, 1P); HRMS (ESI) m/z [MH]+ 425.1134 (calculated for 
C27H22OPS: 425.1123); IR ν cm-1 3052 (s), 2286 (s), 1664 (s), 1609 (s), 1595 (s), 1579 
(s), 1558 (s), 1459 (s), 1446 (s), 1435 (s), 1332 (s), 1311 (s), 1284 (s), 1217 (s), 1178 
(s), 1106 (s), 1014 (s), 997 (s), 984 (s), 734 (s), 634 (s). 
 
β-(2-Bromophenyl)acrylferrocene (42) 
Acetyl ferrocene (0.47 g, 0.002 mol) was dissolved in 95 % ethanol (1.81 mL) and a 
solution of o-bromobezaldehyde (0.43 g, 0.002 mol) in 95% ethanol (0.5 mL) was 
added to the above mixture with stirring, which was continued for 0.5 h until all the 
solid had dissolved. A solution of ethanol (2mL), H2O (2 mL) and NaOH (0.1 g) was 
added dropwise to the above mixture under stirring at room temperature. A reddish 
precipitate was formed, and after two hours TLC analysis indicated the completion of 
the reaction. The mixture was poured into water (10 mL) and neutralized to pH=7 with 
2 M HCl, then cooled and filtered. The solid precipitate was washed with water (10 × 3) 
and dried in vacuo. The crude product was recrystallised from chloroform as dark claret 
red-coloured crystals (0.67 g, 82%). Mp 118-121 °C; 1H-NMR (400 MHz, CDCl3) δ 
8.11 (d, J = 15.7 Hz, 1H), 7.68 (dd, J = 24.5, 8.0 Hz, 2H), 7.38 (t, J = 7.5 Hz, 1H), 7.19 
(s, 1H), 7.04 (d, J = 15.7 Hz, 1H), 4.91 (s,  2H), 4.60 (s, 2H), 4.24 (s, 5H). 13C-NMR 
(100 MHz, CDCl3) δ 193.1, 139.4, 135.4, 133.6, 131.0, 127.9, 127.7, 126.2, 125.8, 80.3, 
73.0 (2C), 70.2 (2C), 69.9 (5C); LRMS (EI) m/z: 394(M+H, 100), 396 (88), 392 (3), 
316 (15), 315 (70), 165 (46), 121 (16), 56 (14) ; HRMS (ESI) m/z [MH]+ 393.97 (Calcd. 
for C19H15BrFeO: 393.97) ; IR υ cm-1  3096 (m), 2360 (s), 1653 (s), 1596 (s), 1454 (s), 
1376 (s), 1077 (s), 1001 (s), 759 (s). 
 
2.5.2 X-Ray Diffraction Data 
 
Diffraction data for ferrochalcone (ijf0903) 32 was collected at 110 K on a Bruker 
Smart Apex diffractometer with Mo-Kα radiation (λ = 0.71073 Å) using a SMART 
CCD camera.  Diffractometer control, data collection and initial unit cell determination 
was performed using “SMART”.  Frame integration and unit-cell refinement was 
carried out with “SAINT+”. Absorption corrections were applied by SADABS.  
Structures were solved by “direct methods” using SHELXS-97 (Sheldrick, 1997)132 and 
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refined by full-matrix least squares using SHELXL-97 (Sheldrick, 1997).133  All non-
hydrogen atoms were refined anisotropically.   
 
Diffraction data for thio-Lei ligand (ijf0927) 46 was collected at 120 K on an Oxford 
Diffraction SuperNova diffractometer with Cu-Kα radiation (λ = 1.5418 Å) using an 
Enhance (Cu) X-ray source.  Structures were solved by “direct methods” using 
SHELXS-97 (Sheldrick, 1997)134 and refined by full-matrix least squares using 
SHELXL-97 (Sheldrick, 1997).135  All non-hydrogen atoms were refined 
anisotropically.   
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Table 1: Single Crystal X-Ray details for ferrochalcone ligand (32) and Thio-Lei 
ligand (46). 
 
Compound reference ijf0903 (32) ijf0927 (46) 
Formula C31H25FeO1.20P C27H21OPS 
Formula weight 503.51 424.47 
temp (K) 110(2) 120(2) K 
Radiation 0.71073 1.5418 
Cryst syst Monoclinic Monoclinic 
Space group Cc P 2(1)/n 
a(Å) 13.3506(15) 8.9290(2) 
b(Å) 22.153(3) 14.3223(2) 
c(Å) 10.0115(11) 17.0656(3) 
α(°) 90° 90 
β(°) 125.790(2) 100.6739(19) 
γ(°) 90° 90 
V (Å3) 2401.9(5) 2144.66(7) 
Z 4 4 
Dcalcd. (Mg M-3) 1.384 1.315 
F(000) 1046.4 888 
Μ(mm-1) 5.038 2.163 
Crystal size (mm3) 0.20 x 0.17 x 0.03 0.21 x 0.21 x 0.21 
θ  range for data 1.84 to 28.30 4.06 to 70.90 
Collection (°) 
Index ranges 
-17 <=h<=17, 
-29<=k<=29, 
-13<=I<=12 
-10<=h<=10, 
-17<=k<=17, 
-20<=l<=20 
 
No. of reflections collected 12146 19785 
Refinement method Full-matrix least-squares on 
F2 
Full-matrix least-squares on 
F2 
GOOF on F2 1.017 1.079 
R1, wR2(I>2σ(I)) 0.0324, 0.0733 0.0425, 0.1186 
R1, wR2(all data) 0.0389, 0.0766 0.0517, 0.1269 
 
Further details can be found in the Appendix, including the cif files on the CD. 
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Chapter 3: Late transition metal complexes of alkene-phosphine and thio alkene 
phosphine ligands 
 
 
Ferrochalcone 32 and thio-ferrochalcone 33 can be regarded as bidentate ligands. The 
ligand can bind through the alkene and phosphine moieties. In some cases coordination 
via the carbonyl group may also be possible. The potential coordination modes (a-d) of 
the ligands to metals are given in Figure 1.  
 
(c)(b) (d)(a)
M= Pt, Pd, Rh, Cu, Au
M
P
O O
P
M
P
M
O
MO
P
M
 
Figure 1: Potential coordination modes of phosphino-alkene ligands to metals. 
 
In our ligands, the phosphines would be expected to be the most strongly coordinating 
moiety to late transition metals (a).  The coordination of the alkenes (b) and/or the 
carbonyl (c) will depend on the oxidation state (e.g. Pt0/Pd0 are expected to be more 
likely to coordinate the alkene than PtII/PdII), the other ligands around the metal, the 
coordination number of the complex and the geometry of the ligand backbone as 
compared to the rest of the complex.  In Rh complexes alkenes generally coordinate as 
long as there are free coordination sites. For most known copper complexes only the 
phosphine is bound to the CuI centre, with the alkene left non-coordinated. However, 
recently a few complexes did show evidence for alkene coordination in CuI complexes 
e.g. dbathiophos.136    
  
As shown in the introduction chapter, phosphino-alkene ligands have been utilised in 
Pd, Pt, Cu and Rh-catalysed reactions137. In this chapter coordination chemistry studies 
involving Pd, Pt, Cu and Rh are described.  These allow one to obtain a greater 
understanding of the ligand environment created around the metal centre. 
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3.1 Synthesis and characterization of palladium and platinum complexes with 
alkene-phosphine ligands 
 
The ferrochalcone ligand 32 and Lei ligand138 17 have three possible coordination 
modes.139 In addition to the electronic nature of olefin, there are certain other factors 
which must be taken into account to understand the alkene-metal coordination. Several 
studies have examined the effect of variables such as metal oxidation state, number of 
d-electrons, and ligand properties on the strength of alkene binding to metal.140 It was 
anticipated that the platinum(II) and palladium(II) complexes will exhibit a square 
planar geometry.141 In the following sub-sections are detailed the coordination of both 
Pd and Pt to ligands 32 and 17. 
3.1.1 PdII complexes 
 
3.1.1.1 Ferrochalcone ligand (32) complexation 
 
[PdCl2(cod)] is a useful PdII precursor complex that can be used to form [PdCl2(L)2] 
complexes.142 Ferrochalcone ligand 32 on reaction with [PdCl2(cod)] resulted in the 
displacement of the labile cod ligand to give a palladium(II) complex which could be  
48a or 48b as a red solid. As with the free ligand the red colour is associated with the 
FeII centre (Scheme 1). 
X = Cl or solvent
48 (b)
rt, (1:1) (0.1 mol)
32
48 (a)
60% yield
[PdCl2(cod)]
CD2Cl2
 
Scheme 2: Synthesis of palladium(II) complex of 32 using [Pd(cod)Cl2]. 
The PdII complex was found to be highly unstable in solution (i.e. it undergoes 
oxidation) and is also light sensitive.  It was difficult to separate the cod ligand from 
complex 48. Repeated attempts to crystallize the complex were unsuccessful. The 31P 
NMR showed a single peak at δ 21.4 in the complexed ligand as compared to non-
coordinated ligand (δ -13.0). No evidence for alkene coordination was observed in the 
1H NMR spectrum. The υ (C=O) stretching frequency for complex  48 was almost 
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unchanged (1652 cm-1) as compared to that of the free ligand (1653 cm-1) hence it could 
be 48 (a). 
Another attempt to synthesise palladium(II) complexes of ferrochalcone ligand 32 was 
carried out using an alternative precursor, namely [PdCl2(MeCN)2]. Ligand 32 was 
reacted with [PdCl2(MeCN)2] in a ligand metal: ratio of 1:1  and 2:1 giving an insoluble 
reddish material 48. The PdII complex crashed out of solution almost instantaneously 
(Scheme 2). 
X = Cl or solvent
48 (b)
48 (c)
rt, (1:1) (0.1 mol)
32
48 (a)
54% yield
CD2Cl2
[Pd(MeCN)2Cl2]
 
Scheme 2: Synthesis of the palladium(II) complex of 32 using [Pd(MeCN)2Cl2]. 
The Pd complex was insoluble in common organic solvents (slightly soluble in 
dichloromethane).  Because of the solubility problem it was difficult to characterize the 
product. A weak 31P NMR spectrum was obtained in both cases, in the 1:1 case a single 
peak at  δ 21.7 was observed which has shifted from δ -13.0 in uncoordinated ligand 
whereas in the 2:1 complex two peaks were observed with a chemical shift value of δ 
21.7 and δ 53.98 indicating two complexes in solution. A similar reaction on 
MonodbaPHOS conducted using [PdCl2(MeCN)2] gave a Pd complex with a structure 
of 48c.143 The 31P NMR for the complex exhibited a peak at 54.0 ppm. So any of the 
above products could be possible. Attempts to separate the complexes by crystallisation 
proved unsuccessful. The material produced in this reaction is most likely polymeric.  
 
3.1.2 Platinum metal complexes 
3.1.2.1 PtII complexes 
 
3.1.2.1.1 Ferrochalcone ligand (32) complexation 
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Complex 51 was prepared by reacting 32 with [cis-Pt(cod)Cl2] in a ligand exchange 
reaction as shown in Scheme 3. 
X= Cl or solvent
[cis-Pt(cod)Cl2]
49 (b)
rt, (1:1) (0.1 mol)
32
49 (a)
50% yield
CD2Cl2
 
Scheme 3: Novel platinum(II) complex containing ligand 32. 
Room temperature stirring of 32 with [cis-PtCl2(cod)] in a metal-to-ligand ratio of 1:1 in 
CH2Cl2 resulted in a dark reddish coloured solution. Finally it was filtered to remove 
insoluble material. The reddish product obtained on removing the solvent in vacuo was 
characterised by different techniques. Initially the structure of the Pt complex was 
established by FT-IR and NMR spectroscopic analysis. The IR spectrum of 49 showed a 
characteristic peak at 1669 cm-1 for the carbonyl group as compared to that of ligand 
(1653 cm-1). The coordination of the phosphine moiety was inferred by the significant 
shift of the 31P signal (δ 23.3) compared to that of the free ligand (δ -13.0). The spin-
spin coupling constant 1J(M-P) are a characteristic property of the metal phosphorus σ 
bond in phosphorus coordination compounds.144 The 1J(Pt-P) value for the above 
complex was determined to be 3059 Hz, which indicates the complex is cis. The 1JPtP 
coupling value can be used to identify cis vs. trans coordination of the phosphines in a 
square planar complex.  Typically, if the phosphines are trans a coupling constant of 
1500-3000 Hz would be expected e.g. trans-[PtCl2(PEt3)2] spin-spin coupling constant 
is 2490, whereas the coupling constant for a cis complex would be higher, >3000 Hz in 
most cases e.g. for cis-[PtCl2(PPh3)2] spin-spin coupling constant is 3673145 However, 
no evidence for alkene coordination was observed in the 1H NMR spectrum as two of 
the alkene protons have only shifted upfield to δ 8.07 (for free ligand δ 8.43) and δ 6.41 
(for free ligand δ 6.86) and hence it could be concluded that the product obtained was 
49a. 
 
On crystallisation of 49 from CH2Cl2/Et2O fine red crystals were formed. These crystals 
were then analysed by X-ray diffraction methods to obtain a solid-state structure. In this 
case the X-ray structure shows that the ferrochalcone ligand 32 acts as bidentate ligand 
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binding through both the phosphorus and the alkene moiety, giving a square planar 
geometry as expected for PtII complexes (Figure 2). 
 
              
 
Figure 2: X-ray crystal structure of  complex 49. 
 
Hydrogen atoms removed for clarity. Thermal ellipsoids shown at 50%. Bond lengths 
(Ǻ):Cl(1)-Pt(1) = 2.3072(8), Cl(2)-Pt(1) = 2.3524(7), P(1)-Pt(1) = 2.2373(8), C(8)-Pt(1) = 
2.140(3), C(7)-Pt(1) = 2.174(3), C(9)-O(1) = 1.219(4), C(7)-C(8) = 1.402(4), C(6)-C(7) = 
1.489(4), P(1)-C(5) = 1.797(3), P(1)-C(20) = 1.809(3), P(1)-C(26) = 1.808(3), Bond 
Angles(º):C(8)-Pt(1)-C(7) = 37.93(11), C(8)-Pt(1)-P(1) = 89.61(8), C(7)-Pt(1)-P(1) = 83.77(8), 
C(8)-Pt(1)-Cl(2) = 90.37(8), C(7)-Pt(1)-Cl(2) = 96.96(8), P(1)-Pt(1)-Cl(2) = 178.77(3), C(8)-
Pt(1)-Cl(1) = 162.89(9), C(7)-Pt(1)-Cl(1) = 159.02(8), P(1)-Pt(1)-Cl(1) = 91.42(3), Cl(2)-Pt(1)-
Cl(1) = 88.23(3). 
 
The complexed alkene double bond C(7)-C(8) in [Pt(C31H25FePO)Cl2] is 1.402 Å as 
compared to that of a non-complexed double bond in alkene (1.334 Ǻ for ethene).146 
This increase in bond length indicates that there is some back-donation occurring. The 
PdII complex obtained on crystallization 49b was different from the one concluded on 
the basis of NMR spectroscopy.  
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3.1.2.1.2 Complexation of the Lei ligand 
 
The Lei ligand 17 was treated with [cis-Pt(cod)Cl2] in a ligand to metal ratio of 1:1 
giving PtII complex 50 in a good yield. The resulting yellow solution was stirred for 2 h 
at rt. Finally it was filtered and the solvent was removed in vacuo to give light yellowish 
solid product (as shown in Scheme 4). 
X = Cl or solvent
[cis-Pt(cod)Cl2]
50 (b)
52% yield
rt, (1:1) (0.1 mol)
17
50 (a)
CD2Cl2
 
Scheme 4: Platinum(II) complex of Lei ligand. 
The structure of the complex was established by FT-IR and NMR spectroscopic 
analysis. The IR spectrum of 50 showed a characteristic peak at 1682 cm-1 for the 
carbonyl group,  as compared to peak at 1667 cm-1 for the free ligand. The 31P NMR 
spectrum showed a chemical shift change from δ -13.0 to δ 24.9, clear evidence of a 
platinum-phosphorus interaction. The 1J(Pt-P) value for above complex was determined 
to be 3038 Hz, which indicates the complex is cis.  A slight shift was observed for both 
α and β protons.  
 
Attempts were made to crystallize the product from a variety of different solvents. Fine 
yellow crystals appeared in the NMR sample after a few days. The X-ray structure of 
the crystals obtained is given in Figure 3. 
 
 
 59
 
Figure 3: X-ray crystal structure of complex 50b. 
 
Hydrogen atoms removed for clarity. Thermal ellipsoids shown at 50%. Bond lengths(Ǻ): 
Cl(1)-Pt(1) = 2.3579(8), Cl(2)-Pt(1) = 2.2924(8), P(1)-Pt(1) = 2.2452(8), C(8)-Pt(1) = 2.152(3), 
C(9)-Pt(1) = 2.161(3), C(7)-O(1) = 1.214(4), C(8)-C(9) = 1.402(5), C(7)-C(8) = 1.402(4), C(6)-
C(7) = 1.489(4), P(1)-C(5) = 1.797(3), P(1)-C(20) = 1.809(3), P(1)-C(26) = 1.808(3), Bond 
Angles(º):C(8)-Pt(1)-C(9) = 37.94(13), C(8)-Pt(1)-P(1) = 85.90(9), C(9)-Pt(1)-P(1) = 84.60(9), 
C(8)-Pt(1)-Cl(2) = 165.55(9), C(9)-Pt(1)-Cl(2) = 156.00(9), P(1)-Pt(1)-Cl(2) = 91.76(3), C(8)-
Pt(1)-Cl(1) = 92.99(9), C(9)-Pt(1)-Cl(1) = 95.67(9), P(1)-Pt(1)-Cl(1) = 177.84(3), Cl(2)-Pt(1)-
Cl(1) = 88.85(3). 
 
The XRD analysis for the crystals confirmed that the Lei ligand acts as a bidentate 
ligand coordinating through both the phosphorus and alkene double bond. The PtII atom 
showed a square-planar coordination mode as expected for platinum(II) metal 
complexes.147 On coordination there was an increase in the bond length for the alkene 
double bond from (1.334 Å) for the non-complexed ligand to 1.402(5) Å for the 
complexed ligand, providing an indication of loss of electron density on coordination to 
PtII. 
 
A comparison of PtII complexes for the different ligands is given in Table 1. All of these 
platinum(II) metal complexes exhibit a square planar geometry.  
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Table 1: Comparison of the bond lengths in Platinum(II) complexes of ferrochalcone, Lei 
ligand and MonodbaPHOS. 
 
 
In addition to this a comparison of the bond lengths between the platinum(II) complexes 
of ferrochalcone 32, Lei ligand 17 and some other alkene ligands is given in Table 2. 
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Bonds 
PtCl2(ferrochalcone) 
(49) 
PtCl2(Lei)  
(50) 
PtCl2(monodbaPHOS)14
3  
(51)  
Pt(1)-P(1) 2.2373 (8) 2.2452 (8) 2.2363 (8) 
Pt(1)-Cl cis to alkene 2.3524 (7) 2.3579 (8) 2.3429 (8) 
Pt(1)-Cl trans to 
alkene 2.3072 (8) 2.2924 (8) 2.2995 (8) 
Pt(1)-C nearest C=O 2.140 (3) 2.152 (3) 2.132 (3) 
Pt(1)-C 2.174 (3) 2.161 (3) 2.175 (3) 
C=C coordinated 1.402 (4) 1.402 (5) 1.399 (5) 
C=C  uncoordinated   1.341 (5) 
C=O 1.219 (4) 1.214 (4) 1.215 (4) 
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The bond length for C=C in ethene is 1.33 Å.  The non-complexed C=C bond length in 
all of these complexes is similar to ethene, 1.334 Å. However, the complexed C=C bond 
length has increased in all of these cases, indicating the increase in sp3-character on 
complexation. From the comparison between these complexes, it is apparent that an 
increase in bond length is larger in the PtII complexes for the ferrochalcone and Lei 
ligand, as compared to Zeise’s salt 52 or complex 53 showing that there is more back-
donation occurring. This is expected as the enone moiety is more electron-accepting 
than ethene.  
3.1.2.2 Pt0 complexes 
 
3.1.2.2.1 Ferrochalcone ligand (32) complexation 
 
Ferrochalcone 32 was reacted with [Pt0(PPh3)2η2-C2H4]150 under different reaction 
conditions to give the Pt0 complex 54. Initially a room temperature reaction over 2 h in 
benzene gave a dark red solution. On removal of the solvent, a dark red solid was 
obtained, which was characterised. The 1H and 31P NMR spectra showed the formation 
of a new complex along with some starting material. The reaction was repeated again by 
increasing the reaction time by 2 giving the same result. The reaction was again 
repeated by increasing the temperature to 60 ºC for 2 h. On cooling the reaction 
mixture, filteration and solvent removal in vacuo which afforded a red powder. The 
crude material was analysed by NMR spectroscopy and found to be a mixture of 
starting material along a small amount of the complex. Attempts to crystallize the Pt0 
complex from different solvents (e.g. chloroform, DMSO and benzene) were 
unsuccessful (Scheme 5). 
[Pt(PPh3)2η2-C2H4)]
54
1. Stirring at rt, 2 h
2. Stirring at 60 °C, 2 h
32
C6D6
 
Scheme 5: Synthesis of platinum(0) complex of 32 using [Pt0(PPh3)2η2-C2H4]. 
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Another attempt at synthesising the Pt0 complex was made using [Pt(dba)2], which is a 
common starting material for synthesizing Pt0 complexes.151 A solution of ferrochalcone 
32 in benzene was added to a solution of Pt(dba)2 in benzene in a ligand to metal ratio 
of 2:1 (Scheme 6). The reaction mixture was stirred at room temperature for 2 h. 
Finally, on removal of the solvent in vacuo after filtration, a red powder was obtained 
54. The crude material was analysed by 1H and 31P NMR spectroscopy and was found 
to be a mixture of starting material 32 and the complex. The 31P NMR spectrum showed 
a shift for the phosphorus signal from δ -13.0 to δ 21.4 with platinum satellite signals 
(JPt-P = 2912 Hz). The yield of the reaction was low (32 %). Also, it was not possible to 
separate the Pt complex from 32. 
[Pt(dba)2]
C6D6, rt, 2 h
32% yield
54
32
 
Scheme 6: Synthesis of platinum(0) complex of 32 using [Pt(dba)2]. 
Tiny red crystals of 54 were obtained on standing a solution of the crude material in 
benzene for 2-3 weeks in the dark.  The yield of the crystals was low and crystal picking 
was needed for the XRD analysis. It is not clear whether this structure is representative 
of the bulk material. The low quantity of the crystals prevented further characterization 
(by NMR, IR spectroscopy and mass spectrometry) (Figure 4).  
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Figure 4: X-ray crystal structure of Pt0 metal complex of 32. 
 
Hydrogen atoms removed for clarity. Thermal ellipsoids shown at 50%. Bond lengths(Ǻ): C(9)-
O(1) = 1.237(3), C(40)-O(2) = 1.239(3), C(8)-C(9) = 1.465(4), C(39)-C(40) = 1.467(4), C(7)-
C(8) = 1.446(4), C(38)-C(39) = 1.444(4), C(8)-Pt(1) = 2.243(3), C(39)-Pt(1) = 2.206(3), C(7)-
Pt(1) = 2.133(3), C(38)-Pt(1) = 2.126(3),  P(1)-Pt(1) = 2.3189(7), P(2)-Pt(1) = 2.3094(7), Bond 
Angles (º): C(7)-C(8)-Pt(1) = 66.62(15), C(6)-C(7)-Pt(1) = 114.80(19), C(8)-C(7)-Pt(1) = 
74.91(16), C(9)-C(8)-Pt(1) = 115.85(19), C(20)-P(1)-C(26) = 104.2(13), C(20)-P(1)-C(1) = 
102.7(13), C(26)-P(1)-C(1) = 103.5(13), C(20)-P(1)-Pt(1) = 126.8(9), C(26)-P(1)-Pt(1) = 
114.5(9), C(1)-P(1)-Pt(1) = 101.9(10). 
 
 
The reaction of [Pt0(dba)2] with ferrochalcone 32 therefore gave a novel Pt(0) complex 
54. The XRD studies showed that each of the two molecules of the ligand are both P 
and π-olefin bound to Pt, giving an 18 e- tetrahedral complex. The chalcone ferrocene 
ligand is acting as a bidentate ligand coordinating through both alkene and phosphine 
moieties. Interestingly, the metal coordination by two P atoms and two π-olefinic bonds 
is intermediate between square-planar and tetrahedral, which would be expected for Pt0 
complexes.152 The olefinic C7=C8 bond lengthens from 1.332 Å (for non-complexed 
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alkene) to 1.446(4) Å, whereas the bond length for olefinic bond C38=C39 lengthens to 
1.444(4) Å in the metal complex. 
 
3.1.2.2.2 Complexation of the Lei ligand 
 
The Pt0 metal complex was obtained by reacting [Pt0(PPh3)2η2-C2H4] with two 
equivalents of the Lei ligand 17 in benzene. The reaction mixture was stirred for 2 h at 
60 ºC (Scheme 7). On cooling, the solvent was removed in vacuo affording a red 
powder.  
[Pt(PPh3)2η2-C2H4)]
55
1. Stirring at rt, 2 h
2. Stirring at 60 °C, 2 h
17
C6D6
1: 38% yield
2: 84% yield
Pt
P
O
P
O
O
Ph
Ph
Ph
Ph
Ph2P
 
Scheme 7: Synthesis of Pt0 complex of the Lei-ligand 17 using [Pt0(PPh3)2η2-C2H4]. 
The structure of the Pt0 complex 55 was established by NMR spectroscopy and mass 
spectrometry. The 31P NMR spectrum showed a chemical shift change from δ -13.0 to δ 
21.2 with platinum satellite signals. This provides evidence of a phosphorus-platinum 
interaction. The 1J(Pt-P) value for above complex was found to be 2933 Hz, which 
shows that the phosphorus atoms are arranged cis. 
 
Similarly, the 1H NMR spectrum of complex 55 showed a shift for both of the α- and β-
protons. Interestingly, in the 1H NMR spectrum there were platinum satellite signals 
confirming Pt-H interaction. A 2D Pt-H HMQC study confirmed the platinum 
interaction with the protons (coordinated to Pt) as shown below in Figure 5. 
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Figure 5: The 1H-135Pt HSQC spectrum of complex 55. 
 
 
The molecular ion peak for the complex appeared at m/z 979.9470, which is 
[Pt(C27H21PO)2]+. The reaction of [Pt0(PPh3)2η2-C2H4] with two equivalents of Lei 
ligand 17 at 60 ºC over 1 h gave a novel Pt0 species.  Attempts to crystallise the 
complex, gave light red crystals from a benzene solution. The X-ray structure for the Pt0 
complex 55 is given in Figure 6 overleaf. 
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Figure 6: X-ray crystal structure of Pt0 metal complex of the Lei ligand 17. 
 
Hydrogen atoms removed for clarity. Thermal ellipsoids shown at 50%. Bond lengths (Ǻ): C(9)-
O(1) = 1.238(7), C(8)-C(9) = 1.457(8), C(7)-C(8) = 1.448(8), C(8)-Pt(1) = 2.255(5), C(7)-Pt(1) 
= 2.125(5), P(1)-C(1) = 1.830(5), P(1)-C(22) = 1.827(6), P(1)-C(16) = 1.818(6), P(1)-Pt(1) = 
2.3161(14), Bond Angles(º): C(7)-C(8)-Pt(1) = 65.9(3), C(6)-C(7)-Pt(1) = 115.4(4), C(8)-C(7)-
Pt(1) = 75.6(3), C(9)-C(8)-Pt(1) = 113.0(4), C(16)-P(1)-C(22) = 106.2(3), C(16)-P(1)-C(1) = 
104.1(3), C(22)-P(1)-C(1) = 106.4(3), C(16)-P(1)-Pt(1) = 121.12(19), C(22)-P(1)-Pt(1) = 
114.79, C(1)-P(1)-Pt(1) = 102.79. 
 
The XRD studies showed that the Pt metal is bonded to two of the ligands and each 
ligand is interacting with the metal through both alkene and phosphine moieties. The 
geometry obtained as a result of XRD studies gives a structure which is somewhat 
intermediate between square-planar and tetrahedral, as expected for Pt0 complexes. The 
olefinic C7=C8 bond lengthens from 1.332 Å (for non-complexed alkene) to the 
average of 1.448(8) in the metal complex due to the Pt0 coordination.  
 
A comparison of the bond lengths between the Pt0 metal complex for the ferrochalcone 
32 and Lei ligand 17 are given in Table 3. 
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Table 3: Comparison of the bond lengths in Pt0 complexes of 54 and 55. 
Pt0 complex (54) Pt0 complex (55) 
Bond Length, Ǻ Bond Length, Ǻ 
C(7)-C(8) 1.446(4) C(7)-C(8)  1.448(8) 
C(9)-O(1) 1.237(3) C(9)-O(1) 1.238(7) 
C(8)-Pt(1) 2.243(3) C(8)-Pt(1)  2.255(5)  
C(7)-Pt(1)  2.133(3) C(7)-Pt(1)  2.125(5) 
P(1)-C(1) 
 P(1)-C(20) 
P(1)-C(26) 
1.817(3) 
1.820(3) 
1.830(3) 
P(1)-C(1) 
 P(1)-C(22) 
P(1)-C(16) 
1.830(5) 
1.827(6) 
1.818(6) 
P(1)-Pt(1) 2.3189(7) P(1)-Pt(1) 2.3161(14) 
 
The comparison of the Pt0 complexes of both ferrochalcone 32 and the Lei ligand 17 
showed that the ligand is acting, in both cases, as a bidentate ligand. An increase in 
bond length was observed on alkene metal coordination as expected. The presence of 
ferrocene in the ferrocenyl chalcone ligand does not alter the coordination behaviour of 
the ligand. 
 
3.2 Rhodium complexes with alkene phosphine ligands 
A significant part of investigations with rhodium involve the use of hemilabile ligands, 
mainly because the relevant complexes are of interest for their catalytic activity in 
several processes.153 RhI complexes normally give rise to trigonal-bipyramidal complex, 
as well as square planar complexes.154 However, in some cases, geometries closer to 
square-pyramidal are also observed.155 Rhodium(I) complexes are industrial 
homogenous catalysts in number of reactions such as alkene hydroformylation, 
asymmetric hydrogenation and methanol carbonylation. 
 
The metal precursor used for the synthesis of Rh metal complexes given in this study 
was [Rh(cod)Cl]2. Both 32 and 17 were treated with Rh metal precursor to give the RhI 
complexes. 
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3.2.1 RhI complexes of the ferrochalcone 32 and Lei ligand 17. 
 
3.2.1.1 Ferrochalcone ligand (32) complexation 
 
 
Ferrochalcone 32 was dissolved in THF and added to a solution of [Rh(cod)Cl]2 in 
THF. The red suspension changed immediately to give an orange/red solution. The 
solution was allowed to stir overnight. The rhodium complex formed was unstable 
(decompose in air) and hence the reaction was conducted inside a glove box (< 0.5 ppm 
O2). THF was then removed in vacuo and the orange/reddish residue was washed with 
diethyl ether, the washing was combined and concentrated in vacuo to give the product 
in a yield of 35% (Scheme 8). Precautionary measures were taken whilst analysing the 
Rh complex, as it was air-sensitive and decomposes in solution form (by a thermal 
decomposition pathway). 
overnight stirring in
        glove box
THF, (2:1)
32
35% yield
[Rh(cod)Cl]2
56  
 
Scheme 8: Synthesis of Rhodium(I) complex of 32 using [Rh(cod)Cl]2. 
The NMR sample was prepared in the glove box using a Young’s tap NMR tube and 
data collected immediately. Initially, the product 56 was expected. However, the 31P 
NMR spectrum showed an interesting result. There was a prominent shift for the 
phosphorus atom in the complexed ligand.  The 31P NMR spectrum showed two sets of 
doublet of doublets, along with some other 31P signals possibly due to cod-containing 
RhI complexes (Figure 7). 
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Figure 7: 31P NMR spectrum for RhI complex of 32 in CD2Cl2. 
 
The chemical shift range for the first coordinated alkene phosphine ligand is δ 20.9-24.4 
with spin-spin coupling constants of JPa-Pb = 470 Hz and  JRh-Pa = 94 Hz. For the second 
ligand the chemical shift range is δ 31.0-34.6 with coupling constant value of JPb-Pa = 
470 Hz and JRh-Pb = 99 Hz. The coupling constant value showed that the rhodium is 
bonded to two different phosphorus giving rise to an AB system- a spin-spin splitting 
pattern for an AB type system is given in Figure 8. 
 
Figure 8: Spin-spin splitting pattern for an AB system, a) first-order pattern and b) 
second-order pattern. 
 
 
   Product  
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The second order pattern is observed as a “roofed” pattern, e.g. the inner peaks are taller 
and outer peaks are shorter in case of AB system.  The 31P NMR spectrum suggested a 
RhI complex with a structure 57a, where Rh is bonded to two ligands interacting 
through both alkene and phosphine 57a (Figure 9). 
Rh
57a  
On standing for a long period the solution of the rhodium complex in diethyl ether led 
to the formation of fine orangish-red crystals. The crystals were run for the x-ray 
diffraction. The structure of the Rhodium(I) complex obtained on crystallization is 
given in Figure 10. 
57b
P
Rh
Cl
O
Rh
P
O
ClPh
Ph
Ph
Ph
Fc
Fc
 
Figure 10: Structure of RhI complex 57b. 
 
The X-ray crystal structure for the complex is given in Figure 11. 
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Figure 11: X-ray crystal structure of RhI metal complex of 57b. 
 
Hydrogen atoms removed for clarity. Thermal ellipsoids shown at 50%. Bond lengths(Ǻ): 
C(19)-C(20) = 1.413(7), C(50)-C(51) = 1.425(7), C(21)-O(1) = 1.242(6), C(52)-O(2) = 
1.240(5), C(19)-Rh(1) = 2.101(5), C(20)-Rh(1) = 2.117(4), C(50)-Rh(2) = 2.117(5), C(51)-
Rh(2) = 2.103(5), Rh(1)-Cl(1) = 2.337(12), Rh(2)-Cl(2) = 2.3299(13), Rh(1)-O(1) = 2.131(3), 
Rh(2)-O(2) = 2.139(3), Rh(1)-P(1) = 2.1887(14), Rh(2)-P(2) = 2.1923(12), Bond Angles(º) 
C(19)-C(20)-Rh(1) = 71.0(3), C(50)-C(51)-Rh(2) = 70.8(3), C(18)-C(19)-Rh(1) = 113.7(3), 
C(49)-C(50)-Rh(2) = 115.6(3), C(19)-Rh(1)-C(20) = 39.14(18), C(51)-Rh(2)-C(50) = 
39.47(18), C(19)-Rh(1)-Cl(1) = 153.08(14), C(50)-Rh(2)-Cl(2) = 161.60(3), C(20)-Rh(1)-Cl(1) 
= 167.79(14), C(51)-Rh(2)-Cl(2) = 158.93(14), P(1)-Rh(1)-O(1) = 175.03(10), P(2)-Rh(2)-O(2) 
= 177.03(9), O(1)-Rh(1)-Cl(1) = 87.35(9), O(2)-Rh(2)-Cl(2) = 86.41(9), P(1)-Rh(1)-Cl(1) = 
94.27(5), P(2), Rh(2), Cl(2) = 93.70(5). 
 
The X-ray structure of [Rh2(ferrochalcone ligand)2] 57b indicated that the RhI is bonded 
to two bridging ligands. The ligand spans two Rh centres by P, alkene-coordination to 
one Rh and then carbonyl coordination to the other Rh atom. The X-ray structure shows 
that ferrochalcone 32 acts as tridentate ligand. The RhI complex exhibits a distorted 
square-planar geometry as expected for RhI complexes.156 An increase in the bond 
length of the alkene bonds was expected as a result of the coordination. The alkene bond 
lengths for the complexed ligand are 1.413(7) Ǻ and 1.425(7) Ǻ, respectively which is 
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indicative of the carbons becoming more sp3-like. A comparison of the bond lengths 
between the two ligands around the Rh metal centre showed quite similar values. 
 
3.2.1.2 Complexation of the Lei ligand 
 
The Lei ligand 17 was treated with [Rh(cod)Cl]2 in the similar fashion to ferrochalcone 
32. Light yellow solid was obtained in a good yield of 71 % (Scheme 9). 
C6D6, (2:1)
rt stirring, 2 h
71% yield
17
58
[Rh2(cod)2Cl2]
 
Scheme 9: Synthesis of Rhodium(I) complex of Lei-ligand using [Rh(cod)Cl]2. 
The IR spectrum of Rh complex 58 showed a strong absorption band at 1652 cm-1 
corresponding to the C=O group together with the characteristic band for the C=C group 
(1595 cm-1). 31P NMR spectroscopic analysis (Figure 12) showed a similar spectrum to 
the RhI complex of 32 (Figure 7)  
 
 Figure 12: 31P NMR spectrum for RhI complex of Lei ligand, 17. 
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A pair of doublet of doublets were observed by 31P NMR spectroscopic analysis for the 
complex (e.g. AB system). The spin-spin coupling constant values for the two doublets 
differ slightly indicating the difference in the environment for the two phosphorus 
atoms giving rise to an AB system. The chemical shift range for the first coordinated 
alkene phosphine ligand is δ 25.2-21.7 with a spin-spin coupling constant of JPa-Pb = 474 
Hz and JRh-Pa = 93 Hz. For the second ligand the chemical shift range is δ 34.4-30.8, 
with coupling constant value of JPb-Pa = 474 Hz and JRh-Pb = 100 Hz.  
 
 The 1H NMR spectrum of complex 58 is given in Figure 13. 
 
 
Figure 13: 1H NMR spectrum for RhI complex of Lei ligand. 
 
The 1H NMR spectrum of complex 58 showed a shift for both of the α- and β-protons. 
The shift is more for the α-proton. The large upfield shifts from the free ligand alkene 
proton is evidence for the alkene binding to the rhodium centre.   The phenyl proton 
peaks were observed between 6.5 to 8.0 ppm.  
 
Fine yellow crystals were obtained by standing a solution of the Rh complex in benzene 
for a few days. The crystals were then analysed by X-ray diffraction (Figure 12). 
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Figure 12: X-ray crystal structure of the RhI metal complex of Lei ligand 17. 
Hydrogen atoms removed for clarity. Thermal ellipsoids shown at 50%. Bond lengths (Ǻ): C(7)-
O(1) = 1.222(2), C(34)-O(2) = 1.223(3), C(7)-C(8) = 1.489(3), C(34)-C(35) = 1.479(3), C(8)-
C(9) = 1.416(3), C(35)-C(36) = 1.428(3), C(8)-Rh(1) = 2.1808(19), C(35)-Rh(1) = 2.1962(19), 
C(9)-Rh(1) = 2.1976(19), C(36)-Rh(1) = 2.128(2),  C(15)-P(1) = 1.818(2), C(16)-P(1) = 
1.830(2), C(22)-P(1) = 1.829(2), C(42)-P(2) = 1.813(2), C(43)-P(2) = 1.829(2), C(49)-P(2) = 
1.842(2), Rh(1)-Cl(1) = 2.4585(6), Rh(1)-P(1) = 2.3654(6), Rh(1)-P(2) = 2.3358(6), Bond 
Angles(º) O(1)-C(7)-C(8) = 121.16(19), O(2)-C(34)-C(35) = 122.2(2), C(9)-C(8)-C(7) = 
122.27(18), C(36)-C(35)-C(34) = 120.96(19), C(8)-Rh(1)-C(9) = 37.72(7), C(36)-Rh(1)-C(35) 
= 38.53(7), C(9)-C(8)-Rh(1) = 71.78(11), C(36)-C(35)-Rh(1) = 68.15(11), C(8)-C(9)-Rh(1) = 
70.50(11), C(35)-C(36)-Rh(1) = 73.31(11), C(15)-P(1)-Rh(1) = 99.38(7), C(42)-P(2)-Rh(1) = 
101.89(7), C(36)-Rh(1)-C(8) = 92.68(8), C(8)-Rh(1)-C(35) = 130.80(8), C(36)-Rh(1)-C(9) = 
129.66(8), C(35)-Rh(1)-C(9) = 168.19(7), C(36)-Rh(1)-P(2) = 81.94(6), C(8)-Rh(1)-P(2) = 
99.33(6), C(35)-Rh(1)-P(2) = 82.81(6), C(9-Rh(1)-P(2) = 95.79(5), C(36)-Rh(1)-P(1) = 
102.83(6), C(8)-Rh(1)-P(1) = 81.30(6), C(35)-Rh(1)-P(1) = 100.44(6), C(9)-Rh(1)-P(1) = 
81.75(5), P(2)-Rh(1)-P(1) = 175.177(19), C(36)-Rh(1)-Cl(1) = 142.04(6), C(8)-Rh(1)-Cl(1) = 
142.04(6), C(8)-Rh(1)-Cl(1) = 125.16(5), C(35)-Rh(1)-Cl(1) = 103.99(6), C(9)-Rh(1)-Cl(1) = 
87.65(5), P(2)-Rh(1)-Cl(1) = 88.264(19), P(1)-Rh(1)-Cl(1) = 87.489(19). 
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The complex was found to exhibit an interesting geometry. The RhI metal is found to be 
coordinated to two ligands. Six and a half molecules of benzene are found in the unit 
cell. The metal is coordinated by two P atoms and two alkene bonds There is a Rh(1)-
Cl(1) bond, with a bond length of 2.4585(6) Ǻ.  The phosphino-alkene ligand is acting 
as a bidentate ligand binding through both the alkene and phosphine moiety. The bond 
lengths for the Rh-P bonds are similar, the Rh(1)-P(1) bond length is 2.3654(6) Ǻ, 
whereas Rh(1)-P(2) bond length is 2.3358(6) Ǻ.  
 
The alkene bond length for the coordinated ligand C(8)-C(9) is 1.416(3) Ǻ. which is 
longer than that for the non-coordinated ligand. The alkene bond length C(35)-C(36) in 
the other ligand is 1.428(3) Ǻ.  
 
A comparison of the bond lengths between the RhI metal complex for the ferrochalcone 
and Lei ligand is given in Table 4. 
Table 4: Comparison of the bond lengths in RhI complexes 57b and 58. 
Rh(I) complex (57b) Rh(I) complex (58) 
Bond Length, Ǻ Bond Length, Ǻ 
C(19)-C(20) 
C(50)-C(51) 
1.413(7) 
1.425(7) 
C(7)-C(8) 
 C(34)-C(35) 
1.489(3) 
1.479(3) 
C(21)-O(1) 
 C(52)-O(2)  
1.242(6) 
1.240(5) 
C(7)-O(1) 
 C(34)-O(2) 
1.222(2) 
1.223(3) 
C(19)-Rh(1) 
 C(20)-Rh(1)  
2.101(5) 
2.117(4) 
C(8)-Rh(1)  
C(9)-Rh(1)  
2.1808(19) 
2.1976(19) 
C(50)-Rh(2) 
 C(51)-Rh(2) 
2.117(5) 
2.103(5) 
C(35)-Rh(1) 
C(36)-Rh(1)  
2.1962(19) 
2.128(2) 
Rh(1)-Cl(1) 
 Rh(2)-Cl(2)  
2.337(12) 
2.3299(13) 
Rh(1)-Cl(1) 2.4585(6) 
Rh(1)-O(1)  
Rh(2)-O(2) 
2.131(3) 
2.139(3) 
-- -- 
Rh(1)-P(1) 
 Rh(2)-P(2)  
2.1887(14) 
2.1923(12) 
Rh(1)-P(1) 
 Rh(1)-P(2) 
2.3654(6) 
2.3358(6) 
 
There is an increase in the alkene bond length in both of the RhI complexes indicating 
that the alkene is interacting with the metal. Also, the Rh-P interaction was observed in 
both of the complexes with Rh(1)-P(1) bond lengths slightly longer than in the Lei Rh 
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complex, 58. As rhodium is binding to Cl in both of the complexes, a comparison of the 
bond lengths of Rh(1)-Cl(1) between the two complexes showed that Rh(1)-Cl(1) bond 
length is higher in Lei Rh complex (58) as compared to ferrochalcone Rh complex (57).  
3.3 Copper complexes with Alkene phosphine ligands 
 
Copper complexes have been of great interest to inorganic and organometallic chemists 
due to their varied coordination chemistry and the resulting properties. Traditionally, 
copper(I) is regarded as a metal ion with soft Lewis acid character,157 and therefore it 
will form covalent bonds with soft ligands (e.g. with S or P as the donor atom).  
Copper(I) alkene complexes are known in literature, with the first reported by Brandt et 
al. The interesting feature of these copper(I) alkene complexes is that they exhibit a 
wide variety of coordination modes. A four coordinate copper(I) alkene complex shows 
a distorted tetrahedral arrangement whereas, a three coordinate copper(I) alkene 
complex with a bulky ligand exhibits a trigonal planar geometry. Copper(I) phosphino-
alkene complexes are also known. In some cases the copper is found to be bonded to the 
phosphine only with no metal alkene coordination. However in a few complexes both 
alkene and phosphine moieties are bonded to copper. The copper metal precursors used 
are [Cu(MeCN)4]PF6 and [Cu(Cl)]. The ligands 32, 33 and 17 were treated with the 
appropriate copper metal precursor under different reaction conditions to give the 
copper(I) metal complex, as detailed below. 
 
3.3.1 CuI complexes 
 
3.3.1.1 Ferrochalcone ligand (32) complexation 
 
The reaction of [Cu(MeCN)4] PF6 with two equivalent of ferrochalcone 32 afforded the 
copper(I) metal complex 59 as light red powder. A solution of [Cu(MeCN)4]PF6 in dry 
degassed dichloromethane was added by cannula to ferrochalcone 32 and the resulting 
solution was stirred for 2 h at room temperature. Finally, the solution was filtered to 
give a clear solution and the solvent was removed in vacuo to give the solid product 
(Scheme 10). 
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Scheme 10: Synthesis of copper(I) complex of 32 using [Cu(MeCN)4]PF6. 
The structure of the complex 59 was analysed by NMR, IR spectroscopy and mass 
spectrometry. In the 31P-NMR spectrum there is a shift from δ-13.0 to δ-4.80, also there 
is a septet at δ-143.8 corresponding to the presence of PF6 ion. In the 1H-NMR spectrum 
there is a only a slight shift for the two protons and hence no evidence of Cu-alkene 
coordination. The molecular ion peak in the mass spectrum appeared at m/z 563.0297 
corresponding to that of [Cu(C31H25FePO)]+. Different attempts were made to 
crystallise the copper(I) metal complex using different solvent combinations, but 
couldn’t succeeded 
 
[Cu(Cl)] was also used as a source for the synthesis of the copper(I) complex of the 
chalcone ferrocene ligand. Ferrochalcone 32 was treated with [Cu(Cl)] in a ligand to 
metal ratio of 1:1, at a room temperature reaction for 1 h giving dull red powder 60 
(Scheme 11). 
DCM, (1:1)
32
[Cu(Cl)]
46% yield
rt, 1 h 60
 
Scheme 11: Synthesis of Copper(I) complex of 32 using [Cu(Cl)]. 
The structure of the complex was established by FT-IR and NMR spectroscopy. The IR 
spectrum of the complex 60 showed a characteristic peak at 1652 cm-1 for the carbonyl 
group. The 31P-NMR spectrum showed a singlet at δ -4.38, which is, compared to the 
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ligand δ -13.0 shifted more downfield. This provides evidence of some sort of 
phosphorus-metal interactions. The 1H-NMR spectrum showed no evidence of Cu-
alkene interaction. Fine crystals were obtained by layering ether over a CH2Cl2 solution 
of copper complex but they were too small to be analysed by XRD. 
 
3.3.1.2 Thio-ferrochalcone ligand (33) complexation 
Cu1 being regarded as a metal ion with soft Lewis acid character shows good reactivities 
towards soft ligands like S or P by forming covalent bond and hence metal coordination 
behaviour of thio-ferrochalcone was explored. Alkene thio-phosphine Cu1 metal 
complex 61 was prepared by reaction of thio-ferrochalcone 33 with [Cu(MeCN)4]PF6 
(Scheme 12). 
33
37% yield
PF6-
rt, (1:1)
61
[Cu(MeCN)4]PF6
CD2Cl2
 
Scheme 12: Synthesis of copper(I) complex of 33 using [Cu(MeCN)4.PF6]. 
There is only very slight shift in the 31P NMR spectrum showing that the metal is not 
coordinating to phosphorus in fact it’s the sulfur forming a bridge with the Cu metal. A 
molecular ion was seen in the mass spectrum at m/z 1127.07 corresponding to 
[Cu(C31H25FePSO)2]+. Fine crystals were grown from dichloromethane but were too 
small for XRD analysis. 
 
Thio-ferrochalcone 33 was also treated with [CuCl] in dichloromethane to obtain the 
copper(I) complex. Reaction over a 2 h at room temperature, with ligand metal ratio of 
1:1, afforded a  giving light red solid product, believed to be 62 (Scheme 13). 
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rt, 2 h
DCM, (1:1)
33
63% yield
62
[Cu(Cl)]
 
Scheme 13: Synthesis of copper(I) complex of 33 using [Cu(Cl)]. 
The structure of the complex was established by FT-IR and NMR spectroscopy. The 
31P-NMR spectrum showed a chemical shift change from δ 42.05 to δ 41.2. The shift is 
not very prominent indicating that phosphorus is not directly coordinating to metal and 
perhaps its sulfur forming the bond with metal. Similarly, a slight shift in the  
1H-NMR spectrum was observed. 
 
In order to gain further information about the coordination mode involved, attempts 
were made to crystallize the complex. Fine red crystals were grown from a 
dichloromethane solution of the complex after ca. 1 week. The determined X-ray 
structure obtained is shown in Figure 13. 
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Figure 13: X-ray crystal structure of  the CuI metal complex containing ligand 33. 
 
Hydrogen atoms removed for clarity. Thermal ellipsoids shown at 50%. Bond lengths (Ǻ): 
C(10)-C(11) = 1.467(5), C(11)-C(12) = 1.499(5), C(12)-C(13) = 1.384(5), C(13)-C(14) = 
1.496(5), C(11)-O(1) = 1.229(4), P(1)-C(19) = 1.807(4), P(1)-C(20) = 1.802(4), P(1)-C(26) = 
1.807(4), P(1)-S(1) = 1.9991(13), S(1)-Cu(1) = 2.2526(11), Cu(1)-Cl(1) = 2.1892(10), C(12)-
Cu(1) = 2.056(4), C(13)-Cu(1) = 2.039(4), Bond Angles (º) : C(12)-Cu(1)-C(13) = 39.49(14), 
C(12)-Cu(1)-S(1) = 142.69(11), C(13)-Cu(1)-S(1) = 103.32(11), C(12)-Cu(1)-Cl(1) = 109.88, 
C(13)-Cu(1)-Cl(1) = 149.34(11), S(1)-Cu(1)-Cl(1) = 107.14(4), P(1)-S(1)-Cu(1) = 100.86(5), 
C(19)-P(1)-S(1) = 111.48(12), C(26)-P(1)-S(1) = 113.30(13), C(20)-P(1)-S(1) = 110.28(13). 
 
The structure of the CuI complex exhibits a trigonal geometry. The X-ray structure 
showed that the crystal contained a molecule of dichloromethane (solvent) in the unit 
cell. The thio-ferrochalcone acts as a bidentate ligand, binding through both the sulphur 
and the alkene moiety. The C=C bond distance of the alkene double bond is 1.384 Ǻ, 
which is slightly longer than that for non-complexed alkene double bond (1.334 Å), 
confirming a weak alkene-metal interaction. 
 
An comparison of the torsion angle for some important atom combinations is given in 
Table 5. 
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Table 5: Torsion angle for the copper(I) complex of 33. 
Bonds Torsion angle (º) Conformation 
C(11)-C(12)-C(13)-C(14) -159.3(4) antiperiplanar(trans) 
Cl(1)-Cu(1)-S(1)-P(1) 174.9(5) antiperiplanar(trans) 
C(12)-Cu(1)-S(1)-P(1) 2.4(2) synperiplanar(cis) 
C(13)-Cu(1)-S(1)-P(1) -1.46(3) synperiplanar(cis) 
O(1)-C(11)-C(12)-Cu(1) 78.9(4) synclinal(gauche/skew) 
C(19)-P(1)-S(1)-Cu(1) -44.37(14) synclinal(gauche/skew) 
C(26)-P(1)-S(1)-Cu(1) 75.95(14) synclinal(gauche/skew) 
C(20)-P(1)-S(1)-Cu(1) -164.39(13) antiperiplanar(trans) 
 
 
 
3.3.1.3 Complexation of the Lei ligand 
 
Both the chalcone ferrocene ligand 32 and the Lei ligand 17 exhibit a similar structure, 
having the common chalcone backbone. The major difference is the presence of 
ferrocene instead of a phenyl ring. A reaction of the Lei ligand 17 was conducted with 
[Cu(MeCN)4]PF6 in a ligand to metal ratio of 2:1 (Scheme 14), conducted which 
afforded a  light yellow product believed to be 63. 
17
rt, 2 h
DCM, (2:1)
PF6-
59% yield
63
[Cu(MeCN)4.PF6]
 
Scheme 14: Synthesis of copper(I) complex of the Lei ligand 17. 
The 31P-NMR spectrum of 63 showed a singlet at δ -4.51, also there is a septet at -143.8 
corresponding to the presence of the PF6 anion. The molecular ion peak in the mass 
spectrum appeared at m/z 849.2133 corresponding to that of [Cu(C27H21PO)2]+. 
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In order to ascertain the geometry of the copper metal complex 63 crystals were grown 
from dichloromethane XRD analysis confirmed the structure of the copper metal 
complex 63 (Figure 14).  
 
 
 
 
 
Figure 14: X-ray crystal structure of Cu (I) metal complex 63. 
 
Hydrogen atoms removed for clarity. Thermal ellipsoids shown at 50%. Bond lengths (Ǻ): C(9)-
O(1) = 1.217(2), C(8)-C(7) = 1.337(2), P(1)-C(1) = 1.8232(17), P(1)-C(16) = 1.8255(17), P(1)-
C(22) = 1.8233(17), P(1)-Cu(1) = 2.2421(5), C(36)-O(2) = 1.225(2), C(34)-C(35) = 1.335(2), 
P(2)-C(28) = 1.8314(17), P(2)-C(43) = 1.8234(17), P(2)-C(49) = 1.8237(16), P(2)-Cu(1) = 
2.2451(5), Cu(1)-N(1) = 1.9593(15), N(1)-C(55) = 1.138(2), Bond Angles(º) C(1)-P(1)-C(16) = 
104.47(8), C(1)-P(1)-C(22) = 104.66(8), C(22)-P(1)-C(16) = 103.40(8), C(1)-P(1)-Cu(1) = 
112.59(5), C(16)-P(1)-Cu(1) = 115.14(6), C(22)-P(1)-Cu(1) = 115.34(6), C(43)-P(2)-C(49) = 
104.91(8), C(43)-P(2)-C(28) = 103.14(7), C(49)-P(2)-C(28) = 104.65(7), C(43)-P(2)-Cu(1) = 
115.39(5), C(49)-P(2)-Cu(1) = 115.92(5), C(28)-P(2)-Cu(1) = 111.51(5), P(1)-Cu(1)-P(2) = 
131.018(18), N(1)-Cu(1)-P(1) = 115.78(5), N(1)-Cu(1)-P(2) = 113.20(5), C(55)-N(1)-Cu(1) = 
172.55(16). 
 
One of the dichloromethane of crystallisation was disordered and modelled over two 
sites with a refined relative occupancy of 4:1.The two ligands were bounded to Cu 
metal centre through phosphorus only and there is no alkene metal coordination. The 
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C=C bond length for C(7)-C(8) is 1.337 Å, whereas for C(34)-C(35) it is 1.335 Å in the 
complexed ligand. If we do a comparison of the alkene bond length in the complexed 
ligand with the non-complexed ligand (1.33 Å), they are almost identical confirming 
that the alkene is not interacting with the metal. Another, interesting comparison of the 
bond lengths is between Cu(1)-P(1) (2.2421 Å) and Cu(1)-P(2) (2.2451 Å) which is also 
quite similar. The bond length for P(1)-C(1) (1.8232 Å) is similar to that of P(2)-C(43) 
(1.8234 Å) showing that both ligands are attached symmetrically to the metal centre. 
Also there was a copper metal coordination with a molecule of acetonitrile. The torsion 
angle for C(43)-P(2)-Cu(1)-P(1) is -49.26(7)º which is similar to that of C(1)-P(1)-Cu(1)-
P(2) 47.39(6)º, with the only difference noted in the direction of rotation. Hence, both of 
torsions exhibit a synclinal conformation. Similarly, C(43)-P(2)-Cu(1)-N(1) and  C(1)-P(1)-
Cu(1)-N(1) give 131.08(8)º and -132.96(8)º exhibit an anticlinal conformation. 
 
Reaction of the Lei ligand 17 with [CuCl] in a ligand metal ratio of 1:1, for 2 h in 
dichloromethane afforded a copper(I) complex which is believed to be 64 in 60% yield 
as given in Scheme 15.  
DCM, (1:1)
60% yield
17
rt, 2 h
[Cu(Cl)]
64  
Scheme 15: Synthesis of copper(I) complex of Lei ligand using [Cu(Cl)]. 
The 31P-NMR spectrum of 63 showed a chemical shift change from δ -13.0 to δ -3.47 
confirming a phosphorus-metal interaction. The shift in the 1H-NMR spectrum is very 
negligible, highlighting little if any alkene-Cu interaction. The mass spectrum gives a 
molecular ion peak at m/z 455.1 corresponding to [Cu(C27H21PO)]+. 
The Lei copper(I) complex 64 was crystallized from a dichloromethane solution layered 
with pentane, which afforded slight yellow crystals suitable for XRD analysis. The X-
ray structure of the copper(I) complex is given in Figure 15, which exists as a dimer in 
the solid-state. 
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(a) 
 
(b) 
 
Figure 15: X-ray crystal structure of CuI metal complex 64, (a) asymmetric unit (b) 
molecular structure 
 
Hydrogen atoms removed for clarity. Thermal ellipsoids shown at 50%. Bond lengths (Ǻ): C(6)-
C(7) = 1.468(2), C(7)-C(8) = 1.334(2), C(8)-C(9) = 1.483(2), C(9)-O(1) = 1.2193(19), P(1)-
Cu(1) = 2.1765(4), Cu(1)-Cl(1) = 2.2635(4), Cu(1)-Cu(11) = 2.8915(3), Cu(1)-Cl(11) = 
2.2635(4), P(1)-C(1) = 1.8338(14), P(1)-C(16) = 1.8182(14), P(1)-C(22) = 1.8192(14), Bond 
Angles(º) C(7)-C(8)-C(9) = 119.41(14), C(8)-C(9)-O(1) = 120.13(15), C(10)-C(9)-O(1) = 
119.52(14), C(1)-P(1)-Cu(1) = 115.80(4), C(16)-P(1)-Cu(1) = 116.55(5), C(22)-P(1)-Cu(1 )= 
107.80(4), P(1)-Cu(1)-Cl(1) = 122.133(15), P(1)-C(1)-C(6) = 119.36(10), P(1)-Cu(1)-Cu(11) = 
167.505(15), P(1)-Cu(1)-Cl(11) = 134.555(16). 
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The Lei ligand acts as monodentate ligand binding through the phosphorus only and 
there is no alkene metal interaction. The C(7)-C(8) distance of the alkene double bond is 
1.334(2) Ǻ which is similar to that for an alkene in a non-coordinated metal complex. A 
comparison of the torsion angle between the different atoms is given in Table 6. 
Table 6: Torsion angle for the copper(I) complex of Lei ligands(64). 
Bonds Torsion angle (º) 
Cu(11)-Cl(1)-Cu(1)-Cl(11) 0.0 
C(1)-P(1)Cu(1)-Cl(1) -48.87(5) 
C(1)-P(1)-Cu(1)-Cu(11) -96.56(8) 
P(1)-Cu(1)-Cl(1)-Cu(11) -167.94(18) 
P(1)-C(1)-C(2)-C(3) -174.04(11) 
P(1)-C(1)-C(6)-C(5) 173.62(10) 
 
 
A comparison of the bond lengths between Cu complex 63 and 64 is given in Table 7. 
Table 7: Comparison of the bond lengths in copper(I) complexes of Lei ligand. 
Cu(I) complex (63) Cu(I) complex (64) 
Bond Length, Ǻ Bond Length, Ǻ 
C(7)-C(8) 1.337(2) C(7)-C(8) 1.334(2) 
C(9)-O(1) 1.217(2) C(9)-O(1) 1.2193(19) 
P(1)-Cu(1) 2.2421(5) P(1)-Cu(1) 2.1765(4) 
Cu(1)-N(1) 1.9593(15) Cu(1)-Cl(1) 2.2635(4) 
P(1)-C(1) 1.8232(17) P(1)-C(1) 1.8338(14) 
P(1)-C(16) 1.8255(17) P(1)-C(16) 1.8182(14) 
P(1)-C(22) 1.8233(17) P(1)-C(22) 1.8192(14) 
 
The bond length for C=C bond in both of these copper complexes is similar to the bond 
length of a non-complexed alkene (1.33 Å), which showed that both of these alkene 
bonds were not involved in any kind of interaction with the metal.   
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3.4 Experimental 
3.4.1 General Information 
NMR spectra were obtained in the solvent indicated, using a JEOL ECX400 or JEOL 
ECS400 spectrometer (400 MHz for 1H, 100 MHz for 13C and 162 MHz for 31P). 
Chemical shifts were referenced to the residual undeuterated solvent of the deuterated 
solvent used (CHCl3 δ = 7.26 and 77.16, CDHCl2 δ = 5.31 and 53.80 and C6D5H δ = 
7.16 and 128.0 for 1H and 13C NMR spectra, respectively). All 13C NMR spectra were 
obtained with 1H decoupling.  31P NMR spectra were externally referenced to H3PO4, 
and obtained with 1H decoupling.  For 13C NMR spectra the coupling constants are 
quoted to ±1 Hz.  For the 1H NMR spectra the resolution varies from ±0.15 to ±0.5 Hz; 
the coupling constants have been quoted to ±0.5 Hz in all cases for consistency.  For 31P 
NMR spectra the coupling constants have been quoted to either ±0.5 or ±1 Hz.  NMR 
spectra were processed using MestrNova software. 
 
Melting points were recorded using a Stuart digital SMP3 machine.  IR spectroscopy 
was undertaken using a Jasco/MIRacle FT/IR-4100typeA spectrometer with an ATR 
attachment on solid and liquid compounds; KBr and solution IR spectra were obtained 
on a Nicolet Avatar 370 FT-IR spectrometer as stated. MS spectra were measured using 
a Bruker Daltronics micrOTOF machine with electrospray ionisation (ESI) or on a 
Thermo LCQ using electrospray ionisation, with <5 ppm error recorded for all HRMS 
samples.  LIFDI mass spectrometry was carried out using a Waters GCT Premier MS 
Agilent 7890A GC, with <15 ppm error recorded for all HRMS.  Mass spectral data is 
quoted as the m/z ratio along with the relative peak height in brackets (base peak = 100).  
TLC analysis was carried out on Merck TLC aluminium sheets (silica gel 60 F254) and 
visualised with UV light (254 nm) and iodine vapour.  All column chromatography was 
run on silica gel 60 using the solvent systems specified in the text.  The fraction of 
petroleum ether used was 40-60 °C.   
 
Dry and degassed toluene, CH2Cl2 and hexane were obtained from a Pure-Solv MD-7 
solvent purification system.  THF and Et2O were either obtained from a Pure-Solv MD-
7 solvent purification system and degassed by the freeze-pump-thaw method or purged 
with N2 under sonication; or dried over sodium-benzophenone ketyl and collected by 
distillation.  Benzene was dried over sodium-benzophenone ketyl, and ethanol was dried 
and distilled from magnesium-iodine.  All air-sensitive reactions were carried out using 
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Schlenk techniques or in a MBraun MG-20-G with TP170b glove-box with an N2 
atmosphere.  Nitrogen gas was oxygen-free and was dried immediately prior to use by 
passage through a column containing sodium hydroxide pellets and silica.  Room 
temperature was typically between 13-25 °C. Commercial chemicals were purchased 
from Sigma-Aldrich or Alfa Aesar.   
 
PdII complex (48 b): Synthesis using PdCl2(cod) 
A solution of PdCl2(cod) (0.020 g, 0.1 mmol) and ferrochalcone 32 (0.050 g, 0.1 mmol) 
in CH2Cl2 (5 mL) was stirred at room temperature for 1 h. Addition of hexane and 
concentration in vacuo to two-thirds the volume afforded a dark red-coloured 
precipitate, which was filtered and dried in vacuo (0.041 g, 60%). Mp 192-194 °C; 1H-
NMR (400 MHz, CDCl3) δ 8.41 (d,  J = 15.7,1H), 7.93 (s, 3H, Ph), 7.80 (m, 1H), 7.43-
7.51(m, 10H), 6.83 (d, J = 15.7, 1H), 4.70-4.83 (m, 2H), 4.54-4.51 (m, 2H), 4.10-4.23 
(m, 5H); 13C-NMR (100 MHz, CDCl3) δ 192.1, 133.8, 133.6, 129.0, 128.8, 128.7, 
128.6, 116.8, 74.5, 71.1, 70.5, 70.2, 69.9, 69.8, 69.7; 31P-NMR (162 MHz, CDCl3) δ 
21.4 (s, 1P); HRMS (LIFDI) [M]+ m/z 639.9518 (Calcd. for [Pd(C31H24FePO)Cl]  
639.9637); IR υ cm-1  3438 (s), 2924 (s), 1652 (s), 1554 (s), 1456 (s), 1377 (s), 1099 (s), 
996 (s), 693 (s). 
  
PdII complex (48 a): Synthesis using PdCl2(MeCN)2 
To a solution of ferrochalcone 32 (0.050 g, 0.1 mmol) in CH2Cl2 (2.5 mL) was added a 
solution of [Pd(MeCN)2Cl2] (0.025 g, 0.1 mmol) in CH2Cl2 (5 mL). The product 
immediately crystallizes out after stirring for 1 h. The product was filtered and dried in 
vacuo (0.037 g, 54 %). Mp 193-195 °C; 1H-NMR (400 MHz, CDCl3) δ 9.00 (d, J = 16 
Hz, 1H), 8.27 (m, 3H), 7.44 (m, 1H), 7.20 (m, 3H), 6.99 (m, 3H), 6.94 (m, 3H), 6.91 (m, 
1H), 6.80 (d, J = 16 Hz, 1H), 4.68 (s, 2H), 4.09 (m, 2H), 3.81 (s, 5H); 31P-NMR (162 
MHz, C6D6) δ (ppm): 21.7 (s, 1P); IR (KBr, υ cm-1): 3444 (bs), 2917 (s), 2349 (s), 2324 
(s), 1653 (s), 1553 (s), 1456 (s), 1436 (s), 1383 (s), 1262(s), 1233 (s), 1099 (s), 1017 (s), 
825 (s), 763 (s), 686 (s), 653 (s); HRMS (LIFDI) [M-Cl]+ m/z 607.01 (Calcd. for 
[Pd(C31H26FePO)]  607.01). 
 
 
PtII complex (49) 
A solution of [cis-PtCl2(cod)] (0.046 g, 0.1 mmol) and ferrochalcone 32 (0.048 g, 0.012 
mmol) in CH2Cl2 (5 mL) was stirred for 30 mins. Addition of hexane and concentration 
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to two-thirds the volume to afford a red solid, which was filtered and dried in vacuo 
(0.037 g, 50%). Mp 278-285 °C; 1H-NMR (400 MHz, CDCl3) δ 8.05-8.10 (m, 2H), 
7.78-7.85 (m, 4H), 7.50-7.58 (m, 2H), 7.38-7.43 (ddt, J = 7.1, 5.1, 3 Hz, 5H), 7.20-7.23 
(m, 1H), 6.41 (d, J = 11.8 Hz, 1H), 5.17 (dd, J = 11.7, 3.3 Hz, 1H), 4.63 (dd, J = 2.5, 1.3 
Hz, 1H), 4.46 (q, J = 2.5 Hz, 1H), 4.39-4.40 (m, 2H),, 3.88 (s, 5H); 13C-NMR (100 
MHz, CDCl3) δ 193.2, 133.8, 134.1, 134.2 , 136.1 (d, J = 10 Hz), 138.2 (d, J = 16 Hz), 
139.4 (d, J = 23 Hz), 140.3 (d, J = 22 Hz), 129.5, 129.1, 129.0, 128.7 (d, J = 7 Hz), 
127.2 (d, J = 4 Hz), 126.3 (d, J = 4 Hz), 80.1, 72.7, 70.2, 69.9; 31P-NMR (162 MHz, 
CDCl3) δ 23.3 (s, 1JPtP = 3059 Hz); HRMS (ESI) [M-Cl]+ m/z 731.0325 (Calcd. for 
[Pt(C31H26FePO)Cl]  731.0342); IR υ cm-1  2922 (s), 1739 (s), 1695 (s), 1669 (s), 1652 
(s), 1558 (s), 1583 (s), 1533 (s), 1464 (s), 1436 (s), 1419 (s), 1105 (s), 728 (s). 
 
PtII complex (50 b) 
A solution of [cis-PtCl2(cod)] (0.017 g, 0.06 mmol) and Lei ligand 17 (0.023 g, 0.06 
mmol) in CH2Cl2 (4 mL) was stirred for 1 h at room temperature. The solvent was 
removed in vacuo giving light yellowish powder (0.020 g, 52%). Mp 211-213 °C; 1H-
NMR (400 MHz, CDCl3) δ 8.02 (ddd, J = 12.5, 8.0, 1.5 Hz, 3H), 7.79 (dd, J = 8.0, 3.0 
Hz, 2H), 7.75 (dd, J = 4.0, 2.5 Hz, 2H), 7.73 (d, J = 2.5 Hz, 1H), 7.69-7.72 (m, 2H), 
7.51-7.56 (m, 3H), 7.46 (s, 1H), 7.42 (d, J = 4.3 Hz, 2H), 7.39 (d, J = 2.5 Hz, 2H), 7.37 
(s, 1H), 7.27 (d, J = 1.5 Hz, 1H), 6.54 (d, J = 11.5 Hz, 1H); 13C-NMR (100 MHz, 
CDCl3) δ 188.1, 150.1 (d, J = 17.5 Hz), 137.6, 136.6, 134.4 (d, J = 2.5 Hz), 133.8 (d, J 
= 11.0 Hz), 133.4, 133.2, 133.1 (d, J = 10.5 Hz), 132.6 (d, J = 5.0 Hz), 131.6, 130.8, 
130.2, 130.1 (d, J = 11.6 Hz), 129.2, 128.9, 128.8, 128.8, 128.7, 128.6, 128.4, 128.2, 
127.5, 126.9, 125.6, 125.3, 124.9, 124.7; 31P-NMR (162 MHz, CDCl3) δ24.8 (s, 1P,  
1
JPt-P = 3038 Hz); HRMS (ESI) [MH]+ m/z 623.0662 (Calcd. for [Pt(C27H22PO)Cl]  
623.0665); IR υ cm-1  3056 (s), 2918 (s), 1682 (s), 1641 (s), 1595 (s), 1481 (s), 1447 (s), 
1435 (s), 1307 (s), 1320 (s), 1240 (s), 1103 (s), 998 (s), 988 (s), 769 (s), 692 (s).  
 
Pt0 complex (54) 
A solution of [Pt(dba)2] (0.07 g, 0.095 mmol) and ferrochalcone 32 (0.05 g, 0.095 
mmol) in benzene (1 mL) was stirred for 2 h at room temperature. The solvent was 
removed in vacuo, giving a red powder (0.037 g, 32%). 31P-NMR (162 MHz, CDCl3) 
δ21.3 (s, 1P, JPt-P = 2912 Hz). 
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Pt0 complex (55) containing ligand 17 
a. Room temperature stirring 
A solution of [Pt0(PPh3)2η2-C2H4] (0.04 g, 0.057 mmol) and Lei ligand (0.02 g, 0.057 
mmol) in benzene (5 mL) was stirred for 2 h at room temperature. The mixture was 
filtered and the solvent was removed in vacuo giving a red powder (0.021 g, 38%).  
b. On heating at 60 ºC 
A solution of [Pt0(PPh3)2η2-C2H4] (0.04 g, 0.057 mmol) and Lei ligand (0.02 g, 0.057  
mmol) in benzene (5 mL) was stirred for 2 h at 60 ºC. The mixture was filtered and the 
solvent was removed in vacuo giving a red powder (0.047 g, 84 %). 
 
Mp 263-265 °C (decomp.); 1H-NMR (400 MHz, C6D6) δ 7.73-7.79 (m, 1H), 7.62 (d, J = 
7.7 Hz, 1H), 7.44 (s, 1H), 7.34-7.44 (m, 10H), 7.03-7.05 (m, 9H), 6.91-6.96 (m, 4H), 
6.76-6.80 (m, 3H), 6.66-6.73 (m, 6H), 5.43 (dd, J = 9.3, 6.6 Hz, 1H), 5.04 (m, 1H); 13C-
NMR (100 MHz, C6D6) δ 189.2, 141.2, 134.1, 132.4, 130.6 (d, J = 30.7 Hz), 129.7 (d, J 
= 3.4 Hz), 129.5, 129.0, 128.9, 128.8, 128.7, 128.6, 128.5, 128.4, 128.3, 128.2, 126.7, 
126.6, 73.4 (d, J = 53.8 Hz), 65.7 (d, J = 2.1 Hz); 31P-NMR (162 MHz, C6D6) δ 21.2 (s, 
1P,  1JPt-P = 2933 Hz); HRMS (ESI) [M]+ m/z 979.9470 (Calcd. for [Pt(C27H21PO)2]+  
979.9472); IR υ cm-1  3052 (s), 2920 (s), 1652 (s), 1622 (s), 1570 (s), 1558 (s), 1464 (s),  
1456 (s), 1436 (s), 1411 (s), 1297 (s), 1213 (s), 1196 (s), 1118 (s), 1095 (s), 1069 (s), 
1018 (s), 998 (s), 745 (s), 693 (s). 
 
RhI complex (57) 
A Schlenk tube was charged with a suspension of [RhCl(cod)]2 (0.037 g, 0.11 mmol) in 
THF (10 mL) was added ferrochalcone 32 (0.110 g, 0.22 mmol) in THF (5 mL). The 
dark reddish suspension changed immediately to a dull red solution. The solution was 
left to stir overnight at room temperature under a N2 atmosphere. After this time, the 
THF was removed in vacuo. The red residue was washed with diethyl ether (3 × 15 mL) 
and the organic washings were collected and filtered, combined and concentrated in 
vacuo to ca. 5 mL. After 24 h a red microcrystalline solid formed, which was separated 
by filtration and the filtrate was left for crystallization giving the title complex (0.088 g, 
35%). Mp  236-238 °C (decomp.); 1H-NMR (400 MHz, CDCl3) δ  8.20 (d, J = 15.7 Hz, 
1H), 7.79 (dd, J = 8.0, 4.0 Hz, 1H), 7.71 (m, 4H), 7.61 (m, 2H), 7.53 (m, 2H), 7.49 (dd, 
J = 7.5, 2.5 Hz, 3H), 7.39 (m, 2H), 6.86 (d, J = 15.7 Hz, 1H), 4.83 (t, J = 4.0 Hz, 2H), 
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4.52 (t, J = 4.0 Hz, 2H), 4.10 (s, 5H); 13C-NMR (100 MHz, CDCl3) δ 167.8, 133.8, 
133.6, 132.8, 132.7, 132.5, 132.2, 132.1, 131.1, 130.8, 130.7, 130.6, 129.2, 128.9 (d, J = 
5.5 Hz), 128.7, 127.1, 78.8 (d, J = 14.0 Hz), 72.8, 70.2, 70.1, 70.1, 69.8, 69.7, 68.3; 31P-
NMR (162 MHz, CDCl3) δ34.6-31.0 (dd, 1P,  JRh-Pb = 99.2 Hz, JPb-Pa = 468.8 Hz), 24.4-
20.9 (dd, 1P, JRh-Pa = 94.4 Hz, JPa-Pb = 470.4 Hz), 56.55 (s), 57.59 (s), 58.62 (s), 60.74 (d, 
JRh-P = 172.80 Hz, 1P); HRMS LIFDI [M]+ m/z  637.99 (Calcd. for 
[Rh(C31H25FePO)2Cl]  637.97); IR υ cm-1 3044 (s), 2821 (s), 1627 (s), 1553 (s), 1473 
(s), 1456 (s),  1325 (s), 1225 (s), 1189 (s), 1044 (s), 759 (s), 696 (s). 
 
RhI complex (58) 
A solution of [RhCl(cod)]2 (0.037 g, 0.11 mmol) and Lei ligand (0.086 g, 0.22 mmol) in 
benzene (10 mL) was stirred for 2h at room temperature. Finally, solvent was removed 
and concentrated to ca. 5 mL giving light yellow crystalline solid (0.145 g, 71%). Mp  
221-223 °C; 1H-NMR (400 MHz, CDCl3); 8.64 (m, 1H), 8.22 (m, 1H), 7.69 (m, 3H), 
7.63 (td, J = 7.0, 6.0, 2.7 Hz, 2H), 7.51 (dd, J = 7.3, 4.0 Hz, 1H), 7.30 (m, 2H), 7.23 (m, 
1H), 7.14 (t, J = 7.5 Hz, 1H), 7.04 (m, 1H), 6.95 (m, 3H), 6.78 (q, J = 8.0, 7.5 Hz, 2H), 
6.53 (m, 1H), 5.52 (m, 1H), 5.32 (ddd, J = 10.5, 7.5, 2.5 Hz, 0.5H), 4.82 (ddd, J = 7.5, 
4.0, 1.7 Hz, 0.5 H); 13C-NMR (100 MHz, CDCl3) δ 197.3, 192.5, 138.7, 137.5, 135.4 (d, 
J = 7.3 Hz), 134.8 (d, J = 8.5 Hz), 134.1, 133.8 (d, J = 6.8 Hz), 132.6 (d, J = 7.0 Hz), 
131.9, 131.5, 130.4, 130.1, 129.9, 129.8, 129.5, 129.4, 129.2 (d, J = 8.7 Hz), 128.9, 
128.8, 128.7, 128.5, 128.1, 127.9, 127.9 (d, J = 7.5 Hz), 127.7, 127.7, 127.3, 127.1, 
127.1, 126.9, 126.1 (d, J = 6.0 Hz), 125.5 (d, J = 5.3 Hz), 125.1, 124.5; 31P-NMR (162 
MHz, CDCl3) δ 34.4-30.8 (dd, 1P,  JPb-Pa = 474 Hz, JRh-Pb = 100 Hz), 25.2-21.7 (dd, 1P,  
JPa-Pb = 474 Hz, JRh-Pa = 93 Hz); HRMS LIFDI [M]+ m/z 887.16 (Calcd. for 
[Rh(C27H21PO)2] 887.17); IR υ cm-1 3054 (s), 2923 (s), 1695 (s), 1652 (s), 1635 (s), 
1595 (s), 1482 (s), 1456 (s), 1433 (s), 1384 (s), 1325 (s), 1225 (s), 1189 (s), 1092 (s), 
1044 (s), 1022 (s), 791 (s), 751 (s), 697 (s).  
 
CuI complex (59) 
[Cu(MeCN)4]PF6 (0.028 g, 0.075 mmol) was dissolved in CH2Cl2 (2.5 mL) and 
transferred by cannula to a solution of ferrochalcone 32 (0.075 g, 0.15 mmol) in CH2Cl2 
(2.5 mL) and stirred for 2 h at room temperature. The solvent was removed in vacuo and 
the crude product redissolved in minimum amount of CH2Cl2. Toluene was added and 
the mixture stirred for 1 h to give dark reddish precipitate, which was then filtered and 
washed with toluene and a small amount of ether to afford title compound (0.081 g, 50 
 92
%). Mp 214-219 °C; 1H-NMR (400 MHz, CD2Cl2) δ 8.12 (d, J =16.5 Hz, 1H), 7.73 (s, 
1H), 7.51 (m, 2H), 7.40 (m, 10H), 7.30 (s, 1H), 6.85-6.90 (m, 1H), 4.71 (m, 2H), 4.67 
(m, 2H), 4.14 (m, 5H); 13C-NMR (100 MHz, CD2Cl2) ; 190.5, 137.8 (d, J =8.3 Hz), 
134.4 (d, J =13 Hz), 134.1 (d, J =7.0 Hz), 133.5 (d, J =12 Hz), 132.9 (d, J =11.5 Hz), 
132.0, 131.2, 130.7 (d, J =19 Hz), 129.7 (d, J =12 Hz), 129.5 (d, J =12.6 Hz), 126.4, 
125.5, 117.3, 101.6 (d, J =9 Hz), 95.7, 74.5, 70.6, 70.1; 31P-NMR (162 MHz, CD2Cl2) δ 
-4.80 (s, 1P), -143.8 (septet, 1JP-F = 719.5 Hz); HRMS (ESI) [M]+ m/z 563.0297 (Calcd. 
For [Cu(C31H25FePO)] 563.0283); IR υ cm-1  3092 (bs), 2891 (s), 2223 (s), 1671 (s), 
1643 (s), 1561 (s), 1428 (s), 1389 (s), 1182 (s), 1092 (s), 997 (s), 831 (s), 776 (s), 692 
(s). 
 
CuI complex (60) 
To a stirred solution of ferrochalcone (0.028 g, 0.057 mmol) in CH2Cl2 (2.5 mL) was 
added a solution of [CuCl] (0.056 g, 0.057 mmol) in CH2Cl2 (2.5 mL) and reaction 
mixture was stirred for 1 h at room temperature. Finally it was filtered, and the filterate 
was concentrated giving light reddish powder (0.016 g, 46 %). Mp 197-199 °C 
(decomp); 1H-NMR (400 MHz, CD2Cl2) δ 8.28 (d, J = 13.7 Hz, 1H), 7.69 (m, 1H), 7.53 
(m, 6H), 7.39 (dt, J =13.0, 6.5 Hz, 5H), 7.32 (d, J =7.6 Hz, 1H), 6.99 (t, J =8.8 Hz, 1H), 
6.78 (d, J =15.0 Hz, 1H), 4.68  (bs, 2H), 4.49 (bs, 2H), 4.04 (s, 5H); 13C-NMR (100 
MHz, CD2Cl2) δ 145.1, 140.6 (d, J =13.5 Hz), 134.9 (d, J =15.5 Hz), 134.3 (d, J =5.8 
Hz), 132.3, 131.3, 131.2, 131.1, 130.1, 129.8 (d, J =6.5 Hz), 129.5 (d, J = 10.7 Hz), 
129.1, 128.7 (d, J = 6.0 Hz), 80.8, 73.4, 72.8, 70.6, 70.6, 70.4, 70.3 (d, J =5.0 Hz), 70.1; 
31P-NMR (162 MHz, CD2Cl2) δ -4.38 (s, 1P); HRMS (ESI) [M]+ m/z 563.0284 (Calcd. 
For [Cu(C31H25FePO)]  563.0277); IR υ cm-1  2921 (bs), 2850 (s), 2359 (s), 1700 (s), 
1652 (s), 1575 (s), 1506 (s), 1465 (s), 1436 (s), 1398 (s), 1314 (s), 1277 (s), 1168 (bs), 
1070 (s), 998 (s), 824 (s), 751 (s), 694 (s). 
 
CuI complex (61)    
 [Cu(MeCN)4]PF6 (0.028 g, 0.075 mmol) was dissolved in CH2Cl2 (2.5 mL) and 
transferred by cannula to a solution of thio-ferrochalcone (0.079 g, 0.15 mmol) in 
CH2Cl2 (2.5 mL) and stirred for 2 h at room temperature. The solvent was removed in 
vacuo and the crude product redissolved in minimum amount of dichloromethane. 
Toluene was added and the mixture stirred for 1 h to give red precipitate, which was 
then filtered and washed with toluene and a small amount of ether to afford title 
compound as a red solid (0.063 g, 37 %). Mp 231-233 °C (decomp.); 1H-NMR (400 
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MHz, C6D6) δ 7.78-7.73 (m, 2H), 7.72 (s, 1H), 7.70-7.66 (m, 4H), 7.64 (dd, J = 7.5, 3.7 
Hz, 4H), 7.60 (m, 1H), 7.46 (tdd, J = 7.5, 2.8, 1.0 Hz, 1H), 7.10-6.99 (m, 1H), 6.84 (d, J 
= 14.0 Hz, 1H), 6.38 (d, J = 14.0 Hz, 1H), 4.92 (app.t, J = 4.0 Hz, 2H), 4.72 (app.t, J = 
4.0 Hz, 2H), 4.23 (s, 5H); 13C-NMR (100 MHz, C6D6) ; 189.5, 137.1 (d, J =9), 134.3 (d, 
J =13), 133.4 (d, J =12), 133.1 (d, J =7.0), 132.8 (d, J =12), 132.0, 131.2, 130.6 (d, J 
=9), 129.7 (d, J =19), 129.5 (d, J =13), 126.4, 125.4, 116.3, 99.6 (d, J =9), 96.7, 74.5, 
70.6, 70.1; 31P-NMR (162 MHz, C6D6) δ 44.5 (s, 1P), -142.06 (septet, 1JP-F = 713 Hz); 
HRMS (ESI) [M]+ m/z  1127.0701 (Calcd. For [Cu(C31H25FePSO)2] 1127.0701); IR 
(KBr, υ cm-1): 3438 (bs), 2922 (s), 2359 (s), 2340 (bs), 1652 (s), 1635 (s), 1599 (s), 
1437 (s), 1377 (s), 1307 (s), 1104 (s), 1083 (s), 841 (s), 752 (s), 692 (s), 604 (s). 
 
CuI complex (62) 
To a stirred solution of thio-ferrochalcone ligand 33 (0.030 g, 0.057 mmol) in CH2Cl2 
(2.5 mL) was added a solution of [CuCl] (0.056 g, 0.057 mmol) in CH2Cl2 (2.5 mL) and 
reaction mixture was stirred for 2 h at room temperature. Finally the reaction mixture 
was filtered, and the filterate concentrated in vacuo affording a light red powder (0.023 
g, 63%). Mp 203-205 °C (decomp.); 1H-NMR (400 MHz, CD2Cl2) δ 7.82 (ddt, J = 13.5, 
7.0, 1.3 Hz, 6H), 7.56-7.59 (m, 3H), 7.51-7.54 (m,  3H), 7.49-7.50 (m, 1H), 7.37 (tdd, J 
= 7.5, 2.3, 1.2 Hz , 1H), 7.10 (dd, J = 7.8, 1.1 Hz, 1H), 6.70 (d, J = 14.5 Hz, 1H), 4.78 
(app.t, J = 4.0 Hz, 2H), 4.55 (app.t, J = 4.0 Hz, 2H), 4.14 (s, 5H); 13C-NMR (100 MHz, 
CD2Cl2) δ 192.1, 139.9 (d, J = 8 Hz), 134.1, 133.6 (d, J = 11 Hz), 133.3, 132.9 (d, J = 
11 Hz), 132.7, 132.6, 129.5, 129.3 (d, J = 13 Hz), 80.7, 73.3, 70.5, 70.2; 31P-NMR (162 
MHz, CD2Cl2) δ 41.2 (s, 1P); HRMS (ESI) [M]+ m/z  595.0 (Calcd. for 
[Cu(C31H25FePSO)] 595.00); IR υ cm-1  2919 (s), 2849 (s), 2361 (s), 1700 (s), 1684 (s), 
1645 (s), 1558 (s), 1520 (s), 1457 (s), 1437 (s), 1374 (s), 1304 (s), 1255 (s), 1104 (s), 
1074 (s), 998 (s), 755 (s), 691 (s), 609 (s). 
 
CuI complex (63) 
 [Cu(MeCN)4]PF6 (0.022 g, 0.060 mmol) was dissolved in CH2Cl2 (2.5 mL) and 
transferred by cannula to a solution of Lei ligand (0.047 g, 0.12 mmol) in CH2Cl2 (2.5 
mL) and the reaction mixture was stirred for 2 h at room temperature. The solvent was 
removed in vacuo and the crude product redissolved in a minimum amount of CH2Cl2. 
Toluene was added and the mixture stirred for 1 h to give a light yellowish precipitate, 
which was then filtered and washed with toluene and a small amount of ether to give the 
product (0.061 g, 59%). Mp 171-173 °C (decomp.); 1H-NMR (400 MHz, CD2Cl2) δ 
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8.09 (d, J = 15.0 Hz, 1H), 7.73 (d, J = 7.7 Hz, 2H), 7.64 (t, J = 7.5 Hz, 1H), 7.59 (s, 
1H), 7.47 (q, J = 8.0 Hz, 5H), 7.39 (s, 3H), 7.24 (t, J = 7.7 Hz, 3H), 7.05 (d, J = 6.5 Hz, 
4H), 7.01-6.90 (m, 1H); 13C-NMR (100 MHz, CD2Cl2) δ 141.5 (d, J = 9.0 Hz), 137.7, 
135.1, 134.3 (d, J = 11.3 Hz), 134.1 (d, J = 12.0 Hz), 131.6, 130.7, 129.8, 129.4, 128.8, 
118.1; 31P-NMR (162 MHz, CD2Cl2) δ -4.51 (s, 1P), -143.8 (septet 1JP-F = 712.8 Hz); 
HRMS (ESI) [M+H]+ m/z 849.2133 (Calcd. for [Cu(C27H2PO)2]  849.2132); IR υ cm-1  
3446 (s), 3056 (s), 2956 (s), 2924 (s), 2853 (s), 2359 (s), 1652 (s), 1600 (s), 1480 (s), 
1436 (s), 1332 (s), 1261 (s), 1215 (s), 1096 (s), 1016 (s), 839 (s), 748 (s), 693 (s).  
 
CuI complex (64) 
To a stirred solution of Lei ligand (0.022 g, 0.057 mmol) in CH2Cl2 (2.5 mL) was added 
a solution of [CuCl] (0.005 g, 0.057 mmol) in CH2Cl2 (2.5 mL) and reaction mixture 
was stirred for 2 h at room temperature. Finally the reaction mixture was filtered, and 
the filterate concentrated in vacuo to give light yellow powder (0.017 g, 60%). Mp 197-
199 °C (decomp.); 1H-NMR (400 MHz, CD2Cl2) δ 8.03 (d, J = 15.5 Hz, 1H), 7.69 (dd, J 
= 7.7, 4.0 Hz, 1H), 7.63 (dd, J = 8.3, 1.2 Hz, 2H), 7.53 (m, 1H), 7.51 (dd, J = 3.0, 1.3 
Hz, 2H), 7.48 (d, J =1.5, 1H), 7.44 (m, 3H), 7.39 (m, 4H), 7.35 (s, 1H), 7.32 (m, 3H), 
7.05 (d, J = 15.5 Hz, 1H), 6.99 (ddd, J = 9.5, 7.8, 1.0 Hz, 1H); 13C-NMR (100 MHz, 
CD2Cl2) δ 190.5, 140.4, 138.2, 134.8 (d, J = 16 Hz), 134.3 (d, J = 6.5 Hz), 132.9, 132.6, 
132.2, 131.2, 131.1 (d, J = 8.0 Hz), 130.8, 130.1 (d, J = 7.0 Hz), 129.5 (d, J = 10 Hz), 
129.1 (d, J = 15.5 Hz), 128.8 (d, J = 6.3 Hz); 31P-NMR (162 MHz, CD2Cl2) δ -3.47 (s, 
1P); HRMS (ESI) [M]+ m/z 455.0621 (Calcd. for [Cu(C27H21PO)] 455.0623); IR υ cm-1  
2922 (s), 1739 (s), 1695 (s), 1669 (s), 1652 (s), 1558 (s), 1583 (s), 1558 (s), 1533 (s), 
1464 (s), 1436 (s), 1419 (s), 1105 (s), 728 (s).  
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3.4.2 X-Ray Diffraction Data 
 
Diffraction data for complex 49, 50, 54, 55, 57, 58, 62 and 63 was collected at 110 K on 
a Bruker Smart Apex diffractometer with Mo-Kα radiation (λ = 0.71073 Å) using a 
SMART CCD camera.  Diffractometer control, data collection and initial unit cell 
determination was performed using “SMART”.  Frame integration and unit-cell 
refinement was carried out with “SAINT+”. Absorption corrections were applied by 
SADABS.  Structures were solved by “direct methods” using SHELXS-97 (Sheldrick, 
1997)158 and refined by full-matrix least squares using SHELXL-97 (Sheldrick, 
1997).159  All non-hydrogen atoms were refined anisotropically.   
 
Diffraction data for complex 64 was collected on a SuperNova diffractometer with Mo-
Kα radiation (λ = 0.7107 Å) using an Enhance (Mo) X-ray source.  OLEX2160 was used 
for overall structure solution, refinement and preparation of computer graphics and 
publication data.  Within OLEX2, the algorithms used for structure solution were 
“direct methods”, using the “A short history of SHELX (Sheldrick, 2007)/Bruker”.  
Refinement by full-matrix least-squares used the SHELXL-97161 algorithm within 
OLEX2.162  All non-hydrogen atoms were refined anisotropically.  Hydrogen atoms 
were placed using a “riding model” and included in the refinement at calculated 
positions.   
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 14: Single Crystal X-Ray details for PtII complex of ferrochalcone ligand (32) and 
Lei ligand (17). 
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Compound reference ijf0845 ijf1009 
Formula C31H25FePOCl2 
Pt 
C27H21POCl2 
Pt 
Formula weight 1005.06 658.40 
temp (K) 110(2) 110(2) K 
Radiation 0.71073 0.71073 
Cryst syst Triclinic Monoclinic 
Space group P-1 P 2(1)/n 
a(Å) 11.8386(5) 9.1527(13) 
b(Å) 12.7592(5) 14.931(2) 
c(Å) 13.7222(6) 16.591(2) 
α(°) 107.9840(10) 90 
β(°) 110.4270(10) 96.855(3) 
γ(°) 98.6050(10) 90 
V (Å3) 1768.81(13) 2251.2(5) 
Z 2 4 
Dcalcd. (Mg M-3) 1.887 1.943 
F(000) 976 1272 
Μ(mm-1) 5.038 2.163 
Crystal size (mm3) 0.27 x 0.05 x 0.03 0.20 x 0.05 x 0.04 
θ  range for data 2.56 to 28.27 1.84 to 28.31 
Collection (°) 
Index ranges 
-15 <=h<=15, 
-16<=k<=17, 
-18<=I<=18 
-12 <=h<=12, 
-19<=k<=19, 
-22<=I<=21 
No. of rflns collected 18390 22990 
Refinement method Full-matrix least-squares 
on F2 
Full-matrix least-squares 
on F2 
GOOF on F2 1.038 1.038 
R1, wR2(I>2σ(I)) 0.0264, 0.0572 0.0242, 0.0536 
R1, wR2(all data) 0.0325, 0.0597 0.0308, 0.0562 
 
Further details can be found in the Appendix, including the cif files on the CD. 
 
Table 15: Single Crystal X-Ray details for Pt0 complex of ferrochalcone ligand (32) and 
Lei ligand (17). 
 
Compound reference ijf0924 ijf0908 
Formula C74H62Fe2P2O2 C54H42P2O2 
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Pt Pt 
Formula weight 1351.97 979.91 
temp (K) 110(2) 110(2) 
Radiation 0.71073 0.71073 
Cryst syst Monoclinic Monoclinic 
Space group P2(1)/c C2/c 
a(Å) 18.7251(11) 10.6144(14) 
b(Å) 18.9632(11) 19.110(3) 
c(Å) 17.6708(10) 20.148(3) 
α(°) 90 90 
β(°) 110.0790(10) 92.197(2) 
γ(°) 90 90 
V (Å3) 5893.3(6) 4083.8(10) 
Z 4 4 
Dcalcd. (Mg M-3) 1.524 1.594 
F(000) 2728 1960 
Μ(mm-1) 2.956 3.559 
Crystal size (mm3) 0.11 x 0.08 x 0.02 0.16 x 0.14 x 0.06 
θ  range for data 1.58 to 30.01 2.02 to 25.10 
Collection (°) 
Index ranges 
-26 <=h<=26, 
-26<=k<=25, 
-24<=I<=24 
-12 <=h<=12, 
-22<=k<=22, 
-23<=I<=23 
No. of rflns collected 66489 15767 
Refinement method Full-matrix least-squares 
on F2 
Full-matrix least-squares 
on F2 
GOOF on F2 1.017 1.072 
R1, wR2(I>2σ(I)) 0.0336, 0.0640 0.0376, 0.0882 
R1, wR2(all data) 0.0552, 0.0707 0.0484, 0.0930 
 
Further details can be found in the Appendix, including the cif files on the CD. 
Table 16: Single Crystal X-Ray details for RhI complex of ferrochalcone ligand (32) and 
Lei ligand (17). 
 
Compound reference ijf0932 ijf0923 
Formula C64.5H55Cl7Fe2O2P2 
Rh2 
C54H42P2O2 . Cl 
Rh 
Formula weight 1489.69 1274.66 
temp (K) 110.0 110(2) 
Cryst syst Triclinic Triclinic 
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Space group P-1 P-1 
a(Å) 12.8584(11) 12.6642(19) 
b(Å) 13.2521(12) 14.165(2) 
c(Å) 20.6616(18) 19.638(3) 
α(°) 82.442(2) 109.472(3) 
β(°) 74.112(2) 103.210(3) 
γ(°) 62.002(2) 93.300(3) 
V (Å3) 2989.9(5) 3199.0(8) 
Z 2 2 
Dcalcd. (Mg M-3) 1.655 1.323 
F(000) 1498 1326 
Μ(mm-1) 1.429 0.408 
Crystal size (mm3) 0.16×0.06×0.03 0.23 x 0.22 x 0.12 
θ  range for data 3.7 to 56.66 1.56 to 28.33 
Collection (°) 
Index ranges 
-17 ≤h≤17, 
-17≤k≤17, 
-27≤I≤27 
-16 <=h<=16, 
-18<=k<=18, 
-26<=I<=26 
No. of rflns collected 23986 33292 
Refinement method Full-matrix least-squares 
on F2 
Full-matrix least-squares 
on F2 
GOOF on F2 0.687 1.031 
R1, wR2(I>2σ(I)) 0.0490, 0.0829 0.0398, 0.0931 
R1, wR2(all data) 0.1038, 0.0959 0.0490, 0.0997 
 
Further details can be found in the Appendix, including the cif files on the CD. 
 
 
Table 17: Single Crystal X-Ray details for CuI complex of ferrochalcone ligand (32) and 
Lei ligand (17). 
 
Compound reference ijf0933 ijf0919 ijsf1105 
Formula C31H25FePSOCl 
Cu 
C56H45P2O2 . PF6 
Cu 
C54H42Cl2O2P2 
Cu2 
Formula weight 716.31 1204.23 982.80 
temp (K) 110(2) 110(2) 110.0 
Cryst syst Triclinic Triclinic Monoclinic 
Space group P-1 P-1 P21/c 
a(Å) 10.9354(12) 13.2476(11) 9.30005(17) 
b(Å) 11.7472(13) 14.7778(12) 18.4790(3) 
c(Å) 12.8931(14) 15.8400(13) 13.1567(3) 
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α(°) 67.871(2) 80.960(2) 90.00 
β(°) 73.376(3) 71.685(2) 97.4728(18) 
γ(°) 84.793(3) 67.983(2) 90.00 
V (Å3) 1469.9(3) 2726.5(4) 2241.84(7) 
Z 2 2 2 
Dcalcd. (Mg M-3) 1.618 1.467 1.456 
F(000) 728 1232 1008 
Μ(mm-1) 1.641 0.749 1.182 
Crystal size (mm3) 0.08 x 0.06 x 0.05 0.42 x 0.22 x 0.05 0.2107 x 0.1733 x 
0.1132 
θ  range for data 1.77 to 25.04 1.36 to 28.30 6.14 to 64.18 
Collection (°) 
Index ranges 
-12 <=h<=13, 
-13<=k<=13, 
-15<=I<=15 
-17 <=h<=17, 
-19<=k<=19, 
-21<=I<=21 
-13 ≤h≤13, 
-26≤k≤27, 
-18≤I≤19 
No. of rflns collected 11967 28307 21151 
Refinement method Full-matrix least-
squares on F2 
Full-matrix least-
squares on F2 
Full-matrix least-
squares on F2 
GOOF on F2 1.004 1.026 1.032 
R1, wR2(I>2σ(I)) 0.0416, 0.0854 0.0355, 0.0877 0.0312, 0.0705 
R1, wR2(all data) 0.0622, 0.0950 0.0462, 0.0938 0.0397, 0.0746 
 
 
Further details can be found in the Appendix, including the cif files on the CD. 
 
 
 
 
Chapter 4: Gold(I) complexes of the alkene-phosphine 
ligands; synthesis and catalytic activity  
 
 “All that glitters may not be gold, but at least it contains free electrons” 
(John Desmond Bernal, Irish Physicist) 
 
4.1 Gold – a precious metal 
Gold has been present in the collective conscience of mankind since the beginning of 
known history.163 Alchemy, whose main goal was to produce gold starting from other 
metals, is considered nowadays as the precursor of modern chemistry.164 The main use 
of gold was and still is in jewellery and decorative arts. Being unaffected by air, 
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moisture and most corrosive reagents, gold is well-suited either as a base metal for 
various objects, or as a protective-coating on other more reactive materials. Being the 
most malleable and ductile of all metals it can be easily shaped into different things. 
However, because of its softness in its pure-state, it is often mixed with other metals 
(such as silver, copper, nickel, palladium etc.) in order to modify its physical properties. 
It equally and effectively possesses numerous industrial applications and used as a 
protective-coating against radiation in the aeronautical and spatial industry, as a heat 
shield in various high tech industries (including in Formula 1 cars) and as reflective 
layer on some optical devices, and as colouring agent in special types of glass, or as a 
toner in photography. 
 
The most important industrial applications are found in electronics due to its excellent 
conductivity and its good general chemical resistance. Gold is also used in medicine. 
Radioactive gold isotopes are utilized in diagnosis, while several gold complexes 
proved to be active against cancer165 or arthritis.166 In dentistry, gold alloys are often 
employed for fillings, crowns, bridges and orthodontic appliances. High quality pure 
metallic gold is non-toxic and non-irritating and can be used in food, having the E175 
label.167 However, it is tasteless and it does not have any nutritional effect, leaving the 
body unaltered. 
 
4.2 Gold in chemistry 
The chemistry of gold has lived in the shadow of other metals for a long time until 
recently chemists have focused their work in this golden direction. Recently, synthetic 
chemists have started paying great interest to the catalytic properties of the gold 
complexes,168 with gold emerging as one of the most discussed topic with in the 
catalysis community.169 The research group of Hashmi, Toste, Bond, Haruta, Hutchings, 
Ito and Hayashi has initiated key contributions towards gold reactivity and opened new 
perspectives for the chemical community.170 
 
For economical reasons, the catalytical transformations involving gold are of course 
much more interesting than the stoichiometrical ones. Examples of catalysis by gold 
have been known since the beginning of the last century,171 but, despite the evidence, 
chemists continued to consider gold as “catalytically dead” because of its stability in 
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elementary state. However, the recent work on the high catalytic activity of gold 
compounds in catalysis proved the opposite.172  
Gold-catalyzed reactions fall into two major categories, heterogeneous catalysis and 
homogenous catalysis. Au-complexes catalyze the transformation of C=C and C≡C 
bonds173 into a diverse array of reactions including: nucleophilic substitution,174 
hydration,175 cycloaddition,176 rearrangement,177 hydrosilylation,178 oxidation,179 
carbene transfer (C-H functionalisation),180 epoxidation,181 hydroamination182 and 
cycloisomerisation.183   
Heterogeneous catalysis can involve gold nanoparticles and thiol-monolayer gold 
surfaces. Solid gold catalysts can be recycled, and when prepared in the form of smaller 
clusters (particle size of ca.5 nm) are highly active and selective for reactions such as 
CO oxidation in the presence of H2,184 water–gas shift,185 alcohol oxidation,186  and 
some C–C forming reactions.187 
Homogenous catalysis involves gold(I) and gold(III) metal complexes and is widely 
used in organic synthesis.188 Since 2000, homogenous gold catalysis of organic 
reactions has experienced exponential growth and now chemists working in 
homogenous catalysis routinely consider gold complexes in their investigation. The use 
of gold(I) and gold(III) complexes as efficient homogenous catalysts in a wide variety 
of organic  transformations has been highlighted in the last years.189 The popularity of 
these processes, which allow the formation of both C-C and C-X bonds, is largely due 
to the significant increase in molecular complexity and the impressive structural 
diversity that they can provide.190 
4.2.1 Gold(I) complexes 
Gold(I) complexes are d10 and exhibit either LAuX or L2Au+ composition. They all 
show a linear, bicoordinated geometry. They usually require a strong σ-donor ligand in 
order to stabilize the metal centre. The most common ligands include phosphines, 
phosphites, N-heterocyclic carbenes or alkenes. The X ligand is generally weakly 
coordinating, which can be easily displaced by the substrate during the catalysis 
reaction. LAuX complexes can be either covalent (X= Cl or Br) or cationic (X= BF4, 
PF6, TfO etc.) Some of the most common gold(I) complexes are given below in Figure 
1. 
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Figure 1: Some of the most common AuI complexes with LAuX composition. 
 
4.2.2 Gold(III) complexes 
Gold(III) catalysts are d8 complexes with AuX3, AuX4- anion or sometimes LAuX3 
composition. Most of these complexes show a square planar geometry. They exhibit 
reduced specificity and are less active as compared to the gold(I) catalyst. Below are 
given some of the important examples of gold(III) catalyst (Figure 2). 
 
..
Na[AuCl4][n-Bu4N][AuCl4]Q[AuR2Cl2] [AuR2Cl]2
Q = (PPh3)2N+, n-Bu4N+
R = C6F5, Mes
 
Figure 2: Some common examples of AuIII complexes. 
 
Au(I) and Au(III) complexes display markedly different behaviour in similar reactions depending on the 
reaction pathway, leading to different products and substitution pattern.191 It is observed that Au(I) could 
be the active species where a soft π-acid is required (such as in cycloisomerisation), whereas Au(III) may 
be the active species where lewis acidity is required (in neutral or cationic form).192 
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It has been found recently that transition metal-catalysed cycloisomerisation reactions of enyne systems 
have been a subject of intense research affording a range of structurally diverse products,193 by 
appropriate choice of the catalyst and substrates.194 The selective synthesis of different cyclic products 
from the same starting materials by subtle modifications to the catalytic conditions is an interesting but 
often troublesome topic for chemists.195 However, the gold catalyst has widened its application in this 
regard by its versatile catalytic activities.196 
 
4.3 Cycloisomerisation 
 
The cycloisomerisation of 1,n-enynes (n=5-8), mediated by AuI and AuIII complexes has received 
considerable attention, particularly 1,5- and 1,6-, although 1,7- and 1,8-enynes have also been 
investigated. Enyne cycloisomerisation can be catalysed by Ru,197 Pd,198 Pt,199 Ir,200 Rh201 and Cu202 
however AuI is usually more active and displays very high selectivity.203 We have concentrated on the 
cycloisomerisation of 1,5-enynes resulting in the synthesis of bicyclo[3.1.0]hexanes, which is particularly 
facile.204 The group of Toste has shown that a range of alkyl and aryl substituted 1,5-enynes undergo 
Au(I)-catalysed cycloisomerisation to afford bicyclo[3.1.0]hexyl ring systems (Scheme 1).205 
R1
R2
R3
R4
[Au]+
R = alkyl , aryl H
R3
R4
R2
R1
 
Scheme 1: AuI-catalyzed cycloisomerisation of 1,5-enynes. 
There are a number of natural products containing the bicyclo[3.1.0]hexane core, for example 
prostaglandin EI analogues such as 65 (Figure 3).206  
65
 
Figure 3: The structure of the prostaglandin EI analogue (65). 
 
Another well known example is of α-cubebene 66 (a tricyclic sesquiterpene), which contain a 
tricyclo[4.4.0.0]decane core sysnthesized by Fürstner using a 1,5-enyne cycloisomerisation reaction 
(Figure 4).207 
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Figure 4: The structure of α-cubebene (66). 
 
Another example from the group of Toste is that of (+)-lycopladine A (67),208 a natural 
product from the club moss Lycopodium complanatum.209 An Au-catlysed 
cycloisomerisation of 1,5-enyne 68 affords the bicyclo[4.3.0]nonane core. 
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[AuCl(PPh3)]/AgBF4 
          (10 mol%)
CH2Cl2, MeOH, 95%
68 69
67
 
 
Scheme 2: Key Au-catalysed transformation in the total synthesis of (+)-lycopladine A. 
 
Nolan et al also reported the synthesis of an unexpected bicyclo[3.1.0]hexene as a product in a Au(I)-
catalysed cycloisomerisation of 1,5-enyne (Scheme 3).210  
 
(IPr)Au(NCMe)PF6
(IPr)AuCl/AgPF6
30%
30%
15%
12%
41%
42%
[Au] (2 mol %)
DCM , rt , 5 min
 
 
Scheme 3: AuI catalyzed cycloisomerisation of 1,5-enynes bearing a propargylic acetate. 
The aim of this part of project was to prepare AuI complexes containing the chalcone- based alkene-
phosphine and alkene-thio phosphine ligands. Previously considerable work has been done on both 
alkene- and phosphine-based ligands, however the chemistry of Au complexes involving hybrid alkene-
phosphine ligands has not been fully explored in benchmark catalytic reactions, which is thus addressed 
in this chapter.  
 
4.4 Results and Discussion 
Ferrochalcone gold(I) chloride complex 70 was formed by  the reaction of ferrochalcone 
32 with dimethylsulfide gold(I) chloride in presence of dry CH2Cl2. Room temperature 
stirring for 2 h, followed by filtration gave clear solution resulting from the formation of 
AuI complex (Scheme 4). 
7032
71% yield
[Au(SMe2)Cl]
DCM
rt, 2 h
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Scheme 4: Synthesis of Au
I
 complex of 32 using [Au(SMe2)Cl]. 
The product was analysed by NMR spectroscopy and mass spectrometry. The 31P NMR 
spectrum of 70 showed a shift from δ -13.0 (free ligand) to δ 28.3 in the complexed 
ligand. The 1H NMR spectrum showed a very negligible shift for the α-H (∆δ=δfree –
δcoordinated (0.03 ppm)) as compared to the shift for the β-H (0.33 ppm). Elemental 
analysis of the product obtained was low in carbon and hydrogen showing the presence 
of an impurity in the complex. However, mass spectrometry (LIFDI) confirmed the 
formation of [Au(C31H25FePO)Cl]+ complex with m/z of 732.0269. 
 
The reaction was performed in the dark, as the complex is light sensitive. Different 
solvents were used to crystallize the complex, and small red crystals were formed in 
CD2Cl2 solution, which were then analysed by XRD to obtain a solid-state single crystal 
structure.  
 
The X-ray structure shows that ferrochalcone 32 acts as a monodentate ligand binding 
through the phosphorus moiety only and there is no alkene interaction at all as given in 
(Figure 5). 
 
 
Figure 5: X-ray crystal structure of Au
I
 complex of 32. 
 
Hydrogen atoms removed for clarity. Thermal ellipsoids shown at 50%.  Bond lengths (Ǻ): 
C(19)-C(20) = 1.340(8), C(20)-C(21) = 1.490(7), C(21)-O(1) = 1.224(7), Au(1)-Cl(1) = 
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2.2878(13), Au(1)-P(1) = 2.2350(13), C(1)-P(1) = 1.807(6), C(7)-P(1) = 1.819(5), C(13)-P(1) = 
1.829(5), Bond Angles (º) : P(1)-Au(1)-Cl(1) = 178.05(5), C(13)-C(18)-C(19) = 123.1(5), 
C(20)-C(19)-C(18) = 122.9(5), C(19)-C(20)-C(21) = 121.9(6), C(22)-C(21)-C(20) = 117.2(5), 
C(1)-P(1)-C(7) = 104.2(3), C(1)-P(1)-C(13) = 107.2(2), C(7)-P(1)-Au(1) = 111.33(17), C(7)-
P(1)-C(13) = 104.2(2), C(13)-P(1)-Au(1) = 114.96(18). 
 
The AuI complex 70 showed a linear geometry with a P-Au-Cl bond angle of 178.05(5) 
as expected for most of the AuI complexes. The alkene bond length for C19-C20 (1.340 
Ǻ) is similar to that for the ethene C=C bond (1.333 Ǻ) showing that the alkene is not 
involved in bonding with the metal.  
 
As for ligand 32, Lei ligand 17 was also treated with dimethylsulfide gold(I) chloride to 
obtain the Au complex (Scheme 5). 
71
[Au(SMe2)Cl]
68% yield
17
DCM
rt, 2 h P
Ph
PhAu
Cl
O
Ph2P
O
 
Scheme 5: Synthesis of AuI complex of 17 using [Au(SMe2)Cl]. 
 The product obtained was then analysed by both 1H and 31P NMR spectroscopy along 
with mass spectrometry. A shift in the position of α-H from δ 6.93 to δ 6.97 and for β-
proton from δ 8.35 to δ 8.12 was observed. A shift by 31P NMR from δ -13.0 to δ 28.7 
(∆δ=δfree–δcoordinated (41.65 ppm)) which confirmed an interaction between metal and the 
ligand. The LIFDI mass spectrum showed a ion at m/z 624.05 corresponding for 
[Au(C27H21PO)Cl]+. The yellow complex 71 is soluble in most solvents. Yellow needles 
were grown from a CD2Cl2 solution of Lei (Au) complex. The crystals were analysed by 
XRD analysis. Surprisingly a [2+2] cycloaddition product was found to have formed 
(Figure 6). As the [2+2] cycloaddition product was formed through photochemical 
reaction, hence it’s not possible to characterise the product. 
 108
72
O
O
Au
Cl
Au
Cl
Ph
Ph
PPh2
PPh2
 
Figure 6:  [2+2] cycloaddition product of complex 71. 
 
These crystals from the same batch were further analysed by Professor Paul Raithby at 
the University of Bath. The structure obtained is shown in Figure 7. 
 
 
Figure 7: X-ray crystal structure of Lei-(Au) complex 71 (determined in Bath). 
 
Hydrogen atoms removed for clarity. Thermal ellipsoids shown at 50%. Bond lengths(Ǻ): 
C(19)-C(20) = 1.333(6), C(20)-C(21) = 1.485(6), C(21)-O(1) = 1.217(5), Au(1)-Cl(1) = 
2.2870(11), Au(1)-P(1) = 2.2356(11), C(13)-P(1) = 1.824(4), C(7)-P(1) = 1.816(4), C(1)-P(1) = 
1.816(4), Bond Angles(º) : P(1)-Au(1)-Cl(1) = 176.90(4), C(22)-C(21)-O(1) = 120.1(4), C(20)-
C(21)-O(1) = 121.9(4), C(18)-C(19)-C(20) = 126.5(4), C(13)-C(18)-C(19) = 121.6(4), P(1)-
C(13)-C(18) = 120.2(3). 
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The crystal-packing for the above structure is given in Figure 8.  
 
 
 
Figure 8: Crystal packing of Lei-(Au) complex 71 (determined in Bath). 
 
The packing distance between C=C bonds was found to be  4.38 Å, which is outside 
Schmidt’s idealized distance for facile [2+2] cycloaddition (ca. 4 Ǻ). The important 
bond length to be considered is C(19)-C(20) alkene double bond which is 1.333(6) Ǻ 
showing no involvement in either alkene metal bonding nor any type of cycloaddition 
reaction as previously observed. Whereas, the bond angle for P-Au-Cl is 176.90º. The 
two alkene bonds are placed quite far apart to be involved in any kind of interaction 
with AuI.  
 
The X-ray analysis for the crystal analysed in York showed that the structure was 
subjected to disorder arising from the presence of the 2+2 cycloaddition dimer. The 
occupancies of the disordered residue were refined to a 70:30 ratio of the 
dimer:monomer respectively. 
 
Cinnamoyl derivatives (chalcones) are prone to photoinduced [2π+2π] photocycloaddit-
-ion (PCA). Two types of cycloaddition are possible: “head-to-head” or “head-to-
tail”.211 It is the E-isomer that is usually involved in the PCA reaction. Also, it is found 
that the conformational transitions of chalcones can affect, to a considerable extent, the 
reactivity of the CH=CH bonds and the stereoisomerism of the PCA products.212 
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The single crystal X-ray structure shows that gold is bonded to the Lei ligand through 
phosphorus only and no alkene involvement is observed. The alkene moiety of the 
ligand undergoes a PCA reaction in the solid-state to give a cyclobutane ring as shown 
below in Figure 9. 
 
 
 
 
 
 
Figure 9: X-ray crystal structure of Lei-(Au) complex (72), [2+2]) cycloaddition product of 
complex 71. 
 
Selected bonds/angles for the [2+2] cycloaddition product. Hydrogen atoms removed for clarity. 
Thermal ellipsoids shown at 50%. Bond lengths (Ǻ): C(35)-C(36) = 1.547(8), C(34)-C(35) = 
1.517(10), C(34)-O(2) = 1.211(18), Au(2)-Cl(2) = 2.2877(10), Au(2)-P(2) = 2.2336(11), C(42)-
P(2) = 1.818(10), C(43)-P(2) = 1.813(4), C(49)-P(2) = 1.817(4), C(36)-C(35#) = 1.594(8), 
C(36#)-C(35) = 1.594(8), Bond Angles(º) : P(2)-Au(2)-Cl(2) = 176.70(4), C(41)-C(42)-P(2) = 
116.9(7), C(37)-C(42)-P(2) = 122.8(7), C(35)-C(36)-C(37) = 118.8(5), C(34)-C(35)-C(36) = 
115.5(5), C(33)-C(34)-C(35) = 116.2(7), C(35)-C(34)-O(2) = 122.1(10), C(33)-C(34)-O(2) = 
121.6(9), C(37)-C(36)-C(35#) = 117.5(5), C(36)-C(35)-C(36#) = 90.7(4). 
 
The bond length for C=C bond was 1.547(8) Ǻ showing a shift from a C=C double bond 
character to single bond, as a result in the formation of a cyclobutane ring. The PCA of 
alkenes (chalcones) can proceed by two paths, through either the singlet state or triplet 
state (due to intersystem crossing). In the former case, the concerted PCA reaction 
occurs, which is allowed by orbital symmetry (through the formation of an excimer). In 
the second case, the PCA reaction proceeds according to the radical mechanism to form 
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an intermediate 1,4-biradical. The crystal structure obtained for the Lei (Au) complex 
confirmed the formation of a cyclobutane ring as a result of photocycloaddition in the 
alkene moiety of the Lei (Au) complex 71. 
 
We then further explored the Au metal coordination chemistry with phosphine variants 
of dba (dibenzylidene acetone). Dba is one of the most widely used ligand in our 
research group.  DbaPHOS 73 and monodbaPHOS 74 are the two ligands used for the 
Au metal coordination studies, and the reason why they were selected is that both of 
these ligands contain an alkene and phosphine moiety similar to that of chalcone alkene-
phosphine ligands (Figure 10). 
73 74
 
Figure 10: The structure of dbaPHOS (73) and monodbaPHOS (74). 
 
The plan was to conduct a small scale study (by NMR) on the synthesis of Au 
complexes with dbaPHOS and monodbaPHOS.213 The reaction of dbaPHOS 73 with 
[Au(SMe2)Cl] was conducted in CH2Cl2 in a ligand metal ratio of (1:2) (Scheme 6).  
The product obtained was analysed by different analytical techniques. There is a shift in 
the 31P NMR spectrum from δ- 14.09 to δ 33.64 showing a phosphorus Au interaction; 
also there is a signal at δ 31.17.Similarly, a small shift in the position of both α-H and β-
H was observed.  
73
[Au(SMe2)Cl]
(1:2), DCM
37% yield
75
rt, 2 h
 
Scheme 6: Synthesis of Au-complex of dbaPHOS using [Au(SMe2)Cl]. 
Monodba-PHOS was reacted in the same way with [Au(SMe2)Cl] in CD2Cl2 (Scheme 
7).  
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74
[Au(SMe2)Cl]
(1:1), DCM
41% yield
76rt, 2 h
 
Scheme 7: Synthesis of Au-complex of monodbaPHOS using [Au(SMe2)Cl]. 
A shift in the 31P NMR spectrum from δ -13.75 (free ligand) to δ 28.02 with a shift of 
38.76 ppm (∆δ=δfree –δcoordinated) was observed in the 31P NMR spectrum. A slight shift 
for the two protons was also observed in the 1H NMR spectrum. The LIFDI mass 
spectrum gives a mass ion at m/z 650.0698 corresponding to [C29H23POAuCl]+, 
confirming the formation of AuI complex for the MonodbaPHOS. It was observed that 
the monodbaPHOS Au complex crystallizes out as yellow needles from the NMR 
sample after a few days. XRD analysis confirmed 77 as the structure (Figure 11). 
77
Au
Cl
Au
Cl
O
O
PPh2
PPh2
 
Figure 11: [2+2] cycloaddition product of complex 76. 
 
The X-ray crystal structure for the monodba-PHOS (Au) complex is given in Figure 12. 
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Figure 12: X-ray crystal structure of monodbaPHOS-(Au) complex. 
Selected bonds/angles for the [2+2] cycloaddition product 77. Hydrogen atoms removed for 
clarity. Thermal ellipsoids shown at 50%. Bond lengths (Ǻ): C(6A)-C(7A) = 1.57(4), C(7A)-
C(8A) = 1.551(14), C(8A)-C(9A) = 1.53(3), C(9A)-C(10) = 1.56(5), C(9A)-O(1) = 1.29(4), 
C(7A)-C(8A1) = 1.596(16), C(8A)-C(7A1) = 1.596(16), Au(1)-Cl(1) = 2.2880(8), Au(1)-P(1) = 
2.2305(8), Bond Angles(º) : C(6A)-C(7A)-C(8A) = 113.9(14), C(7A)-C(8A)-C(9A) = 115(2), 
C(6A)-C(7A)-C(8A1) = 127(2), C(7A)-C(8A)-C(7A1) = 89.1(8), C(8A)-C(7A)-C(8A1) = 
90.9(8), C(9)-O(1)-C(9A) = 14(2), O(1)-C(9A)-C(8A) = 129(3), O(1)-C(9A)-C(10) = 109(2), 
P(1)-Au(1)-Cl(1) = 175.12(3). 
The presence of the dimerised cycloaddition product is not unprecedented for dba. Dba 
has been shown to undergo intermolecular [π2s+π2s] cycloaddition in the solution 
state.214 In isolation dba does not undergo photochemical [π2s+π2s] cycloaddition in the 
solid-state as the structure does not meet the required criteria.  According to Schmidt’s 
topochemical principles dba cannot undergo cycloaddition in the solid-state as the C=C 
double bonds in adjacent molecules are more than 4 Å apart. Dba has been shown to 
undergo photochemical cycloadditions when co-crystallised with additives such as 
UO2Cl2 and SnCl4.215 These additives change the crystal packing of the dba molecules, 
therefore aligning the alkene bonds in an orientation that allows them to react. It is 
worthy of note that the [2+2] cycloaddition reaction has occurred on the most hindered 
alkene. The presence of the mixture of compounds in the crystal suggested that a 
photochemical [π2s+π2s] reaction could be occurring in the solid-state. 
 
A comparison of AuI complexes for ligand (32), (17) and (74) is given in Table 1. All of 
these AuI metal complexes exhibit a linear geometry.  
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Table 1 : Comparison of the bond lengths in Au(I) complexes of ferrochalcone (70), Lei 
ligand (71). 
 
Au(I) complex (70) Au(I) complex (71) 
Bond Length, Ǻ Bond Length, Ǻ 
C(19)-(20) 1.340(8) C(19)-C(20) 1.333(6) 
C(20)-(21) 1.490(7) C(20)-C(21) 1.485(6) 
C(21)-O(1)  1.224(7) C(21)-O(1) 1.217(5) 
C(1)-P(1) 1.807(6) C(1)-P(1) 1.816(4) 
C(7)-P(1) 1.819(5) C(7)-P(1) 1.816(4) 
C(13)-P(1) 1.829(5) C(13)-P(1) 1.824(4) 
Au(1)-P(1) 2.2350(13) Au(1)-P(1) 2.2356(11) 
Au(1)-Cl(1) 2.2878(13) Au(1)-Cl(1) 2.2870(11) 
 
The bond length for the C=C double bond in ethane is 1.33 Å.216 The bond length for 
the non-complexed and complexed ligand is similar to ethene, 1.334 Å indicating that 
alkene is not involved in any interaction with the metal. The ligand is coordinated to 
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metal through phosphorus giving a linear geometry. A comparison between other 
important bonds showed very similar values. 
In addition to this a comparison of the bond lengths between gold(I) complexes of Lei 
ligand ([2+2] cycloaddition product) 72 and monodbaPHOS ligand ([2+2] cycloaddition 
product) 77 was done as given in Table 2. 
Table 2: Comparison of the bond lengths in gold(I) complexes of  Lei ligand (72) and 
monodbaPHOS ligand (77). 
 
Au(I) complex (72) 
(2+2) cycloaddition product of 71 
Au(I) complex (77) 
(2+2) cycloaddition product of 76 
Bond Length, Ǻ Bond Length, Ǻ 
C(35)-C(36) 1.547(8) C(7A)-C(8A) 1.551(14) 
C(34)-C(35) 1.517(10) C(8A)-C(9A) 1.53(3) 
C(34)-O(2) 1.211(18) C(9A)-O(1) 1.29(4) 
C(36)-C(35#) 1.594(8) C(7A)-C(8A1) 1.596(16) 
C(36#)-C(35) 1.594(8) C(8A)-C(7A1) 1.596(16) 
Au(2)-P(2) 2.2336(11) Au(1)-P(1) 2.2305(8) 
Au(2)-Cl(2) 2.2877(10) Au(1)-Cl(1) 2.2880(8) 
 
The C=C bond length in the cyclobutane of the Lei-Au(I) complex 72 is 1.547(8) Ǻ 
which is quite higher than the bond length for C=C double bond in ethane 1.33 Å and is 
similar to that of a single bond. The same phenomena were observed for the 
monodbaPHOS-AuI complex 77.    
 
A small scale reaction (by NMR) was conducted for the synthesis of Au complex for the 
triphenylphosphine ligand. To a CD2Cl2 solution of [Au(SMe2)Cl] was added PPh3 and 
the reaction mixture was stirred for 2 h. The solution was filtered to get a clear solution, 
reduced in vacuo and analysed by NMR spectroscopy (Scheme 8). The 31P NMR 
spectrum showed a shift in the position of phosphorus peak from δ -4.57 (ligand) to δ 
34.1. The synthesis of complex was further confirmed by mass spectrometric analysis. 
 
[Au(SMe2)Cl]
78 79
58% yield
PPh3
(1:1), DCM
rt, 2 h
 
Scheme 8: Synthesis of Au-complex of PPh3 using [Au(SMe2)Cl]. 
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4.4.1 Catalysis 
As we have successfully managed to synthesise Au complexes for different alkene 
phosphine ligands including the chalcone ferrocene ligand, the Lei ligand and the dba 
ligand, the plan was to use them in homogenous catalysis. The reactivity of these 
complexes as catalysts for the cycloisomerisation of 4-phenyl-1-hexen-5-yne was thus 
assessed. The substrate, 4-phenyl-1-hexen-5-yne 80 was synthesised by reacting 1-
phenyl-prop-2-yn-1-ol with allyltrimethylsilane in acetonitrile.  Dropwise addition of 
solution of anhydrous FeCl3 in acetonitrile was necessary, which resulted in the 
synthesis of the target 1,5-enyne 80 (Scheme 9). 
 
80
85% yield
FeCl3
MeCN
Overnight stirring
 
 
Scheme 9: Synthesis of 4-phenyl-1-hexen-5-yne (80). 
4-phenyl-1-hexen-5-yne 80 has been shown to undergo AuI catalysed cycloisomerisatio-
-n to afford a bicyclo[3.1.0]hexyl ring system 81 (Scheme 10).  
80 81
[Au]+
H
H
 
 
Scheme 10: The Au-catalysed cycloisomerisation of 4-phenyl-1-hexen-5-yne (80) to 
produce 3-phenylbicyclo[3.1.0]hex-2-ene (81). 
The group of Toste217 has shown that the simple Pd or Pt complexes PdCl2(MeCN)2 and 
PtCl2 achieve less than 5% conversion.  However, when AuIII complex was used 50 % 
conversion after 3 hours was observed (without added salts), and quantitative 
conversion when 3 equivalents of AgBF4 (relative to substrate) was added at 5 mol% 
Au loading.  
 
The first step of the reaction involves the binding of a gold cation (typically formed by 
halide abstraction from a gold complex by a silver salt) to the alkyne (Scheme 11, step 
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I). This withdraws electron density from the bond, due to a lack of backbonding from 
gold to the alkyne antibonding orbitals, making it susceptible to nucleophilic attack. The 
alkene acts as a nucleophile and attacks the alkyne in the Markovnikov position to form 
the bicyclo[3.1.0]hexane structure via a 5-endo-dig cyclisation (Step II). The Au 
complex is thought to help stabilise the carbocation by a π-backbonding to give the Au-
carbon bond carbene character (the lower energy of the empty carbocation p orbital 
allows backbonding c,f. gold alkyne bonding). A hydride then migrates to form a 
carbocation at the adjacent position (step III) which is quenched by elimination of Au to 
give the bicyclohexene (Step IV). From this mechanism it would be logical to assume 
that a more electropositive Au cation would bind and activate the alkyne more strongly.  
I
II
III
IV
[Au]+
[Au]
H
H
H
H
H
H
H
[Au]H
[Au]+
[Au]+
+
+
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Scheme 11: The mechanism of gold-catalysed 5-endo-dig cycloisomerisation of 4-phenyl-1-
hexen-5-yne (80) to produce 3-phenylbicyclo[3.1.0]hex-2-ene (81). 
 
The cycloisomerisation of 4-phenyl-1-hexen-5-yne using gold complexes (70, 71, 75, 
76 and 79) was carried out using two different experimental conditions, with microwave 
and without microwave.   
 
In the absence of microwave irradiation 1 equiv. of 4-phenyl-1-hexen-5-yne was reacted with 0.01 equiv. 
of Au catalyst at 25 °C for 3 mins using AgSbF6 as an additive. The reaction proceeded with good 
conversions in almost all cases except for the dbaPHOS. No reaction was observed when the 
cycloisomerisation was carried out using gold complex of dbaPHOS.  
A brief summary of the cycloisomerisation of 4-phenyl-1-hexen-5-yne without microwave irradiation is 
given in Table 3. 
Table 3: Cycloisomerisation of 4-phenyl-1-hexen-5-yne without microwave. 
 Au 
catalyst 
Amount 
(mol %) 
Ag 
additive 
Amount 
(mol %) 
Temp 
(°C) 
Time 
(hours) 
Conv. 
(%) 
1 71 1 AgSbF6 1 25 3 >98 
2 70 1 AgSbF6 1 25 3 >98 
3 79 1 AgSbF6 1 25 3 >98 
4 75 1 AgSbF6 1 25 3 No rex 
5 76 1 AgSbF6 1 25 3 70 
 
The cycloisomerisation was also carried out using microwave irradiation. 4-phenyl-1-hexen-5-yne was 
treated with Au catalysts at 50 °C for 5 mins. The best result was obtained using Lei(Au) catalyst 71 
giving a conversion of >99%. However, for the ferrochalcone(Au) catalyst 70 a conversion of 39% was 
observed. It was found that reaction did not go to completion even after increasing the reaction time 
perhaps due to the decomposition of ferrochalcone complex under microwave conditions. The Ph3P(Au) 
catalyst gave an intermediate yield of  45%. No reaction was observed for dbaPHOS whereas a poor 
conversion was obtained using MonodbaPHOS. An interesting result was that no reaction was observed 
in the absence of a Au complex confirming that the reaction is not catalysed independently by either Au 
catalyst or AgSbF6. This is consistent with previous work and suggests that a cationic Au centre is 
required for effective catalytic cycloisomerisation. 
 
A brief summary of the cycloisomerisation of 4-phenyl-1-hexen-5-yne with microwave is given in Table 
4. 
Table 4: Cycloisomerisation of 4-phenyl-1-hexen-5-yne with microwave. 
 Au 
catalyst 
Amount 
(mol %) 
Ag 
additive 
Amount 
(mol %) 
Temp 
(°C) 
Time 
(mins) 
Conv. 
(%) 
1 71 1 AgSbF6 1 50 5 >99 
2 70 1 AgSbF6 1 50 5 39 
3 -- 1 AgSbF6 1 50 5 No rex 
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4 79 1 AgSbF6 1 50 5 45 
5 76 1 AgSbF6 1 50 5 8 
6 75 1 AgSbF6 1 50 5 No rex 
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4.5 CV studies of Au complexes 
Cyclic voltammetry is a versatile electrochemical technique for the characterization of 
electroactive species. This method provides valuable information regarding the stability 
of the oxidation states and the rate of electron transfer between the electrode and the 
analyte. Applications of the cyclic voltammetry have been extended to almost every 
aspect of chemistry; for example, the investigation of biosynthetic reaction pathways 
and the examination of the ligand effect on the metal complex potential as well as 
enzymatic catalysis.218  
 
4.5.1 Principle 
Cyclic voltammetry is a method in which information about the analyte is obtained from 
the measurement of the Faradic current as a function of the applied potential. The 
current response over a range of potentials is measured, starting at an initial value and 
varying the potential in a linear manner up to a limiting value. At this limiting potential 
the direction of the potential scan is reversed and the same potential range is scanned in 
the opposite direction (hence the term “cyclic”).  Consequently, the species formed by 
oxidation on the forward scan can be reduced on the reverse scan. This technique is 
accomplished with a three-electrode arrangement: the potential is applied to the working 
electrode with respect to a reference electrode while an auxiliary (or counter) electrode 
is used to complete the electrical circuit. A typical cyclic voltammogram is shown in 
Figure 13. 
 
 
Figure 13: Diagrammatic representation of a typical cyclic voltammogram. 
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The scan starts at a slightly negative potential, Ei up to some positive switching value, 
Eswitch at which scan is reversed back to the starting potential. The current is first 
observed to peak at Epa (with value ipa) indicating that an oxidation is taking place and 
then drops due to depletion of the reducing species from the diffusion layer. During the 
return scan the processes are reversed (reduction is now occurring) and a peak current is 
observed at Epc (corresponding value, ipc). 
 
4.5.2 Electrochemistry of ferrocene 
The oxidation of ferrocene [Fe(C5H5)2] to the ferrocenium cation [Fe(C5H5)2]+ is a 
standard one-electron transfer reversible process because the rate of electron transfer is 
incredibly fast.219 Consequently, the redox system [Fe(C5H5)2]+/Fe(C5H5)2 has received 
considerable attention in electrochemistry because it can be used for instrumental and 
reference potential calibrations in organic media.220 Oxidation of ferrocene can be done 
by different oxidants such as silver nitrate or conc. H2SO4. 
 
4.5.3 Electrochemistry of ferrochalcone ligand 32 
We were interested in tuning the electronic properties of these chalcone ferrocene 
ligands by converting them to ferrocenium ion. The electrochemical behaviour of 
chalcone ferrocene based phosphine-alkene ligands is of interest due to the ideal 
reversible redox behaviour of ferrocene, for which the [Fe(C5H5)2]+/ [Fe(C5H5)2] couple 
has received notable attention in the electrochemistry field. Thus, a system containing 
ferrocene along with another transition metal (e.g. Pt, Pd) can behave as a electroactive 
species, that could help in tuning the metal complex (and alkene). 
 
The cyclic voltammetric experiments were conducted using 0.1 M TBAPF6 in CH2Cl2. 
A Glassy carbon working electrode was used with a decamethylferrocene internal 
reference. FcH*/[FcH*]+ = -0.48 V (which places ferrocene at 0.0 V).  E1/2 value 
displayed for ferrochalcone ligand 32 was performed at ca. – 40 °C, whereas for the 
metal complex it was performed at room temperature.  The CV results obtained for 
ligand 32 and AuI complex 70 are summarised in Table 5. 
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Table 5: Cyclic Voltammetric results for ferrochalcone ligand (32) and complex (70). 
Complex Oxidation, E1/2 / V Reduction, Epa / V 
B-Ligand 0.35 -1.20 
 B-Au Complex 0.32 -1.12 
 
An FcH* internal standard near –0.5 volts was observed which is not the part of the 
sample and is likely to be an impurity. The cyclic voltammogram (Figure 14) displayed 
a ferrocene-based oxidation, more or less reversible, between 0.30 - 0.40 V (i.e. harder 
to oxidise than ferrocene itself, likely a consequence of the vinyl ketone, for 
ferrochalcone 32. There is also irreversible vinyl-ketone most likely based reduction. 
The second irreversible oxidation is harder to ascribe with confidence as it could easily 
be a decomposition product formed from the first irreversible reduction.  
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Figure 14: The cyclic voltammogram for ferrochalcone 32. 
 
The CV of the AuI metal complex for ferrochalcone 32 showed a reversible cycle at E1/2 
= 0.32 V, corresponding to the redox process of the ferrocenyl unit and an anodic peak 
(Epa) value of -1.12 V. 
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Figure 15: The cyclic voltammogram for AuI complex of ligand 32. 
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4.6 Experimental 
 4.6.1 General Information 
 
1H-NMR spectra were obtained in the solvent indicated using a JEOL EXC400 or JEOL 
ECS400 spectrometer (400MHz for 1H, 100 MHz for 13C and 162 MHz for 31P). 
Chemical shifts were referenced to the residual undeuterated solvent of the deuterated 
solvent used (CHCl3 δ = 7.26 and 77.16 and DCM δ = 5.31 and 53.80 for 1H and 13C 
NMR spectra respectively). NMR spectra were processed using MestrNova software. 
All 13C NMR spectra were obtained with 1H decoupling.  31P NMR were externally 
referenced to H3PO4, and obtained with 1H decoupling.  For 13C NMR spectra the 
coupling constants are quoted to ±1 Hz.  For the 1H NMR spectra the resolution varies 
from ±0.15 to ±0.5 Hz; the coupling constants have been quoted to ±0.5 Hz in all cases 
for consistency.   
 
Melting points were recorded using a Stuart digital SMP3 machine. IR spectroscopy 
was undertaken using a Jasco/MIRacle FT/IR-4100typeA spectrometer with an ATR 
attachment on solid and liquid compounds; solution and KBr IR spectra were obtained 
on a Nicolet Avatar 370 FT-IR spectrometer.  The relative intensities of the peaks are 
denoted by (s) = strong, (m) = medium and (w) = weak, whilst (br) is used to describe 
broad peaks. MS spectra were measured using a Bruker Daltronics micrOTOF MS, 
Agilent series 1200LC with electrospray ionisation (ESI and APCI) or on a Thermo 
LCQ using electrospray ionisation, with <5 ppm error recorded for all HRMS samples. 
Mass spectral data is quoted as the m/z ratio along with the relative peak height in 
brackets (base peak = 100). Dry and degassed toluene, ether, DCM and hexane were 
obtained from a solvent system. Nitrogen gas was oxygen-free and was dried 
immediately prior to use by passage through a column containing sodium hydroxide 
pellets and silica gel. THF and benzene were dried over sodium-benzophenone ketyl 
and ethanol was dried and distilled from magnesium-iodide. Commercial chemicals 
were purchased from Sigma-Aldrich or Alfa Aesar. Elemental analysis was carried out 
on an Exeter Analytical CE-440 Elemental Analyser. All column chromatography was 
run on silica gel 60 using the solvent systems specified in the text.  The fraction of 
petroleum ether used was that boiling at 40-60 °C.   
 
Dry and degassed toluene, CH2Cl2, MeCN and hexane were obtained from a ‘Pure Solv’ 
MD-7 solvent purification system.  THF and Et2O were either obtained from a ‘Pure 
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Solv’ MD-7 solvent purification system and degassed by the freeze-pump-thaw method 
or purged with N2 under sonication, or dried over sodium-benzophenone ketyl and 
collected by distillation.  All air sensitive procedures were carried out using Schlenk 
techniques.221  Nitrogen gas was oxygen-free and was dried immediately prior to use by 
passage through a column containing sodium hydroxide pellets and silica.  Room 
temperature is quoted as the broadest range 13-25°C, but it was typically 18-20 °C.  
Commercial chemicals were purchased from Sigma-Aldrich and Alfa Aesar and used 
directly unless stated in the text.  Brine refers to a saturated aqueous solution of NaCl.   
 
Ferrochalcone gold(I) chloride complex (70) 
A solution of [Au(SMe2)Cl]  (0.087 g, 0.297 mmol) in dry CH2Cl2 (5 ml) and β-[2`-
(diphenylphosphino)phenyl]acryl ferrocene (0.148 g, 0.297 mmol) in dry CH2Cl2 (10 
ml) was mixed together and stirred for 2 h at room temperature. The reaction mixture 
was then filtered and the solvent was removed under vacuo giving light reddish solid 
(0.155 g, 71%). Mp 210-211°C; 1H-NMR (400 MHz, CDCl3) δ 8.10 (d, J =14.8 Hz, 
1H), 7.75 (s, 2H), 7.63 (dd, J =13.4, 7.1 Hz, 4H), 7.50-7.55 (m, 7H), 7.39 (m, 1H), 7.01-
7.06 (m, 1H), 6.84 (d, J =15.2 Hz, 1H), 4.77-4.79 (m, 2H), 4.51-4.55 (s, 2H), 4.21 (s, 
1H), 4.16 (s, 4H); 13C-NMR (100 MHz, CDCl3) δ 191.5, 140.1 (d, J =10 Hz), 137.6 (d, 
J =12 Hz), 134.6 (d, J =14 Hz), 134.1 (d, J =9 Hz), 132.4 (d, J =2 Hz), 132.3 (d, J =2 
Hz), 129.6, 129.5, 129.5, 128.9, 128.8 (d, J =4 Hz), 128.1, 127.7, 127.4, 79.9, 73.1, 
70.2, 69.9; 31P-NMR (162 MHz, CDCl3) δ 28.31 (s, 1P); HRMS (LIFDI) [M]+: 
732.0269 (Calcd. for [Au(C31H25FePO)Cl]  732.0347); IR υ cm-1  2920 (s), 2359 (s), 
1653 (s), 1601 (s), 1559 (s), 1456 (s), 1436 (s), 1377 (s), 1314 (s), 1277 (s), 1101 (s), 
1078 (s), 1027 (s), 998 (s), 824 (s), 693 (s), 543 (s), 504 (s). ; Anal. Calcd for 
[Au(C31H25FePO)Cl]: C, 39.84; H, 2.90; N, 0. Found: C, 50.81; H, 3.44; N, 0. 
 
Lei gold(I) chloride complex (71) 
A solution of [Au(SMe2)Cl]  (0.087 g, 0.297 mmol) in dry CH2Cl2 (5 ml) and Lei ligand 
(0.116 g, 0.297 mmol) in dry CH2Cl2 (10 ml) was mixed together and stirred for 2 h at 
room temperature. The reaction mixture was then filtered and the solvent was removed 
under vacuo giving light reddish solid (0.127 g, 68%). Mp 172-174 °C; 1H-NMR (400 
MHz, CD2Cl2) δ 8.12 (d, , J =15.5 Hz, 1H),  7.83 (dd, J =7.7, 4.7 Hz, 1H), 7.76 (d, J 
=1.1 Hz, 1H), 7.74 (d, J =1.5 Hz, 1H), 7.63-7.55 (m, 8H), 7.52-7.46 (m, 6H), 7.43-7.38 
(m, 1H), 7.17 (d, J =15.4 Hz, 1H), 6.97 (ddd, J =13.0, 7.8, 1.1 Hz, 1H); 13C-NMR (100 
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MHz, CD2Cl2) δ 191.1, 142.1 (d, J =13 Hz), 139.8 (d, J =10 Hz), 135.1 (d, J =14 Hz), 
134.3 (d, J =8 Hz), 133.1, 132.8 (d, J =2.5 Hz), 132.7 (d, J =2 Hz), 130.4 (d, J =10 Hz), 
130.1, 129.9, 129.2, 129.1, 129,1, 128.9, 128.8, 128.4, 127.8, 127.7; 31P-NMR (162 
MHz, CD2Cl2) δ 28.33 (s, 1P); HRMS (LIFDI) [M]+: 624.0586 (Calcd. for 
[Au(C27H21PO)Cl]  624.0684); IR υ cm-1  3054 (s), 2359 (s), 1663 (s), 1642 (s), 1604 
(s), 1577 (s), 1480 (s), 1460 (s), 1436 (s), 1319 (s), 1268 (s), 1219 (s), 1181 (s), 1101 
(s), 1014 (s),  997 (s), 963 (s), 754 (s), 712 (s), 693 (s), 658 (s), 586 (s), 504 (s); Anal. 
Calcd for [Au(C27H21PO)Cl]: C, 51.90; H, 3.39; N, 0. Found: C, 48.16; H, 3.30; N, 0 
 
Dba PHOS gold(I) chloride complex (75) 
A solution of [Au(SMe2)Cl] (73 mg, 0.25 mmol) in dry, degassed CH2Cl2 (5 mL) was 
added by cannula to a solution of dbaPHOS, (150 mg, 0.25 mmol) in dry degassed 
CH2Cl2 (10 mL) in a metal ligand ratio of (2:1). The resulting solution was stirred for 2 
h at room temperature. CH2Cl2 was removed in vacuo to give a yellowish powder.(79 
mg, 37%). Mp 176-179°C (dec.); 1H-NMR (400 MHz, CDCl3) δ 8.00 (d,  J =16 Hz, 
2H),  7.68 (d, J =6.8 Hz, 10H), 7.51 (t, J =7.5 Hz, 2H), 7.45 (t, J =7.5 Hz, 4H), 7.36 (t, J 
=7.8 Hz, 10H), 6.95 (m, 2H), 6.42 (d, J =16 Hz, 2H);13C-NMR (100 MHz, CDCl3) δ 
140.9 (t, J =8.1 Hz), 137.8 (t, J =5.7 Hz), 134.9 (t, J =8.1 Hz), 133.4 (t, J =3.0 Hz), 
131.4, 130.9,  130.1 (t, J =3.7 Hz), 129.3 (t, J =5.5 Hz), 128.2, 127.5 (t, J =3.2 Hz); 31P-
NMR (162 MHz, CDCl3) δ 33.64 (bs, 1P), 31.17 (s, 1P); HRMS (LIFDI) [M]+: 
799.1320 (Calcd. for [Au(C41H32P2O)] 799.1594); IR υ cm-1  3051 (s), 2953 (s), 1651 
(s), 1605 (s), 1581 (s), 1428 (s), 1410 (s), 1289 (s), 1212 (s), 1174 (s), 1042 (s), 1014 
(s), 954 (s), 787 (s), 732 (s), 644 (s); Anal. Calcd for [Au(C41H32P2O)Cl]: C, 58.97; H, 
3.86; N, 0. Found: C, 55.75; H, 3.72; N, 0 
 
Mono dba PHOS gold(I) chloride complex (76) 
A solution of [Au(SMe2)Cl] (73 mg, 0.25 mmol) in dry, degassed CH2Cl2 (5 mL) was 
added by cannula to a solution of Mono dbaPHOS, (104 mg, 0.25 mmol) in dry, 
degassed CH2Cl2 (10 mL) in a metal ligand ratio of (1:1).  The resulting solution was 
stirred for 2 h at room temperature. CH2Cl2 was removed in vacuo to give a yellowish 
powder. (68 mg, 41%) 197-198°C (dec.); 1H-NMR (400 MHz, CDCl3) δ 8.28 (d, J 
=15.8 Hz, 1H),  7.72 (dd, J =7.6, 4.7 Hz,1H), 7.66 (d, J =2.2 Hz, 1H), 7.64 (d, J =1.6 
Hz, 1H), 7.63 (d, J =1.2 Hz, 1H), 7.61 (t, J =1.5 Hz, 1H), 7.59 (s, 1H), 7.58-7.57 (m, 
2H), 7.54 (d, J =2.2 Hz, 1H), 7.52 (dd, J =3.3, 1.5 Hz, 1H), 7.48 (d, J =2.6 Hz, 2H), 
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7.47-7.45 (m, 2H), 7.45-7.44 (m, 1H), 7.43 (s, 1H), 7.42-7.40 (m, 2H), 7.39 (s, 1H), 
7.05 (d, J =15.8 Hz, 1H), 6.95 (ddd, J =12.9, 7.8, 1.0 Hz, 1H), 6.65 (d, J =15.9 Hz, 1H); 
13C-NMR (100 MHz, CDCl3) δ 188.9, 144.1, 139.7 (d, J =13.5 Hz), 139.4 (d, J =10 
Hz), 134.8, 134.71, 134.6, 133.7 (d, J =8.5 Hz), 132.6 (d, J =2.5 Hz), 132.4 (d, J =2.0 
Hz), 131.3, 130.7, 129.9, 129.8, 129.6 (d, J =12.0 Hz), 129.1, 128.8, 128.7 (d, J =3.5 
Hz), 128.1, 127.8, 127.2, 122.5; 31P-NMR (162 MHz, CDCl3) δ 27.49 (s, 1P); HRMS 
(LIFDI) [M]+: 650.0698 (Calcd. for [Au(C29H23OP)Cl]  650.0841); IR υ cm-1 3023 (w),  
2928 (w), 1629 (s), 1610 (s), 1573 (s), 1567 (m), 1431 (w), 1414 (w), 1419 (m), 1335 
(m), 1167 (s), 1079 (s); Anal. Calcd for [Au(C29H24OP)Cl]: C, 53.43; H, 3.71; N, 0. 
Found: C, 51.21; H, 3.44; N, 0. 
 
Triphenylphosphine gold(I) chloride complex (79)222 
A solution of [Au(SMe2)Cl] (88 mg, 0.3 mmol) in dry, degassed CH2Cl2 (5 mL) was 
added to a solution of Ph3P (78 mg, 0.3 mmol) in dry, degassed CH2Cl2 (5 mL).  The 
resulting solution was stirred for 2 h at room temperature. The reaction solution was 
filtered to get a clear solution. CH2Cl2 was removed under vacuum giving a  
concentrated solution (4 mL), which was then  layered with ether (5 mL) to afford off-
white precipitates (87 mg, 58%) separated by filtration. Mp 235-237 °C; 1H-NMR (400 
MHz, CDCl3) δ 7.55 (t, , J =1.3 Hz, 1H),  7.53 (d, J =1.6 Hz, 2H), 7.52-7.50 (m, 3H), 
7.49 (d, J =2.6 Hz, 3H), 7.46 (d, J =2.6 Hz, 2H), 7.44 (d, J =1.4 Hz, 3H), 7.43-7.41 (m, 
1H); 13C-NMR (100 MHz, CDCl3) δ 134.2 (d, J =13 Hz), 132.1 (d, J =3 Hz), 129.3 (d, J 
=12 Hz), 128.6; 31P-NMR (162 MHz, CDCl3) δ 34.14 (s, 1P); HRMS (LIFDI) [M]+: 
494.7042 (Calcd. for [Au(C18H15P)Cl]  494.7068); IR υ cm-1  3057 (s), 1898 (s), 1816 
(s), 1683 (s), 1585 (s), 1479 (s), 1433 (s), 1312 (s), 1179 (s), 1109 (s), 1026 (s), 998 (s); 
Anal. Calcd for [Au(C18H15P)Cl]: C, 43.98; H, 3.09; N, 0. Found: C, 43.70; H, 3.06; N, 
0 
 
4-Phenyl-1-hexen-5-yne (80) 
1-Phenyl-2-propyn-1-ol (2.53 ml, 20.4 mmol, 1 equiv.) and allyltrimethylsilane (9.78 
ml, 61.4 mmol, 3 equiv.) were mixed in 40 ml of dry acetonitrile. FeCl3 (anhydrous, 166 
mg, 1.02 mmol, 0.05 equiv.) in 5 ml dry acetonitrile was added dropwise. The reaction 
was stirred for 2 hours at room temperature. Again, FeCl3 (anhydrous, 166 mg, 1.02 
mmol, 0.05 equiv.) in 5 ml dry acetonitrile was added dropwise and the reaction was 
stirred for further 1 hour at room temperature. The solution was reduced in vacuo and 
the product was purified by column chromatography, eluting with 100 % petroleum 
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ether (40-60) to give the title compound as colourless oil (2.70 g, 17.3 mmol, 85%). 1H-
NMR (400 MHz, CDCl3) δ 7.41-7.32 (m, 4H), 7.29-7.24 (m, 1H), 5.87 (ddtd, J= 17.1, 
10.2, 7.0 and 1.3 Hz, 1H), 5.13-5.06 (m, 2H), 3.72 (td, J= 7.2 and 2.4 Hz, 1 H), 2.54 (t, 
J= 7.2 Hz, 2H), 2.32 (app.d, J= 2.4 Hz, 1H); 13C-NMR (100 MHz, CDCl3) δ 140.7, 
135.1, 128.5, 127.4, 126.9, 117.1, 85.3, 71.4, 42.4, 37.6; HRMS (EI) [M]+: 156.0943 
(Calcd. for [C12H12]  156.0939). Data in accordance with the literature.223 
 
 
4.6.2 Catalysis; Synthesis of 3-Phenylbicyclo[3.1.0]hex-2-ene (81) 
             
4.6.2.1 With out Microwave 
 
 
1. Using Lei-(Au)Cl complex 
 
To a solution of 4-phenyl-1-hexen-5-yne (50.0 mg, 321 µmol, 1 equiv.) in 
dichloromethane (0.64 mL, 0.50 M), AgSbF6 (0.8 mg, 3.1 µmol, 0.01 equiv.) and gold 
complex (3.2 µmol, 0.01 equiv.) were added. The solution was stirred at 25 °C for 3 
hours and filtered through a plug of silica gel which was washed with dichloromethane 
(2 ml). The solution was reduced in vacuo and conversion was determined by 1H NMR 
spectroscopy and is found to be > 98 %. 
 
2. Using Ferrochalcone-(Au)Cl complex 
To a solution of 4-phenyl-1-hexen-5-yne (50.0 mg, 321 µmol, 1 equiv.) in 
dichloromethane (0.64 mL, 0.50 M), AgSbF6 (0.8 mg, 3.1 µmol, 0.01 equiv.) and gold 
complex (3.2 µmol, 0.01 equiv.) were added. The solution was stirred at 25 °C or 3 
hours and filtered through a plug of silica gel which was washed with dichloromethane 
(2 ml). The solution was reduced in vacuo and conversion was determined by 1H NMR 
spectroscopy and is found to be > 98 %. 
 
3. Using PPh3-(Au)Cl complex 
To a solution of 4-phenyl-1-hexen-5-yne (50.0 mg, 321 µmol, 1 equiv.) in 
dichloromethane (0.64 mL, 0.50 M), AgSbF6 (0.8 mg, 3.1 µmol, 0.01 equiv.) and gold 
complex (3.2 µmol, 0.01 equiv.) were added. The solution was stirred at 25 °C or 3 
hours and filtered through a plug of silica gel which was washed with dichloromethane 
(2 ml). The solution was reduced in vacuo and conversion was determined by 1H NMR 
spectroscopy and is found to be > 98 %. 
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4. Using dba-PHOS (Au) complex   
To a solution of 4-phenyl-1-hexen-5-yne (50.0 mg, 321 µmol, 1 equiv.) in 
dichloromethane (0.64 mL, 0.50 M), AgSbF6 (0.8 mg, 3.1 µmol, 0.01 equiv.) and gold 
complex (3.2 µmol, 0.01 equiv.) were added. The solution was stirred at 25 °C or 3 
hours and filtered through a plug of silica gel which was washed with dichloromethane 
(2 ml). The solution was reduced in vacuo and analysed by 1H NMR spectroscopy 
confirming the presence of starting material only and hence no reaction has occurred.  
 
5. Using mono dba-PHOS  
To a solution of 4-phenyl-1-hexen-5-yne (50.0 mg, 321 µmol, 1 equiv.) in 
dichloromethane (0.64 mL, 0.50 M), AgSbF6 (0.8 mg, 3.1 µmol, 0.01 equiv.) and gold 
complex (3.2 µmol, 0.01 equiv.) were added. The solution was stirred at 25 °C for 3 
hours and filtered through a plug of silica gel which was washed with dichloromethane 
(2 ml). The solution was reduced in vacuo and analysed by 1H NMR spectroscopy 
confirming 70 % conversion by NMR.  
 
4.6.2.2 With Microwave 
 
1. Using Lei-(Au)Cl complex 
To a solution of 4-phenyl-1-hexen-5-yne (50.0 mg, 321 µmol, 1 equiv.) in 
dichloromethane (0.64 mL, 0.50 M) in microwave reaction tube was added AgSbF6 (0.8 
mg, 3.1 µmol, 0.01 equiv.) and gold complex (3.2 µmol, 0.01 equiv.). The solution was 
stirred at 50 °C for 5 mins and filtered through a plug of silica gel which was washed 
with dichloromethane (2 ml). The solution was reduced in vacuo and conversion was 
determined by 1H NMR spectroscopy and is found to be > 99 %. 
 
2. Using B-(Au)Cl complex 
To a solution of 4-phenyl-1-hexen-5-yne (50.0 mg, 321 µmol, 1 equiv.) in 
dichloromethane (0.64 mL, 0.50 M) in microwave reaction tube was added AgSbF6 (0.8 
mg, 3.1 µmol, 0.01 equiv.) and gold complex (3.2 µmol, 0.01 equiv.). The solution was 
stirred at 50 °C for 5 mins and filtered through a plug of silica gel which was washed 
with dichloromethane (2 ml). The solution was reduced in vacuo and conversion was 
determined by 1H NMR spectroscopy and is found to be 39 %. The reaction was 
repeated on same scale by increasing the reaction time to 15 mins instead of 5 mins 
giving the product in 26 % yield. 
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3. Without using Au complex, only in the presence of AgSbF6                                                                                             
To a solution of 4-phenyl-1-hexen-5-yne (50.0 mg, 321 µmol, 1 equiv.) in 
dichloromethane (0.64 mL, 0.50 M) in microwave reaction tube was added AgSbF6 (0.8 
mg, 3.1 µmol, 0.01 equiv.). The solution was stirred at 50 °C for 5 mins and filtered 
through a plug of silica gel which was washed with dichloromethane (2 ml). The 
solution was reduced in vacuo. The 1H NMR showed the starting material only hence 
reaction did not occur at all.  
 
4. Using PPh3-(Au)Cl complex 
To a solution of 4-phenyl-1-hexen-5-yne (50.0 mg, 321 µmol, 1 equiv.) in 
dichloromethane (0.64 mL, 0.50 M) in microwave reaction tube was added AgSbF6 (0.8 
mg, 3.1 µmol, 0.01 equiv.) and gold complex (3.2 µmol, 0.01 equiv.). The solution was 
stirred at 50 °C for 5 mins and filtered through a plug of silica gel which was washed 
with dichloromethane (2 ml). The solution was reduced in vacuo and conversion was 
determined by 1H NMR spectroscopy and is found to be 45 %. 
 
5. Using mono dba-PHOS-(Au)Cl complex 
To a solution of 4-phenyl-1-hexen-5-yne (50.0 mg, 321 µmol, 1 equiv.) in 
dichloromethane (0.64 mL, 0.50 M) in microwave reaction tube was added AgSbF6 (0.8 
mg, 3.1 µmol, 0.01 equiv.) and gold complex (3.2 µmol, 0.01 equiv.). The solution was 
stirred at 50 °C for 5 mins and filtered through a plug of silica gel which was washed 
with dichloromethane (2 ml). The solution was reduced in vacuo and conversion was 
determined by 1H NMR spectroscopy and is found to be 8 %. 
 
6. Using dba-PHOS-(Au)Cl complex  
To a solution of 4-phenyl-1-hexen-5-yne (50.0 mg, 321 µmol, 1 equiv.) in 
dichloromethane (0.64 mL, 0.50 M) in microwave reaction tube was added AgSbF6 (0.8 
mg, 3.1 µmol, 0.01 equiv.) and gold complex (3.2 µmol, 0.01 equiv.). The solution was 
stirred at 50 °C for 15 mins and filtered through a plug of silica gel which was washed 
with dichloromethane (2 ml). The solution was reduced in vacuo. The 1H NMR showed 
the starting material only hence reaction did not occur at all.   
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1H NMR (400 MHz, CDCl3) δ 7.45-7.42 (m, 2H), 7.38-7.33 (m, 2H), 7.26 (m, 1H), 6.48 
(q, J= 2 Hz, 1H), 3.08 (ddd, J= 17, 7.5, 2, 1H), 2.80 (app. D, J= 17 Hz, 1H), 2.01 (m, 
1H), 1.79 (m, 1H), 1.00 (td, J= 7.5, 4 Hz, 1H), 0.17 (dd, J=7.0, 4.0 Hz, 1H); 13C NMR 
(100 MHz, CDCl3) δ 139.7, 136.6, 129.6, 128.2, 126.7, 125.1, 36.3, 23.8, 17.6, 15.4; 
HRMS (EI) [M]+: 156.0943 (Calcd. for [C12H12]  156.0939). Data in accordance with 
the literature.224 
 
4.6.3 X-Ray Diffraction Data 
 
Diffraction data for Lei AuI complex ijf1018 71 was collected at 110 K on a Bruker 
Smart Apex diffractometer with Mo-Kα radiation (λ = 0.71073 Å) using a SMART 
CCD camera.  Diffractometer control, data collection and initial unit cell determination 
was performed using “SMART”.225  Frame integration and unit-cell refinement was 
carried out with “SAINT+”.226 Absorption corrections were applied by SADABS.227  
Structures were solved by “direct methods” using SHELXS-97 (Sheldrick, 1997)228 and 
refined by full-matrix least squares using SHELXL-97 (Sheldrick, 1997).229  All non-
hydrogen atoms were refined anisotropically.   
 
Diffraction data for ferrochalcone AuI complex (ijf1116) 70, monodbaPHOS AuI 
complex ijf1117 76 were collected at 110 K on an Oxford Diffraction SuperNova 
diffractometer with Mo-Kα radiation (λ = 0.71073 Å) using a EOS CCD camera.  The 
crystal was cooled with an Oxford Instruments Cryojet.  Diffractometer control, data 
collection, initial unit cell determination, frame integration and unit-cell refinement was 
carried out with “Crysalis”.230  Face-indexed absorption corrections were applied using 
spherical harmonics, implemented in SCALE3 ABSPACK scaling algorithm.231  
OLEX2232 was used for overall structure solution, refinement and preparation of 
computer graphics and publication data.   
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Table 6: Single Crystal X-Ray details for AuI complex of ferrochalcone (32), Lei 
ligand (17) and monodba-PHOS (76). 
 
Compound 
reference 
ijf1116 ijf1018  ijf1117 
Formula C31H25AuClFePO C108H84Au4Cl4P4O4 C29H23AuClPO 
Formula weight 732.75 2499.31 650.86 
temp (K) 110(10) 110(2)  110(10)  
Cryst syst Monoclinic Monoclinic Monoclinic 
Space group C2/c P 2(1)/c C2/c 
a(Å) 30.0863(15) 9.1617(5) 27.4947(4) 
b(Å) 8.8904(6) 18.2335(9) 9.21591(14) 
c(Å) 19.2451(10) 28.1227(14) 18.9937(3) 
α(°) 90.00 90 90 
β(°) 93.235(4) 97.0600(10) 90.4571(14) 
γ(°) 90.00 90 90 
V (Å3) 5139.5(5) 4662.3(4) 4812.64(12) 
Z 8 2 8 
Dcalcd. (Mg M-3) 1.894 1.780 1.797 
F(000) 2848 2416 2528 
Μ(mm-1) 6.457 6.511 6.311 
Crystal size 
(mm3) 
0.2026 x 0.1082 x 
0.0524 
0.21 x 0.20 x 0.14 0.1984 x 0.1517 x 
0.0566 
θ  range for 
data 
6.12 to 58 1.46 to 28.32 5.92 to 64.34 
Collection (°) 
Index ranges 
-39 ≤ h ≤ 37, 
-12 ≤ k ≤ 6, 
-24 ≤ I ≤ 23 
-12 <=h<=12, 
-24<=k<=24, 
-37<=I<=37 
-24 ≤ h ≤ 41, 
-12 ≤ k ≤ 12, 
-24 ≤ I ≤ 27 
No. of rflns 
collected 
11219 47922 12407 
Refinement 
method 
Full-matrix least-
squares on F2 
Full-matrix least-
squares on F2 
Full-matrix least-
squares on F2 
GOOF on F2 1.149 1.050 1.101 
R1, 
wR2(I>2σ(I)) 
0.0411, 0.0807 0.0343, 0.0647 0.0305, 0.0566 
R1, wR2(all 
data) 
0.0512, 0.0861 0.0473, 0.0684 0.0385, 0.0595 
 
Further details can be found in the Appendix, including the cif files on the CD. 
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Chapter 5: Investigating nitrite impurities in “Pd(OAc)2” 
 
The work detailed in this chapter resulted in the following publication: On the 
appearance of nitrite anion in [PdX(OAc)L2] and [Pd(X)(C˄N)PPh3]syntheses (X = OAc 
or NO2): photocrystallographic identification of metastable Pd(η1-ONO)(C˄N)PPh3: S. 
E. Bajwa, T. E. Storr, L. E. Hatcher, T. J. Williams, C. G. Baumann, A. C. Whitwood, 
D. R. Allan, S. J. Teat, R. R. Raithby* and I. J. S. Fairlamb* Chemical Science 
DOI:10.1039/c2sc01050j 
 
Palladium chemistry has rapidly become an indispensable tool for synthetic organic 
chemists. Palladium is a chemical element with the chemical symbol Pd and an atomic 
number of 46. It is a rare and lustrous silvery-white metal discovered in 1803 by 
William Hyde Wollaston.233 It basically belongs to a group of elements called the 
platinum group metals (PGMs).234 They all have very similar chemical properties but 
pall 
adium has the lowest melting point and is least dense. The common oxidation states of 
palladium are 0, +1, +2 and +4. Palladium is a versatile metal for homogenous catalysis 
and is effectively used in combination with a broad variety of ligands for highly 
selective chemical transformations.235 Palladium catalysis has gained widespread use in 
industrial and academic synthetic chemistry laboratories as a powerful methodology for 
the formation of C-C and C-heteroatom bonds.236 Palladium is also used in electronics, 
dentistry, medicine, hydrogen purification, chemical applications and groundwater 
treatment. Palladium catalysts are effectively used in the field of organic and 
organometallic chemistry. When it is finely divided, such as palladium on carbon, 
palladium forms a versatile catalyst and speeds up hydrogenation and dehydrogenation 
reactions as well as in the petroleum cracking. A large number of carbon-carbon bond 
forming reactions in organic chemistry are facilitated by catalysis with palladium 
compounds.  
 
5.1 Cyclopalladation 
 
Cyclopalladation involves the formation of a chelated metallocycle from the reaction of 
a suitable C-H substrate containing a donor group e.g. nitrogen or sulphur. The C-H 
bond ortho- to the reacting centre is activated by the metal, leading to the formation of a 
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metal carbon-bond. This reaction was first discovered by Arthur C. Cope and co-
workers, who found that azoerenes237 and benzylamines react with PdII to give a 
cyclopalladated product.238 The cyclopalladation of azobenzene was one of the first 
examples, reported in 1965 (Scheme 1). 
PdCl2
 
Scheme 1: The cyclopalladation of azobenzene. 
 
Cyclopalladation represents one of the most powerful methods for the activation of 
Csp2-H bonds and ortho-functionalization of aromatic compounds. The application of 
cyclopalladated compounds, especially those bearing nitrogen-chelating atom have been 
widely used in organic synthesis, e.g. in the Heck reaction,239 and Suzuki coupling 
reaction,240 as palladacyclic precatalyst. A leading example is Hermann’s commercially 
available [Pd(OAc)C˄N]2 complex. 
 
5.2 Palladium compound as catalysts 
 
Palladium compounds are effectively used as catalyst in various types of reactions. Well 
known palladium catalyst precursors include, allylpalladiumchloride dimer, bis(acetoni-
-trile)palladium(II) chloride, bis(benzonitrile)palladium(II) chloride , bis(dibenzylidene-
-acetone)palladium, palladium(II) acetate, palladium(II) chloride, tetrakis(acetonitrile)p-
-alladium(II) tetrafluoroborate. Whereas following palladium compounds are efficiently 
used as catalysts in various types of reactions, [1,2-bis(diphenylphosphino)ethane]dichl-
-oropalladium(II), bis(triphenylphosphino)palladium(II) acetate, bis[tri(o-tolyl)phosphi- 
-ne]palladium(II) chloride, dichlorobis(tricyclohexylphosphine)palladium(II), tetrakis(t-
-riphenylphosphine)palladium (0). A few selected but representative examples are given 
in Figure 1. 
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82
Palladium(II) acetate
Dichlorobis(tricyclohexylphosphine)palladium(II)
[1,2-Bis(diphenylphosphino)ethane]dichloropalladium(II)
bis(benzonitrile)palladium(II) chloride
Bis(acetonitrile)dichloropalladium(II)
 
Figure 1: Some commonly used Palladium catalysts. 
 
The aim of this part of the project was to investigate the purity of palladium(II) acetate 
and its employment in  cyclopalladation reactions. Its origin is in the work reported by 
Nonoyama on the cyclopalladation of papaverine using Pd(OAc)2 where they observed 
a nitro-palladated product on reacting papaverine with Pd(OAc)2 in presence of 
acetonitrile.241 The formation of nitro-derived palladated product was unexpected and 
hence a detailed study involving the cyclopalladation of papaverine was conducted to 
address this issue. 
 
Papaverine 83, 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxyisoquinoline (abbrev-
iated as Hpap) (Figure 2), is found in the opium plant is an alkaloid with medicinal 
properties. For example it exhibits smooth muscle relaxation and is a vasodilator 
(cerebal). The structure of Hpap made this alkaloid suitable for doing cyclopalladation 
studies using Pd(OAc)2. 
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Figure 2: Structure of papaverine (abbreviated as Hpap) 
 
The reaction of Hpap with Pd(OAc)2 in refluxing acetonitrile resulted in the formation 
of a complex with the unexpected composition [Pd(NO2)(pap)(CH3CN)].H2O, 84 
(Scheme 2).241 
 
83 84
L: CH3CN (solvent)
Pd(OAc)2
reflux, ca. 3.5 h
CH3CN
 
Scheme 2: Reaction of Hpap with Pd(OAc)2 as reported by Nonoyama. 
 
It was reported that decomposition of CH3CN and the formation of NO2- was catalysed 
by metallic Pd (the dark colour of the reaction mixture suggested formation of colloidal 
Pd) during the reaction. The following stoichiometry was suggested without supporting 
evidence, as given in Scheme 3. 
 
Hpap + (CH3CO2)2Pd + 2CH3CN + 7/2O2
[Pd(NO2)(pap)(CH3CN)].H2O + 2CH3CO2H + 2CO2  
Scheme 3: Stoichiometric equation explaining the formation of the nitrite Pd adduct 
reported by Nonoyama. 
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The result reported was supported mostly on the basis of IR. Two characteristic strong 
bands at 1379 and 1336 cm-1 were associated with a nitrite group. A band at 314 cm-1 
was assigned to ν (Pd-N). No band assignable to an acetate group was present.  
 
In the same year Nonoyama conducted further cyclopalladation reactions of 2-(2-
pyridyl)benzo[b]furan (Hpbf), (85) and 1-(2-pyridyl and 2-pyrimidyl)indole (Hpyi & 
Hpmi) (86 & 87) using Palladium(II) acetate (Figure 3).242 On refluxing the Hpyi and 
Hpmi ligands with Pd(OAc)2 in the presence of acetonitrile, the solution darkens and 
the formation of metallic palladium was noted.  
 
Hpmi
  87
Hpbf
  85
Hpyi
  86
 
Figure 3: Structure of furan (Hpbf) and indole derived (Hpyi & Hpmi) ligands. 
 
The product obtained was formulated on the basis of the analytical results, as 
[Pd(NO2)(L)(CH3CN)] (Figure 4). 
88 89 90
 
Figure 4: Palladium complexes containing nitrite ligands. 
 
Again, the formation of palladium-derived “NO2” complexes was unexpected and was 
supposed to result from the oxidation of CH3CN catalyzed by metallic palladium as 
given in Scheme 3 earlier.  
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Some reactions of CH3CN are known but there seems to be no precedent for its 
oxidation reaction to form NO2-. It seemed unlikely to us that nitrite was being formed 
by oxidation of acetonitrile. Therefore we set about assessing this reaction in further 
detail. 
 
5.3 Palladium(II) Acetate 
Palladium(II) acetate 82 is a chemical compound of formula Pd(O2CCH3)2 or Pd(OAc)2. 
When warmed with alcohols or on prolonged boiling with other solvents, Pd(OAc)2 
decomposes to give Pd0.243 It catalyses many organic reactions, is easily reduced by 
light or heat to form thin films of Pd and can produce colloids and nanowires.244 The 
primary use of Palladium(II) acetate is as a starting material for the syntheses of other 
Pd(II) compounds as well as for the preparation of palladium catalysts and their 
precursors. 
 
Palladium(II) acetate is trimeric, consisting of an equilateral triangle of Pd atoms each 
pair of which is bridged with two acetate groups in a butterfly conformation.245 Each 
metal atom achieves approximate square planar co-ordination. In the solid state, the 
structure is generally trinuclear with nearly idealized D3h symmetry in which each of the 
three palladium atoms is in square planar environment and there are six bridging acetate 
groups.  
 
In solution, the structure of palladium acetate has remained somewhat controversial. 
Claims have been made supporting the persistence of the trinuclear molecules in 
solution, while other evidence is said to support the formation of various aggregates of 
[Pd(OAc)2]n (n=1, 2, 3 etc.) (Figure 5).246 The 1H NMR spectrum of palladium acetate 
in methanol has been reported to show a large number of signals in the range where 
single acetate signal would be expected for the symmetrical triangular structure. This 
was said to be indicative of a variety of aggregated and possibly even the occurrence of 
ionic species.247 
 
 139
 
Pd3(OAc)6 - "Pd(OAc)2"  
H2O
OH2
 
Figure 5: Structure of palladium acetate in solution, Pd3(OAc)6OH2.  
 
5.3.1 Preparation of Pd(OAc)2 
 
Palladium(II) acetate is commercially available and there are several routes describing 
its preparation. One of the most successful and commonly used synthetic routes was 
reported by Zhang and co-workers.248 The method is summarized by the following pair 
of reactions, (Scheme 4). 
 
PdCl2 + NaHCO2 + NaOH Pd + CO2 + 2NaCl + H2O
3Pd + 6HNO3 + 6HOAc Pd3(OAc)6 + 6NO2 + 6H2O  
 
Scheme 4: Route used for the synthesis of Pd(OAc)2. 
 
The first reaction occurs as reported with rapid formation of finely divided palladium 
metal. The freshly formed powder is subsequently oxidized by a mixture of HNO3 and 
acetic acid, and the product is extracted in to a 1:2 mixture of CH2Cl2:hexane. Crystals 
are obtained by evaporation under a stream of N2. This last step is very important as it 
allows the nitrous gases to be removed, vide infra. 
 
5.4 Cyclopalladation reactions involves Pd(OAc)2: a case study with papaverine 
 
The plan was to do cyclopalladation reaction of papaverine using Pd(OAc)2. Before 
carrying on the reaction the purity of different substrates involved was checked. 
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Papaverine is commercially available from Sigma Aldrich and was >99 % pure, as 
confirmed by 1H NMR spectroscopic analysis. The acetonitrile used in the reaction was 
dried and purified by triply-distillation over anhydrous AlCl3, Li2CO3 and lastly CaH, 
according to a procedure reported by Walter and Ramaley (method A).249 Finally the 
purity of Pd(OAc)2 was confirmed by running a 1H NMR spectrum of commercial 
samples (Figure 6). 
 
Figure 6: 1H NMR spectrum of commercially available Pd(OAc)2. 
 
The commercially available sample of Pd(OAc)2, was a mixture of Pd compounds as 
confirmed by 1H NMR spectrum and hence a detailed study over the synthesis and 
purity of Pd(OAc)2 was carried out.  
 
In an important study Cotton and Murillo highlighted the non-trivial behaviour of 
Pd(OAc)2.250 Pd3(OAc)6 is prepared by oxidation of metallic Pd (derived from PdCl2) 
with HNO3 / AcOH,251 as shown above and as a consequence of poor N2 flow, nitrogen 
oxides bring about the formation of the purple complex, Pd3(OAc)5NO2.252  A 1H NMR 
spectroscopic comparison of the two different products obtained during synthesis of 
Pd(OAc)2 is shown in Figure 7.  
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Figure 7: A comparison of the two different products obtained during synthesis of 
Pd(OAc)2 by 1H NMR spectroscopic analysis. 
 
The 1H NMR spectroscopic analysis of commercially available Pd(OAc)2 in CDCl3 
showed the presence of Pd3(OAc)5NO2.. In order to check the ratio of the impurity, the 
Pd complex was subjected to elemental analysis. A comparison of elemental analysis of 
impure Pd(OAc)2 with pure Pd(OAc)2 is given below in Table 1. 
 
Table 1: The comparison of E.A of Impure Pd(OAc)2 with pure Pd(OAc)2. 
   % C % H % N 
Observed Impure material Pd material 18.47 2.24 1.72 
Calculated Pd3(OAc)5NO2 18.18 2.29 2.12 
Calculated Pd3(OAc)6 21.40 2.69 - 
 
 
The percentage ratio of Pd3(OAc)5NO2 (based on nitrogen content) in the commercially 
available sample of Pd(OAc)2 is (1.72/2.12)x100 = 81.1% 
 
Ratio of NO2:OAc in 81% Pd3(OAc)5NO2 
 
Ratio of Pd3(OAc)5NO2:Pd3(OAc)6 = 81.1:18.9 = 4.3:1 
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Total (relative) OAc content =  
                                                   4.3x5 OAc {from (Pd3(OAc)5NO2} 
                                                   6 OAc {from Pd3(OAc)6} 
       Total= 27.5 OAc 
 
Total (relative) NO2 content = 4.3 NO2 {from (Pd3(OAc)5NO2} 
Ratio of OAc:NO2 = 27.5:4.3 = 6.4:1 
   
Different samples of Pd(OAc)2 (a variety of commercial suppliers) from the Department 
of chemistry (University of York) were collected  and analysed by 1H NMR 
spectroscopy. Surprisingly, almost all of them showed the presence of nitrite impurities, 
with the exception of a samples (>99%) Pd3(OAc)6 (Figure 8). 
 
Pd3(OAc)5NO2 (ca. 95%)
Pd3(OAc)5NO2 (ca. 81%)
York 1
York 2
York 3
York 4
York 5
Pure Pd(OAc)2 (>99%) in dry CDCl3*
* = residual water in Pd(OAc)2 not removed
 
 
Figure 8: The 1H NMR comparison of different samples of Pd(OAc)2 from University of 
York. (using reagent grade ‘wet’ CDCl3 unless otherwise specified) (400 MHz). The purple 
circles highlight trace Pd3(OAc)5NO2.  For reference purposes, 1H NMR spectra of 
Pd3(OAc)5NO2 (ca. 95% and 81% purity materials) and pure Pd(OAc)2 in dry CDCl3 are 
included. 
 
Also, it was observed that this trinuclear ‘triangle’ complex, formally Pd3(OAc)6, has a 
nearly idealized D3h symmetry in the solid-state.  In the presence of trace H2O in CDCl3 
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(e.g. laboratory grade CDCl3), Pd3(OAc)6 readily gives Pd3(OAc)6(OH2) (OAc 
displacement by H2O results in desymmetrization) as reported by Cotton and co 
workers.  
 
The presence of nitrite impurity in Pd(OAc)2 could explain the result reported by 
Nonoyama on the cyclopalladation of papaverine as shown in Scheme 13. It was found 
that the reaction of Pd(OAc)2 with papaverine 83 in CH3CN at reflux in air for 3.5 h 
(filtered whilst hot to remove metallic Pd0 residues) gave a filtrate containing 
84·CH3CN, which precipitates out of solution (overnight) as reported by Nonoyama.  
Recrystallization of this precipitate from warm DMSO afforded 84·DMSO.   
 
The reaction of papaverine 83 was repeated with  pure (>99%) Pd3(OAc)6  under air 
using reagent grade CH3CN. The reaction mixture was heated at reflux for 3.5 h. Finally 
it was filtered while hot to remove metallic Pd0 residues and left for precipitation. The 
precipitates was slow to appear (ca. 3-14 days at 5 °C),253 although 83 had been fully 
consumed (as shown by 1H NMR spectroscopy). Finally, a yellow semi-crystalline 
material appeared, which was filtered and analysed.  Elemental analysis and LIFDI 
mass spectrometric analysis showed this material to have the composition of 
[Pd(OAc)(C^N)] and not [Pd(NO2)(C^N)].  1H NMR spectroscopy (in d6-DMSO) 
revealed that cyclopalladation had occurred, and whilst being similar to the data for 
84·DMSO, some differences were apparent. The reaction was repeated several times 
and in all cases the same result was observed. 
 
A series of control reactions with triply-distilled CH3CN (from AlCl3, Li2CO3 and 
CaH)254, in both the presence and absence of air, gave the same product as detailed 
above.  In the absence of DMSO the product formed was suspected to be 
[Pd(OAc)(C^N)]·CH3CN 85 as given in Scheme 5. 
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X: CH3CN or DMSO (solvent)
83 85
Pd(OAc)2
reflux, ca. 3.5 h
CH3CN
N
Pd
N X
MeO
MeO
MeO OMe
OAc
OMeMeO
MeO
MeO
 
Scheme 5: Cyclopalladation of Hpap with Pd(OAc)2. 
 
Yellowish-coloured crystals grew from CH3CN solution after a week, which were 
analysed by XRD analysis. The X-ray studies gave a novel dimeric Pd(II) acetate 
bridged complex 86 (representative of the bulk material) with the following struture 
(Figure 9), and the X-ray structure is given in Figure 10. 
 
86
 
 
Figure 9: The structure of novel dimeric Pd(II) acetate bridged complex, 86. 
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Figure 10: X-ray structure of 86 with 3 CH3CN molecules and H-atoms omitted for 
clarity; selected atoms labelled. 
 
Solvent and hydrogen atoms are removed for clarity. Thermal ellipsoids shown at 50%. Bond 
lengths (Ǻ): Pd(1)-Pd(2) = 3.0258(4), Pd(1)-N(1) = 2.033(2), Pd(2)-N(2) = 2.032(2), Pd(1)-
C(12) = 1.980(3), Pd(2)-C(32) = 1.959(3), Pd(1)-O(9) = 2.0523(19), Pd(1)-O(11) = 2.166(2), 
Pd(2)-O(10) = 2.135(2), Pd(2)-O(12) = 2.0571(19), Bond Angles(º) O(10)-Pd(2)-O(12) 
= 92.36(8), O(9)-Pd(1)-O(11) = 90.70(8), O(9)-Pd(1)-Pd(2) = 79.30(6), O(10)-Pd(2)-Pd(1) = 
75.71(5), N(1)-Pd(1)-O(11) = 90.27(8), C(12)-Pd(1)-O(9) = 89.63(10), C(32)-Pd(2)-N(2) = 
87.44(10), C(32)-Pd(2)-O(12) = 89.13(10), N(2)-Pd(2)-O(10) = 90.48(9). 
 
 
The complex crystalises in the triclinic space group P-1, with one dimeric complex and 
three CH3CN molecules in the asymmetric unit. N-coordination (from the papaverine 
ligand) to PdII leads to a pseudo-anti relationship of the two palladated ligands. The 
palladacyclic moiety 1 {containing Pd(1)} is found in a true boat conformation whereas 
the palladacyclic moiety 2 {containing Pd(2)} is slightly twisted as a result of modest π-
π stacking interactions between neighbouring quinolinyl groups (ca. 4.1 Å between both 
aromatic ring systems).  The Pd(1)-Pd(2) bond distance is 3.0258(4)Å. Thus in the 
solid-state and in the presence of CH3CN, 85·CH3CN is not observed, and only 
binuclear Pd complex 86·CH3CN is obtained.  Moreover, there was no sign of nitrite 
anion. 
The complex also crystallized from DMSO giving yellow crystals, which were analysed 
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by XRD. The X-ray analysis confirmed the formation of a novel dimeric Pd(II) acetate 
bridged complex as above. However, an interesting observation was that the CH2 
bridged carbons has been oxidised, giving following structure (Figure 11). 
 
87  
Figure 11: The structure of novel dimeric Pd(II) acetate bridged complex, 87. 
 
DMSO has been previously reported to be involved in oxidation of cyclometallated 
product. Oxidation of Pt(II) by coordinated DMSO was established in 1968 upon 
treatment of cis-[PtCl2(DMSO)2] with concentrated aqueous HCI to give trans-
[PtCl4(SMe2)2]255 and is more widely recognised reaction now.256 A similar type of 
oxidation was also observed by Bruce and co-workers in their work on liquid crystalline 
organoplatinum(II) complexes.257 
 
The X-ray crystal structure of the Pd-dimer complex 87 is given in Figure 12. 
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Figure 12: X-ray structure of 87 with  2 (CH3)2SO molecules and H-atoms omitted for 
clarity; selected atoms labelled. 
 
Solvent and hydrogen atoms are removed for clarity. Thermal ellipsoids shown at 50%. Bond 
lengths(Ǻ): Pd(1)-Pd(2) = 2.9539(3), Pd(1)-N(1) = 2.0092(19), Pd(2)-N(2) = 2.0310(19), Pd(1)-
C(20) = 1.953(3), Pd(2)-C(40) = 1.961(2), Pd(1)-O(1) = 2.1548(18), Pd(1)-O(3) = 2.0462(17), 
Pd(2)-O(2) = 2.1307(17), Pd(2)-O(4) = 2.0687(16), C(14)-O(7) = 1.217(3), C(34)-O(12) = 
1.224(3), Bond Angles(º) O(1)-Pd(1)-O(3) = 87.43(7), O(2)-Pd(2)-O(4) = 84.49(7), O(1)-C(1)-
O(2) = 125.2(2), O(3)-C(3)-O(4) = 115.0(2), Pd(1)-N(1)-C(13) = 124.25(16), Pd(2)-N(2)-C(33) 
= 128.42(16), N(1)-Pd(1)-C(20) = 88.74(9), N(2)-Pd(2)-C(40) = 90.19(9), Pd(1)-Pd(2)-O(1) = 
82.09(5), Pd(1)-Pd(2)-O(4) = 80.88(5), C(33)-C(34)-C(35) = 119.0(2), C(13)-C(14)-C(15) = 
118.8(2). 
 
 
This complex crystallised in the P21/c space group  (Z = 4), with several DMSO 
molecules in the unit cell.   By contrast with [Pd(OAc)(C^N)] ·CH3CN, N-coordination 
to PdII exhibits a pseudo-syn relationship and the two quinolinyl groups π-π stack 
intramolecularly, causing both palladacyclic moieties to form twisted boat 
conformations. The Pd(1)-Pd(2) bond distance is 2.9539(3) Å, and is  shorter than that 
found in [Pd(OAc)(C^N)].CH3CN dimer complex. 
 
A similar series of reactions was repeated by using an impure batch of Pd(OAc)2 (ca. 
81% Pd3(OAc)5NO2). Cyclopalladation of papaverine 87 using impure Pd(OAc)2 in 
presence of dry CH3CN and under a N2 atmosphere gave an interesting result. The 1H 
NMR spectrum of this material revealed the presence of a mixture of products. 
 148
Although the starting material was fully consumed, the reaction solution was filtered 
while hot to remove metallic palladium formed during the reaction and was left for 
precipitation. No precipiate was obtained from CH3CN solution. The reaction was then 
repeated in the presence of air giving a similar product. A comparison of the 1H NMR 
spectrum for the different products obtained under the various reaction conditions is 
given in Figure 13. 
 
Figure 13: 1H NMR spectra (400 MHz, in DMSO-d6). A: Reaction of papaverine with 
impure Pd(OAc)2 (red)  B:  Reaction of papaverine with pure Pd(OAc)2 (green). C: 
Crystals of Pd-dimer (blue). D: papaverine 83 (note: the signal at δ 6.8 integrates for 2H, 
thus 7H in total in the aromatic region) (purple). 
 
 
 
 149
Spectrum A corresponds to the product obtained by reacting impure batch of Pd(OAc)2 
with papaverine. It shows the presence of two products. 1H NMR spectroscopy was 
used to check the ratio of OAc:NO2 containing-products, which was found to be 1:0.6 
and whilst this does not match the OAc:NO2 ratio in the impure Pd(OAc)2 batch, it can 
be accounted for by the low overall yield (27%) (which is consistent with considerable 
PdII degradation and Pd0 black formation). 
 
To account for the other major component in spectrum A (Figure 16) an authenitic 
sample of 84  needed to be prepared.  Reaction of 86·CH3CN with NaNO2 (10 eq.) gave 
84 in 66% yield (exact composition [Pd(NO2)(C^N)CH3CN]1.5H2O, which compares 
well to the reported composition  of [Pd(NO2)(C^N)CH3CN]3H2O  (Scheme 6).  
 
66% yield
8486
CH3CN
2 hr reflux
5 eq. NaNO2
 
Scheme 6: Synthesis of an authentic sample of [Pd(NO2)(C^N)CH3CN]·1.5H2O, (84). 
 
The comparison of the 1H NMR spectra for the complex 88 (reported and synthesized) 
is given in Table 2a. The 1H NMR spectroscopic data confirmed the formation of NO2-
palladated papaverine.  
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Table 2: The comparison of 1H NMR spectrum of 88 (reported258 and synthesized). 
 
1H signal [Pd(NO2)(C^N)CH3CN]·3H2Ob 
complex 88 (reported) 
[Pd(NO2)(C^N)CH3CN]·1.5H2Oc 
complex 88 (synthesized) 
H-3 8.26 (d, J = 6.3) 8.23 (br s) 
H-4 7.62 (d, J = 6.3) 7.58 (br s) 
H-5,8 7.47 (s) 
7.88 (s) 
7.44 (s) 
7.85 (s) 
H-5`,6` 7.04 (s) 
6.96 (s) 
6.98 (s) 
6.91 (s) 
CH2 4.79 (s) 4.74 (br s) 
OCH3 4.11 (s) 
3.99 (s) 
3.70 (s) 
3.66 (s) 
4.07 (s) 
3.95 (s) 
3.65 (s) 
3.61 (s) 
 
a Reported atom-numbering was used. 
b Reported data for the palladium-nitrito adduct (in DMSO-d6, 400 MHz).258  
c in DMSO-d6 at 400 MHz, 300 K.  
 
A comparison of the 1H NMR spectrum of  [Pd(NO2)(C^N)CH3CN]1.5H2O (in DMSO-
d6) D is done with the two products obtained in spectrum A and is found to resemble 
with one of the component in the reaction of 83 with impure Pd(OAc)2 (orange circles) 
(Figure 14). Thus, using impure Pd(OAc)2 both CH3CN adducts of 84 and 86 are 
observed under the reaction conditions. 
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Figure 14: 1H NMR spectra (400 MHz, in DMSO-d6). A: Reaction of papaverine with 
impure Pd(OAc)2  B:  Reaction of papaverine with pure Pd(OAc)2. C: Crystals of Pd-
dimer  86. D: Reaction of Pd-dimer with NaNO2. E: papaverine 83 (note: the signal at δ6.8 
integrates for 2H, thus 7H in total in the aromatic region) (purple). 
 
 
In an attempt to synthesize [Pd(NO2)(C^N)CH3CN].1.5H2O complex we come across 
an interesting result which is the formation of an unexpected [Pd(N-Hpap)2(NO2)2], 88 
complex formed during a reaction of complex 86, with the NaNO2 in refluxing CH3CN 
(a single crystal was picked from the bulk material), giving the structure shown in 
Figure 15. 
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88  
 
Figure 15: The structure of unexpeccted Pd-dinitro complex [Pd(N-Hpap)2(NO2)2], 88. 
 
The X-ray crystal structure of the complex 88 is given in Figure 16. 
 
 
 
Figure 16: X-ray structure of unexpected Pd(N-Hpap)2(NO2)2] complex, 88 
 
Solvent and hydrogen atoms are removed for clarity. Thermal ellipsoids shown at 50%. Bond 
lengths (Ǻ): Pd(1)-N(1) = 2.0408(14), Pd(1)-N(31) = 2.0359(15), N(1)-Pd(1) = 2.0407(14), 
N(3)-Pd(1) = 2.0359(14), N(3)-O(5) = 1.220(2), N(3)-O(6) = 1.238(2), C(9)-N(1) = 1.340(2), 
C(1)-N(1) = 1.366(2), Bond Angles (º):N(1)-Pd(1)-N(3) = 90.97(6), O(5)-N(3)-O(6) = 
121.74(16), N(3)-Pd(1)-N(31) = 180.000(2), N(1)-Pd(1)-N(11) = 180.000(1), N(3)-Pd(1)-N(1) = 
90.97(6), C(1)-N(1)-Pd(1) = 113.76(11), C(9)-N(1)-Pd(1) =125.08(11). 
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The formation of Pd(N-Hpap)2(NO2)2 88 from complex 86 requires some explanation.  
We did speculate that 86 may not have formed fully, leaving Pd(N-Hpap)2(OAc)2 as an 
initially formed complex prior to palladacycle formation. However, we have so far been 
unable to independently prepare Pd(N-Hpap)2(OAc)2 (an obvious precursor to Pd(N-
Hpap)2(NO2)2 by reaction of Hpap with Pd(OAc)2). On this basis a tentative mechanism 
which may explain the formation of Pd(N-Hpap)2(NO2)2 is given in the Scheme 7.   
Further studies are needed to be done to independently prepare this complex, allowing 
its full characterisation to be accomplished and chemical reactivity to be assessed. 
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Scheme 7: Proposed mechanism explaining the formation of Pd(N-Hpap)2(NO2)2, 88. 
 
Reaction of papaverine with  pure Pd(OAc)2 (>99%) gave a product similar to that of 
the crystals of Pd-dimer (Figure 17). This material is either a mixture of isomeric 
dinuclear compounds in DMSO-d6 solution, or mononuclear and dinuclear compounds. 
In order to further confirm this the Pd-dimer crystals obtained were dissolved in 
 154
pyridine-d5 giving a single mononuclear complex [Pd(OAc)(C^N)pyr-d5]1, (85.·pyr-d5) 
as shown by the 1H NMR spectrum (Figure 17). 
85-pyr-d5
 
 
 
Figure 17: 1H NMR spectra of complex 85 in pyridine-d5 (400 MHz). 
 
In order to further confirm the presence of a mononuclear compund, a stable phosphine 
adduct of papaverine Pd-dimer 86 was obtained by reacting Pd-dimer crystals with with 
PPh3 (1:1, PdII:PPh3) in DCM affording mononuclear complex [Pd(OAc)(C^N)PPh3] 89 
in 78% yield. The reaction takes 2 h. The reaction mixture was concentrated to one fifth 
of its intial volume. Slow addition of diethyl ether completed the crystallization of the 
                                                 
1
 Experiment performed by Prof. I. J. S. Fairlamb. 
 155
complex, which was filtered off, washed with ether and air-dried (Scheme 8). 
78% yield
1.05 eq PPh3
DCM
8986
2 hr reflux
 
Scheme 8: Synthesis of [Pd(OAc)(C^N)PPh3]. 
 
1H NMR spectroscopy showed the expected four singlet proton resonances for the 
methoxy groups at δ 4.09, 3.97, 3.69 and 2.91; proton resonances for papaverine and 
phenyl moieties, two pseudo-diastereotopic palladacylic methylene protons (ca. δ 4.89), 
and methyl singlet resonance for the acetoxy group (δ 1.21). We manage to obtain the 
crystals for the [Pd(OAc)(C^N)PPh3] product 89, which were analysed by XRD 
studies. An X-ray structure of a single crystal is given in  Figure 18. 
 
Figure 18: X-ray structure of [Pd(OAc)(C^N)PPh3], 89. 
 
Solvent and hydrogen atoms are removed for clarity. Thermal ellipsoids shown at 50%. Bond 
lengths (Ǻ): Pd(1)-P(1) = 2.2434(7), Pd(1)-C(16) = 1.990(3), N(1)-Pd(1) = 2.091(2), O(5)-Pd(1) 
= 2.111(2), N(1)-C(9) = 1.328(4), P(1)-C(35) = 1.822(3), P(1)-C(29) = 1.818(3), P(1)-C(23) = 
1.821(3), O(5)-C(21) = 1.261(4), O(6)-C(21) = 1.242(4), C(21)-C(22) = 1.515(4), Bond Angles 
(º):N(1)-Pd(1)-C(16) = 85.43(10), C(16)-P(1)-Pd(1) = 118.48(9), C(29)-P(1)-Pd(1) = 
113.98(10), C(23)-P(1)-Pd(1) = 112.29(2), C(35)-P(1)-C(29) = 104.27(13), C(29)-P(1)-C(23) = 
103.92(13). 
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The XRD data showed that the PPh3 complex crystallised in the monoclinic C2/c space 
group The palladacycle once again sits in a boat conformation. The N(1)-Pd(1) bond 
distance (2.091(2) Å) is longer than the equivalent N-Pd bond found in Pd-dimer 86 
(2.033(2) Å). The dihedral angle for C(9)-N(1)-Pd(1)-P(1) showed synperiplanar 
conformation (-3.9 °) whereas P(1)-Pd(1)-O(5)-(C21) exhibited synclinal and O(5)-
Pd(1)-N(1)-C(9) exhibited anticlinal conformation with torsion angle of -76.98(19) ° 
and 124.6(2) ° respectively. 
 
Hence by using pure Pd(OAc)2, 86 is the only product (as a mixture isomeric, 
mononuclear or dinuclear compounds, verified by the independent synthesis of 89).  It 
can therefore be concluded that nitrite impurities explain the formation of nitrite adducts 
from Pd(OAc)2 and papaverine 83 (in the presence or absence of air). 
 
Repeated attempts to crystallize the [Pd(NO2)(C^N)CH3CN].1.5H2O complex from 
both CH3CN and DMSO failed. We were keen to crystallize the complex to further 
confirm the formation of pap-NO2 complex, 84. Whilst this was not possible for either 
84·CH3CN or 84·DMSO, it was possible to prepare the PPh3 adduct by the reaction of 
84·CH3CN with PPh3 (in a 1:1 ratio) in CH2Cl2 at reflux for 2 h (Scheme 21). The 
product was characterized by NMR spectroscopy, mass spectrometry and elemental 
analysis, and found to be [Pd(NO2)(C^N)PPh3] 90 (Scheme 9).  
68% yield
1.05 eq PPh3
84 90
DCM
2 h reflux
 
Scheme 9: Synthesis of [Pd(NO2)(C^N)PPh3] complex (90). 
 
It was possible to crystallize complex 90 from DCM. The light yellowish crystals 
obtained were analysed by XRD. The XRD analysis showed an interesting structure 
where the NO2 was coordinated to palladium as expected but as a mixture of ‘Pd-η1-
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NO2’ (90a) and ‘Pd-η1-ONO’ (90b) isomers (Figure 19). 
 
Figure 19: X-ray  diffraction analysis of complex. Ground state structure (150 K) showing 
a mixture of ‘Pd-η1-NO2’ (90a) and ‘Pd-η1-ONO’ (90b). 
 
Solvent and hydrogen atoms are removed for clarity. Thermal ellipsoids shown at 50%. Bond 
lengths (Ǻ): Pd(1)-P(2) = 2.2661(5), Pd(1)-C(30) = 2.004(2), N(2)-Pd(1) = 2.1149(17), O(1)-
Pd(1) = 2.144(2), Pd(1)-N(1A) = 2.185(7), N(1A)-O(1A) = 1.104(10), O(1)-N(1) = 1.258(4), 
O(2)-N(1) = 1.225(4), P(2)-C(1) = 1.826(2), P(2)-C(7) = 1.823(2), P(2)-C(13) = 1.825(2), Bond 
Angles (º):C(30)-Pd(1)-N(2) = 85.39(7), C(30)-Pd(1)-P(2) = 93.46(6), C(30)-Pd(1)-N(1A) = 
159.78(19), C(30)-Pd(1)-O(1) = 170.00(8), N(2)-Pd(1)-P(2) = 174.29(5), N(2)-Pd(1)-N(1A) = 
90.07(18), O(1)-Pd(1)-N(1A) = 21.59(17), O(1)-N(1)-O(2) = 117.6(3), O(1A)-N(1A)-O(2A) = 
124.3(9). 
 
 
There were two binding modes for the nitro/nitrito ligand. The ratio of nitrito (bound by 
one oxygen, N1, O1, O2 with Pd cis to O2)  and nitro (N-bound, N1a O1a O1b) refined 
to 74:26. The  nitro/nitrito atoms were modelled isotropically and the N-O distance for 
the nitro were restrained to be equal. Similar nitrito complexes of NiII have been 
previously reported259 and are found to be effectively in use in data storage devices. 
These nitrito complexes of NiII exhibit linkage isomerisation (by photoexcitation). 
Coppens has pioneered this area and has determined the structures of a number of 
metastable linkage isomers including metal nitrosyl,260 metal nitrite261 and metal sulphur 
dioxide complexes.262 Hence, a detailed study of these complexes was investigated and 
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some more comprehensive photocrystallographic experiments were conducted using 
synchrotron radiation. 
 
5.5 Photocrystallographic study of [Pd(NO2)(C^N)PPh3] complex; 
(Crystallographic experiments conducted by Bath investigators) 
 
Photocrystallography is a rapidly growing technique that allows the full three-
dimensional structures of short-lived and metastable photoactivated species to be 
determined using X-ray diffraction method. By using this technique we can not only 
determine the structure of a transient species but can also follow a dynamic process 
within a crystal.  The XRD analysis for [Pd(NO2)(C^N)PPh3] complex (90) showed an 
interesting result where NO2 was coordinated to palladium as expected but as a mixture 
of ‘Pd-η1-NO2’ (90a) and ‘Pd-η1-ONO’ (90b) isomers. The group of Prof. Paul Raithby 
(University of Bath) has been working on similar kind of complexes and so a 
collaboration was initiated. A series of experiments were carried out to study the linkage 
isomerisation behaviour for the complex, [Pd(NO2)(C^N)PPh3], including the ratio for 
the two isomers under both photochemical and thermal conditions. 
  
5.5.1 XRD studies 
5.5.2 Instrumentation 
X-ray diffraction studies on complex 90 were conducted on beamline I19 at the 
Diamond Light Source, Rutherford Appleton Laboratory, UK and on Station 11.3.1 of 
the Advanced Light Source, Lawrence Berkeley National Laboratory, California, USA.  
Single crystal data collections at Diamond were carried out on a Rigaku Saturn CCD 
diffractometer equipped with an Oxford Cryosystems Cobra cryostream, while at the 
ALS data were collected using a Bruker APEXII CCD diffractometer equipped with a 
Oxford Cryosystems Cryostream Plus.    
 
5.5.3 Photocrystallographic Experiment 
An X-ray data set was collected in the absence of light at 150 K and the structure was 
solved and refined. The complex 90 crystallizes in the monoclinic space group P21/c 
and exists as a ca. 3:1 mixture of ‘Pd-η1-NO2’ (90a) and ‘Pd-η1-ONO’ (90b) linkage 
isomers (Table 6) at this temperature.  The crystal was then irradiated at 150 K using a 
specifically designed LED ring,263 which supports six 400 nm LEDs in a circle, 1 cm 
from the crystal to ensure uniform irradiation. After 1 h the crystal structure was 
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redetermined and it was found that the photoactivated nitrito complex ‘Pd-η1-ONO’ 
(90b) is fully formed (100% conversion).  Further irradiation (1.5 h) caused no 
appreciable change, confirming the 100% nitrito form to be a photostationary state. 
Notably, this isomer is retained at 150 K in the dark (over 1 h), showing that the system 
is metastable under these conditions.  The Pd-η1-ONO’ (90b) isomeric structure remains 
in the same space group P21/c, with little change in the packing arrangement.and only a 
∆V = 0.14% increase in the unit cell volume observed, in comparison to the initially 
determined mixed-isomer structure. Variable temperature parametric studies (VT) 
determined that the metastable state exists on warming to 180 K, however further 
heating to 200 K causes the system to revert back to its mixed-isomer structure initially 
observed at 150 K.  
 
Table 6: Crystallographically determined percentage ratios of 90a and 90b in a single 
crystal as a function of exposure to 400 nm radiation and variable temperature. a GS = 
ground state. b Photostationary state. c System is metastable at 150 K (8b). dVT = variable 
temperature. 
 
Experiment Irridation 
time / h 
Temp / K Conversion % 
GSa 0 150 23 77 
UV 1 150 0 100 
UV 1.5 150 0 100 
1 h Dark 1.5 150 0 100 
VTd 1.5 160 0 100 
VTd 1.5 180 0 100 
VTd 1.5 200 23 77 
 
 
5.5.4 Thermal Crystallographic Experiment 
Recent studies for another mixed nitro:nitrito NiII complex have shown that conversion 
between isomers can also be controlled thermally.264  As such, in separate experiments 
on Station 11.3.1 at the Advanced Light Source, Berkeley, California, USA, a single 
crystal of 90 was slow-cooled in-situ and a series of identical datasets collected at 
regular intervals to monitor any changes in nitro:nitrito occupation.  Conversion to the 
nitro isomer, 90a, was found to increase, from 77% at ambient temperature to a 
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maximum 86% on slow-cooling to 150 K (Table 3).   
 
Table 3: Crystallographically determined percentage of 90b in a single crystal as a 
function of temperature. 
 
The increase in 90a on slowly decreasing the temperature indicates that the major 
component is the more thermodynamically stable isomer at lower temperatures, which 
correlates with results obtained for the NiII system. The matching 77% conversion 
between the room temperature structure and the initial structure determined in the 
photocrystallographic experiments indicate that flash-cooling of the crystal appears to 
thermally trap the system in its ambient state. 
 
5.6 Further studies with pure and impure Pd(OAc)2 
 
In order to further confirm that there was no oxidation of CH3CN observed during the 
cyclopalladation reaction and it was the nitrite impurity in the Pd(OAc)2 catalyst, which 
was the cause of the nitrito-derived palladated products. Further experiments were 
conducted. Dr. C. J. Richards and co-workers in 2007 reported the synthesis of series of 
COP catalysts, di-µ-acetatobis[(η5-(S)-(pR)-2-(2`-(4`-methylethyl)oxazolinyl)cyclop-
entadienyl, 1-C, 3`-N)(η4-tetraphenylcyclobutadiene)cobalt]dipalladium ([COP-OAc]2)  
91 was synthesized by reacting (η5-(S)-2-(4-methylethyl)oxazolinyl-cyclopentadienyl)-
(η4-tetraphenylcyclobutadiene)cobalt 92 with Pd(OAc)2 in glacial acetic acid (Scheme 
10). The red solution was then heated to 95 °C for 0.5 h giving an orangish precipitate . 
The solution was cooled to room temperature, filtered, washed with  glacial acetic acid  
and dried under vacuum to afford 91 as a mustard-coloured solid.  
 
Temp / K Conversion / % 
298 76 
250 78 
200 84 
150 86 
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Pd(OAc)2
AcOH
2
95°C , 30 mins
92 91  
Scheme 10: Synthesis of ([COP-OAc]2) catalyst, 91. 
 
The same chemistry was repeated and the synthesis of [COP-OAc]2 91 was carried out 
using both pure and impure batch of Pd(OAc)2. In both cases a pure product was 
obtained as confirmed by 1H NMR spectroscopic analysis and there was no formation of 
Pd(II) nitrito adduct was observed in either case.265 
 
The same cyclopalladation chemistry was repeated using 2-phenylpyridine 93 (Scheme 
11). 2-Phenyl pyridine was treated with both a pure and impure batch of Pd(OAc)2. In 
the first reaction a mixture of 2-phenyl pyridine (1 mmol) and ultra-pure Pd(OAc)2 (1 
mmol) in  acetonitrile was heated at reflux for 3.5 hr with stirring. The solution was 
filtered whilst hot and left in fridge for crystallization. After 1 week a yellowish 
precipitate started appearing in the flask, which was then filtered, washed with hexane 
and dried. The product was obtained with a yield of 46%. The product was run for its 
mass spectrometry (LIFDI) and was found to have a peak at 637.9620  which 
corresponds to [Pd2(C26H22N2O4)] showing the formation of a cyclopalladated product 
and there is no nitrito adduct for PdII was observed.  
Pd(OAc)2, air
MeCN
2 h reflux
Pure Pd(OAc)2: 46% yield
Impure Pd(OAc)2: 35% yield
93 94
2
 
Scheme 11: Cyclopalladation of 2-phenylpyridine, (93). 
 
Similarly, in the second reaction 2-phenylpyridine was treated with impure Pd(OAc)2. 
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The reaction was carried out under similar conditions. Yellowish precipitates started 
appearing after a week, which were then filtered, washed with hexane and dried to give 
the product with a yield of 35%. The LIFDI mass spectrum for the product gave the 
peak at 637.9683 corresponding to formation of cyclopalladated product 
[Pd2(C26H22N2O4)]. The 1H NMR confirmed the presence of a mixture of product as 
expected for the impure Pd(OAc)2. 
 
The yellowish product obtained was soluble in most of the organic solvents (e.g. DCM, 
chloroform, benzene, ethyl acetate) and hence attempts were done to crystallize the 
cyclopalladated product formed. Light yellowish crystals started appearing in a DCM 
solution of product. The crystals were submitted for their XRD studies and were found 
to have the following structure (Figure 20). 
94
O O
Pd
N
OO
Pd
N
 
Figure 20: The structure of cyclopalladated 2-phenylpyridine, 94. 
 
The X-ray crystal structure of the complex 94 is given in Figure 21. 
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Figure 21: X-ray crystal structure of complex 94.  
 
Solvent and hydrogen atoms are removed for clarity. Thermal ellipsoids shown at 50%. Bond 
lengths (Ǻ): Pd(1)-Pd(2) = 2.8693(5), Pd(1)-N(1) = 2.014(3), Pd(2)-N(3) = 2.012(3), Pd(1)-
C(11) = 1.962(4), Pd(2)-C(22) = 1.967(4), Pd(10-O(1) = 2.057(3), Pd(1)-O(3) = 2.157(3), 
Pd(2)-O(2) = 2.149(3), Pd(2)-O(4) = 2.056(3), C(23)-O(1) = 1.272(5), C(23)-O(2)= 1.249(5), 
C(25)-O(3) = 1.265(5), C(25)-O(4) = 1.255(5), Bond Angles (º) O(1)-Pd(1)-O(3) 
= 93.80(11), O(3)-C(25)-O(4) = 126.0(4), O(2)-Pd(2)-O(4) = 98.37(11), N(3)-Pd(2)-C(22) = 
81.84(5), N(1)-Pd(1)-C(11) = 81.49(15), O(3)-Pd(1)-Pd(2) = 73.81(8), Pd(1)-Pd(2)-O(2) = 
82.06(8), N(1)-Pd(1)-O(1) = 172.51(13), N(1)-Pd(1)-O(3) = 93.03(12), N(3)-Pd(2)-O(2) = 
94.84(13), N(3)-Pd(2)-O(4) = 175.34(12). 
 
The complex crystalizes in the monoclinic space group P21/c. The Pd(1)-Pd(2)  bond 
distance (2.8693(5) Å) is shorter than that of Pd-dimer 86 (3.0258(4) Å). The bond 
distances for Pd(1)-N(1) (2.014(3) Å) and Pd(2)-N(3) (2.012(3) Å) in complex 94 are 
similar to that of  Pd(1)-N(1) (2.033(2) Å) and Pd(1)-N(2) (2.032(2) Å) in complex 86. 
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5.7 Experimental 
 
5.7.1 General Information 
 
1H-NMR spectra were obtained in the solvent indicated using a JEOL EXC400 or JEOL 
ECS400 spectrometer (400MHz for 1H, 100 MHz for 13C and 162 MHz for 31P). 
Chemical shifts were referenced to the residual undeuterated solvent of the deuterated 
solvent used(CHCl3 δH = 7.26 and δC = 77.16 (CDCl3), CDHCl2 δH = 5.31 and δC = 54.0 
(CD2Cl2), (CHD2)SO(CD3) δH = 2.50 and δC = 39.52 {SO(CD3)2}, 1H and 13C, 
respectively).. NMR spectra were processed using MestrNova software. All 13C NMR 
spectra were obtained with 1H decoupling.  31P NMR were externally referenced to 
H3PO4, and obtained with 1H decoupling.  For 13C NMR spectra the coupling constants 
are quoted to ±1 Hz.  For the 1H NMR spectra the resolution varies from ±0.15 to ±0.5 
Hz; the coupling constants have been quoted to ±0.5 Hz in all cases for consistency.   
 
Melting points were recorded using a Stuart digital SMP3 machine. IR spectroscopy 
was undertaken using a Jasco/MIRacle FT/IR-4100typeA spectrometer with an ATR 
attachment on solid and liquid compounds; solution and KBr IR spectra were obtained 
on a Nicolet Avatar 370 FT-IR spectrometer.  The relative intensities of the peaks are 
denoted by (s) = strong, (m) = medium and (w) = weak, whilst (br) is used to describe 
broad peaks. MS spectra were measured using a Bruker Daltronics micrOTOF MS, 
Agilent series 1200LC with electrospray ionisation (ESI and APCI) or on a Thermo 
LCQ using electrospray ionisation, with <5 ppm error recorded for all HRMS samples. 
LIFDI mass spectrometry was carried out using a Waters GCT Premier MS Agilent 
7890A GC (usually for analysis of organometallic compounds when ESI or APCI are 
not satisfactory ionisation methods). Mass spectral data is quoted as the m/z ratio along 
with the relative peak height in brackets (base peak = 100).  Elemental analysis was 
carried out on an Exeter Analytical CE-440 Elemental Analyser. UV-visible spectra 
were recorded using a JASCO V-560 instrument with quartz cells (1 cm path length).  
Spectra were processed in SigmaPlot version 10.0 (2006 Systat Software, Inc.).  
 
Dry and degassed acetonitrile and dichloromethane were obtained from a Pure Solv 
MD-7 solvent purification system. ‘Dry’ dimethyl sulfoxide was obtained from Acros 
(99.7+% extra dry over molecular sieves).  Acetonitrile used some reactions (indicated 
below in individual reactions) was dried and purified by triply distilling over anhydrous 
AlCl3, then Li2CO3 and finally CaH, according to a procedure reported by Walter and 
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Ramaley (method A).266 Nitrogen gas was oxygen-free and dried immediately prior to 
use by passage through a column containing sodium hydroxide pellets and silica. 
Commercial chemicals were purchased from Sigma-Aldrich or Alfa Aesar. 
 
All air sensitive procedures were carried out using Schlenk techniques (high vacuum, 
liquid nitrogen trap on a standard in-house built dual line). Where necessary a glove 
(dry) box was used (<0.5 ppm O2). Room temperature upper and lower limits are stated 
as 13-25 °C, but typically 21 °C was recorded. Commercial chemicals were purchased 
from Sigma-Aldrich and Alfa Aesar and used directly unless otherwise stated in the 
text.  Brine refers to a saturated aqueous solution of NaCl. 
 
 
Pd(II) dimer complex (86): Reactions of Hpap (83) with Pd(OAc)2 (>99%) 
 
a) In air using reagent grade CH3CN 
 
A mixture of Pd(OAc)2 (224 mg, 1 mmol) and Hpap (339 mg, 1 mmol) in acetonitrile 
(30 mL) was refluxed for 3.5 h (under air atmosphere) with stirring.  The resultant dark 
coloured solution was filtered whilst hot to remove metallic palladium formed during 
the reaction. The filtrate was then kept in the fridge which led to yellow crystals being 
formed. After 14 days, the yellow semi-crystalline material was filtered, washed with 
hexane and dried in vacuo to give 86 (0.415 g, 82%).  
 
b) In air using triply-distilled CH3CN 
 
Procedure identical to as given above. After 14 days, the yellow semi-crystalline 
material was filtered, washed with hexane and dried in vacuo to give 86 (0.225 g, 44%).  
 
c) Under N2 atmosphere using triply-distilled CH3CN 
 
Procedure identical to as given above, with the exception that the reaction was 
conducted under N2 (Schlenk techniques). After 14 days, the yellow semi-crystalline 
material was filtered, washed with hexane and dried in vacuo to give 86 (0.339 g, 67%). 
1H NMR (400 MHz, pyr-d5) δ 9.48 (d,  J = 6.5 Hz, 1H), 7.86 (s, 1H), 7.49 (d, J = 6.5 
Hz, 1H), 7.24 (s, 1H), 7.20 (s, 1H), 6.47 (s, 1H), 5.18 (s, 2H), 3.94 (s, 3H), 3.87 (s, 3H), 
3.70 (s, 3H), 3.52 (s, 3H) and 2.32 (s, 3H) (note: after 24 h in solution this complex 
does degrade to give other uncharacterised species); Mp 225-226 (decomp.)°C; LIFDI 
MS m/z 503 ([M]+.), 337 (100); HR-MS m/z 503.0524 ([M]+) (calc. for Pd(C22H23NO6 
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503.0560) {note: a complex mixture of ions were observed at m/z 1002-1014 (dimer), 
but an accurate mass could not be determined}; IR (KBr) υ cm-1 2938, 2835, 1618, 
1575, 1511, 1484, 1465, 1423, 1274, 1254, 1239, 1207, 1159, 1043, 1027, 987, 857, 
824, 781, 681; Elemental Analysis, Calcd. for C48H58N2O14Pd2S2 (6·2DMSO) (found) 
%: C 49.53 (48.98), H 5.02 (4.82), N 2.41 (2.37) (note: elemental analysis on 
crystalline material derived from DMSO).  
 
Reactions of Hpap (83) with impure Pd(OAc)2 {mixture of Pd3(OAc)6 and 
Pd3(OAc)5NO2} 
 
a) In air using triply-distilled CH3CN 
 
Procedure (and scale) identical to that used for Pd(OAc)2. The reaction in this case was 
done with impure Pd3(OAc)6 {ca. 81% Pd3(OAc)5NO2}. After 14 days, the yellow 
semi-crystalline material was filtered, washed with hexane and dried in vacuo to give a 
mixture of compounds (0.137 g, ca. 27%); The 1H NMR spectrum of this material was 
quite complicated ( mixture of products), MS analysis reveals only the presence of a 
[Pd(C^N)(OAc)] adduct – LIFDI MS m/z 503.06 ([M]+.); Elemental analysis of this 
material, Found: C, 48.73; H, 4.45; N, 4.20 (high nitrogen content).  
 
b) Under N2 atmosphere using triply-distilled CH3CN 
 
Procedure (and scale) identical to that used for Pd(OAc)2. The reaction in this case was 
done with impure Pd3(OAc)6 {ca. 81% Pd3(OAc)5NO2}. After 14 days, the yellow 
semi-crystalline material was filtered, washed with hexane and dried in vacuo to give a 
mixture of compounds (0.175 g, ca. 35 %); The 1H NMR spectrum of this material was 
quite complicated ( mixture of products),, MS analysis reveals only the presence of a 
[Pd(pap)(OAc)] adduct – LIFDI MS m/z 503.01 ([M]+.), 339.12 (100); Elemental 
analysis of this material, Found: C, 47.9; H, 4.64; N, 8.62 (high nitrogen content). 
 
Complex 89,  [Pd(OAc)(C^N)PPh3] 
 
Palladium complex 6 (150 mg, 0.15 mmol) was dissolved in dichloromethane (15 mL) 
containing triphenylphosphine (39.1 mg, 0.15 mmol, 1 eq. per Pd) was added. The 
solution was refluxed at 40 ºC for 2 h, and then concentrated in vacuo to one fifth of its 
initial volume.  Slow addition of diethyl ether led to precipitation of the complex, which 
was filtered off, washed with diethyl ether and air-dried to afford a pale yellow solid 
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(0.089 g, 78%). Mp 135-137 (decomp.); 1H NMR (400 MHz, CD2Cl2) δ 8.53 (d,  J = 
6.3 Hz, 1H), 7.55-7.66 (br m, 7H), 7.41-7.45 (br m, 3H), 7.34-7.39 (br m, 7H), 7.03 (s, 
1H), 6.81 (s, 1H), 6.04 (d,  J = 4.5 Hz, 1H), 4.96 (br d, ca. 12 Hz, 1H), 4.82 (br d, ca. 12 
Hz, 1H), 4.09 (s, 3H), 3.97 (s, 3H), 3.69 (s, 3H), 2.91 (s, 3H), 1.21 (s, 3H); 13C NMR 
(101 MHz, CD2Cl2) δ 177.3 (4º), 158.3 (4º), 154.8 (4º), 151.5 (4º), 146.3 (4º, d, J = 2.5 
Hz), 146.1 (4º), 142.8 (CH), 135.5 (CH, d, J = 11.5 Hz), 134.5 (4º), 131.5 (4º, d, J = 48 
Hz), 131.1 (4º), 130.9 (CH, d, J = 1.5 Hz), 128.8 (CH, d, J = 10.5 Hz), 122.9 (4º, d, J = 
2.5 Hz), 119.9 (CH, d, J = 11 Hz), 119.2 (CH), 112.8 (CH), 105.9 (CH), 104.6 (CH), 
56.7 (CH3), 56.6 (CH3, 2C), 55.1 (CH3), 45.1 (CH2), 24.1 (CH3); 31P NMR (162 MHz, 
CD2Cl2) δ 34.6 (s, 1P); IR (KBr) υ cm-1 2935, 2834, 1619, 1575, 1510, 1483, 1464, 
1422, 1337, 1312, 1274, 1238, 1207, 1160, 1096, 1042, 987; LIFDI MS m/z 765 [M]+., 
503 (100), HR-MS m/z 765.1260  ([M+H]+) (calc. for C40H38NO6PdP 766.1312). 
 
 
Complex 84, authentic sample of [Pd(NO2)(C^N)CH3CN]·1.5H2O 
 
 
To a stirred solution of NaNO2 (73.8 mg, 1.07 mmol, 5 eq.) in CH3CN (10 mL) was 
added semi-crystalline 6·CH3CN (0.112 g, 0.107 mmol, 0.5 eq.).  The mixture was 
refluxed for 2 h (temperature ca. 90 ºC, solution turned from yellow to green), and then 
filtered through dried Celite® whilst hot to remove any insoluble material (trace 
palladium black and insoluble NaNO2/NaOAc).  The title complex precipitated out of 
solution overnight (left open to air), which was filtered and washed with diethyl ether 
and then dried in vacuo affording a pale yellow solid (78.0 mg, 69%). Mp 204-206 
(dec.); 1H NMR (400 MHz, DMSO-d6) δ 8.23 (br s, 1H, H-3), 7.85 (s, 1H, H-8), 7.58 
(br s, 1H, H-4,), 7.44 (s, 1H, H-5), 6.98 (s, 1H, H-5`), 6.91 (s, 1H, H-6`), 4.74 (br s, 2H, 
CH2), 4.07 (s, 3H, OCH3), 3.95 (s, 3H, OCH3), 3.65 (s, 3H, OCH3), 3.61 (s, 3H, OCH3), 
2.07 (s, 2H, liberated CH3CN); 13C NMR (101 MHz, DMSO-d6, note: weak spectrum – 
an improved spectrum was recorded in CD2Cl2, see below) δ 158.7, 154.1, 150.9, 146.0, 
144.9, 141.4, 133.3, 122.0, 118.1, 111.9, 105.8, 104.9, 56.4, 56.1, 56.0, 55.6, 48.6, 30.7, 
1.2 (liberated CH3CN); 13C NMR (101 MHz, CD2Cl2) δ 159.0, 155.5, 152.1, 147.4, 
146.3, 142.2, 134.6, 128.4, 123.2, 119.8, 117.2, 111.9, 105.8, 104.6, 56.9, 56.8, 56.7, 
55.7 44.3; IR (KBr) υ cm-1 2970, 2839, 2283, 1619, 1564, 1512, 1484, 1462, 1451, 
1424, 1378, 1336, 1273, 1237, 1207, 1160, 1043, 988; LIFDI MS m/z 490.05 [M-
CH3CN]+., 339.15 (100); Elemental Analysis, Calcd. for Pd(C22H26N3O7.5) (found) %: C 
47.28 (47.42), H 4.69 (4.35), N 7.52 (7.86) (note: the complex is mononuclear and 
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assigned as [Pd(NO2)(C^N)CH3CN]·1.5H2O). 
 
Complex 90, [Pd(NO2)(C^N)PPh3] 
 
Complex [Pd(NO2)(C^N)CH3CN].1.5H2O (0.035 g, 0.063 mmol) was dissolved in 
CH2Cl2 (10 mL).  PPh3 (16.4 mg, 0.063 mmol, 1 eq.) was then added. The solution was 
refluxed (40 ºC) for 2 h, and then concentrated in vacuo to one fifth of its initial volume. 
Addition of diethyl ether (5 mL) led to product precipitation, which was filtered, 
washed with diethyl ether (2 x 5 mL) and air-dried (32.3 mg, 68%). Mp 185-187 
(decomp.); 1H NMR (400 MHz, CD2Cl2) δ 8.24 (br d, J ca. 5 Hz, 1H), 7.63-7.56 (m, 
7H), 7.50-7.45 (m, 3H), 7.41-7.34 (m, 7H), 7.09 (s, 1H), 6.77 (s, 1H), 6.01 (d, J = 4.7 
Hz, 1H), 5.01 (d, J = 14.1Hz, 1H), 4.84 (d, J = 14.1 Hz, 1H), 4.10 (s, 3H), 3.98 (s, 3H), 
3.68 (s, 3H), 2.98 (s, 3H); 13C NMR (101 MHz, CD2Cl2) δ 158.6 (4º), 155.1 (4º), 151.8 
(4º), 146.54 (4º), 146.46 (4º, d, J = 4.0 Hz), 141.9 (CH), 137.0 (4º), 135.2 (CH, d, J = 
11.5 Hz), 134.7 (4º), 131.3 (CH, d, J = ca. 3 Hz), 131.0 (4º, d, J = ca. 45 Hz), 130.8 
(4º), 129.0 (CH, d, J = 10.5 Hz), 123.2 (4º d, J = 3.5 Hz), 120.5 (CH, d, J = 12 Hz, 
119.3 (CH, d, J = 2.5 Hz), 112.5 (CH), 106.0 (CH), 104.7 (CH), 56.73 (CH3), 56.7 (2C, 
CH3), 55.3 (CH3), 45.1 (CH2) {confirmed by DEPT135 experiment); 31P NMR (162 
MHz, CD2Cl2) δ (ppm): 32.7 (s, 1P); LIFDI MS m/z 706.22 [C38H35NO4PPd]+ (base 
peak); Elemental Analysis, Calcd. For C38H35N2O6PdP·1.25CH2Cl2 (found) %: C 54.86 
(54.37), H 4.40 (4.46), N 3.26 (3.35) (note: dichloromethane adduct). 
 
Synthesis of COP-catalyst, 91 
 
A flame-dried, single-necked, 250-mL round-bottomed flask was fitted with a stirring 
bar and an argon-inlet. The flask was evacuated, refilled with argon and then, while 
temporarily removing the argon inlet, charged with (η5-(S)-2-(4-
methylethyl)oxazolinylcyclopentadienyl)-(η4-tetraphenylcyclobutadiene)cobalt (0.08 g, 
0.135 mmol) and  0.8 mL of glacial acetic acid. Palladium(II) acetate (0.03 g, 0.135 
mmol) was then added and the red solution was heated at 95°C. After some time orange 
precipitate started forming. After 30 mins the solution was cooled to room temperature 
and filtered to provide an orange solid. Which was then washed with 0.4 mL glacial 
acetic acid and dried under vacuum to gave the mustrad coloured solid. 1H NMR (400 
MHz, CD2Cl2) δ 7.42-7.44 (m, 8H), 7.19-7.29 (m, 14H), 5.13-5.14 (m, 1H), 5.05 (m, 
1H), 4.78 (q, J = 2.5 Hz, 1H), 4.70 (q, J = 2.5 Hz, 1H), 3.61 (d, J = 9.5 Hz, 1H), 3.46 (t, 
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J = 8.0 Hz, 1H), 3.37-3.41 (m, 1H), 1.26 (s, 4H), 0.94 (d, J = 6.6 Hz, 3H), 0.74 (d, J = 
6.5 Hz, 3H).267  
NMR data(using impure Pd(OAc)2: The 1H NMR spectrum was quite complicated ( 
mixture of products). 
 
Cyclopalladation of 2-phenylpyridine, 94 
a) Using pure Pd(OAc)2 (>99%) 
 
A mixture of Pd(OAc)2 (224 mg, 1 mmol) and 2-phenylpyridine (155 mg, 1 mmol) in 
acetonitrile (30 ml) was refluxed for 3.5 h with stirring and the resulted dark coloured 
solution was filtered while hot to remove metallic palladium formed during the reaction. 
The filtrate was then kept in fridge for precipitation. After a week, yellow precipitate 
formed. The yellow solid product was filtered, washed with hexane and dried (0.148 g, 
46.4%). 1H NMR (400 MHz, CD2Cl2) δ 8.09 (d, J = 3.5 Hz, 1H), 7.33-7.36 (m, 1H), 
7.23-7.25 (m, 1H), 7.08-7.16 (m, 3H), 6.84-6.88 (m, 2H), 6.69-6.81 (m, 1H), 6.71-6.75 
(td, J = 7.8, 1.6 Hz, 1H), 6.62 (ddd, J = 8.5, 4.3, 2.0 Hz, 1H), 6.44 (d, J = 8.1 Hz, 1H), 
6.29 (dd, J = 8, 1.5 Hz, 1H), 6.20-6.24 (m, 2H), 5.81 (ddd, J = 7.2, 6, 1.2 Hz, 1H), 1.65 
(s, 3H), 1.42 (s, 3H); HRMS (LIFDI) [M]+ m/z  637.9620 (Calcd. for [Pd2(C26H22N2O4)] 
637.9649 ); Anal. Calcd for [Pd2(C26H22N2O4)]:C, 48.84; H,3.46; N,4.38. Found: C, 
53.67; H, 3.82; N, 4.97. 
 
b) Using impure Pd(OAc)2 {mixture of Pd3(OAc)6 and Pd3(OAc)5NO2} 
 
 
A mixture of Pd(OAc)2 (224 mg, 1 mmol) and 2-phenylpyridine (155 mg, 1 mmol) in 
acetonitrile (30 ml) was refluxed for 3.5 h with stirring and the resulted dark coloured 
solution was filtered while hot to remove metallic palladium formed during the reaction. 
The filtrate was then kept in fridge for precipitation. After 2 to 3 weeks, a yellow 
precipitate formed. The yellow solid product was filtered, washed with hexane and dried 
(0.113 g, 35.4%). HRMS (LIFDI) [M]+ m/z 637.9683 (Calcd. for [Pd2(C26H22N2O4)] 
637.9649 ); Anal. Calcd for [Pd2(C26H22N2O4)]:C, 48.84; H,3.46; N,4.38. Found: C, 
50.28; H, 3.67; N, 6.30. 
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5.7.2 X-ray crystallography 
5.7.2.1 X-Ray Diffraction Data for compound 90 
The programs CrystalClear and APEXII were used for collecting frames, indexing 
reflections and determination of lattice parameters at Diamond and the ALS 
respectively, and the program SADABS was used for absorption correction at the ALS 
while CrystalClear was used to apply absorption corrections for the Diamond 
synchrotron data.  The structures were solved by direct methods using SHELXS-86268 
and refined by full-matrix least-squares on F2 using SHELXL-97.269  In all the 
structures the ordered non-hydrogen atoms were refined with anisotropic displacement 
parameters, while disordered atoms were refined with occupancies summed to unity.  
Hydrogen atoms were placed in idealised positions and allowed to ride on the relevant 
carbon atoms.  Refinements continued until convergence was reached. 
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Table 4: Details of the photoexcitation experiments with compound 90. 
 
Compound 
reference 
90_GS150K 90_UV150K 90_VT200K 
Formula C39H37Cl2N2O6PPd C39H37Cl2N2O6PPd C39H37Cl2N2O6PPd 
Formula weight 837.98 837.98 837.98 
Cryst syst Monoclinic Monoclinic Monoclinic 
a(Å) 10.7223(5) 10.7119(4) 10.7245(5) 
b(Å) 21.7779(13) 21.7420(12) 21.8948(15) 
c(Å) 16.3387(7) 16.4105(6) 16.3488(8) 
Α(°) 90.00 90.00 90.00 
Β(°) 105.321(4) 105.404(4) 105.251(5) 
Γ(°) 90.00 90.00 90.00 
V (Å3) 3679.6(3) 3684.7(3) 3703.7(4) 
Temp (K) 150(2) 150(2) 190(2) 
Space group P2(1)/c P2(1)/c P2(1)/c 
No. of formula 
units per unit cell, 
Z 
4 4 4 
Absorption 
coefficient, µ/mm-1 
0.743 0.742 0.738 
No. of reflections 
measured 
41375 40979 41224 
No. of independent 
reflections 
11231 11231 11279 
Rint 0.0398 0.0380 0.0526 
Final R1 values (I 
> 2σ(I)) 
0.0340 0.0328 0.0417 
Final wR(F2) 
values (I > 2σ(I)) 
0.0789 0.0771 0.1001 
Final R1 values (all 
data) 
0.0429 0.0407 0.0546 
Final wR(F2) 
values (all data) 
0.0836 0.0814 0.1092 
Goodness of fit on 
F
2 
1.044 1.046 0.949 
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Table 5: Details of the slow cool experiments with compound 90. 
 
Compound 
reference 
298K 250K 200K 150K 
Formula C39H37Cl2N2O6
PPd 
C39H37Cl2N2O6P
Pd 
C39H37Cl2N2O6P
Pd 
C39H37Cl2N2O6
PPd 
Formula weight 837.98 837.98 837.98 837.98 
Cryst syst Monoclinic Monoclinic Monoclinic Monoclinic 
a(Å) 10.786(8) 10.7248(5) 10.7075(7) 10.6878(7) 
b(Å) 22.362(17) 22.0346(11) 21.8698(14) 21.7334(14) 
c(Å) 16.405(12) 16.3099(8) 16.3273(10) 16.3349(10) 
Α(°) 90.00 90.00 90.00 90.00 
Β(°) 104.945(9) 105.1660(10) 105.3090(10) 105.4190(10) 
Γ(°) 90.00 90.00 90.00 90.00 
V (Å3) 3823(5) 3720.1(3) 3687.7(4) 3657.7(4) 
Temp (K) 298(2) 250(2) 200(2) 150(2) 
Space group P2(1)/c P2(1)/c P2(1)/c P2(1)/c 
No. of formula 
units per unit cell, 
Z 
4 4 4 4 
Absorption 
coefficient, µ/mm-
1 
0.715 0.735 0.741 0.747 
No. of reflections 
measured 
38082 39374 38982 39140 
No. of 
independent 
reflections 
11705 11236 11142 11046 
Rint 0.0518 0.0560 0.0576 0.0793 
Final R1 values (I 
> 2σ(I)) 
0.0465 0.0454 0.0455 0.0472 
Final wR(F2) 
values (I > 2σ(I)) 
0.1399 0.1312 0.1341 0.1207 
Final R1 values 
(all data) 
0.0618 0.0606 0.0572 0.0563 
Final wR(F2) 
values (all data) 
0.1521 0.1408 0.1422 0.1262 
Goodness of fit on 
F
2 
1.004 0.988 1.006 1.071 
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5.7.2.2 Crystallographic data for compounds analysed and solved in York 
 
 
Diffraction data for complex 86.(CH3CN) and 87.(DMSO) are given in Table 6 
whereas for [Pd(OAc)(C^N)PPh3] complex 89 and the unexpected [Pd(N-
Hpap)2(NO2)2] complex 88 are given in Table 7. The diffraction data for 
[Pd(NO2)(C^N)PPh3] complex 90 and cyclopalladated 2-phenylpyridine 94 is given in 
Table 8. The data was collected at 110 K on a Bruker Smart Apex diffractometer with 
Mo-Kα radiation (λ = 0.71073 Å) using a SMART CCD camera.  Diffractometer 
control, data collection and initial unit cell determination was performed using 
“SMART”.1  Frame integration and unit-cell refinement was carried out with 
“SAINT+”.1 Absorption corrections were applied by SADABS.1  Structures were 
solved by “direct methods” using SHELXS-97 (Sheldrick, 1997)1 and refined by full-
matrix least squares using SHELXL-97 (Sheldrick, 1997).1   
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Table 6: Single crystal X-Ray details for complex (86-CH3CN) and (87-DMSO). 
 
Compound 
reference 
ijf1020m (86.CH3CN) ijsf1109 (87.DMSO) 
Formula C44H46N2O12Pd2·3(C2H3N) C44H42N2O14Pd2·2(C2H6OS) 
Formula 
weight 
1130.79 1191.85 
temp (K) 110(2) 110.0 
Cryst syst Triclinic Monoclinic 
Space group P-1 P21/c 
a(Å) 11.1250(17) 13.3081(5) 
b(Å) 15.392(2) 26.2365(10) 
c(Å) 15.758(2) 14.0067(6) 
α(°) 74.695(3) 90.00 
β(°) 77.903(3) 99.483(4) 
γ(°) 70.463(3) 90.00 
V (Å3) 2430.9(6) 4823.7(3) 
Z 2 4 
Dcalcd. (Mg M-3) 1.545 1.641 
F(000) 1156 2432 
Μ(mm-1) 0.808 0.906 
Crystal size 
(mm3) 
0.22 × 0.19 × 0.09 0.165 × 0.132 × 0.032 
θ  range for 
data 
1.75 to 28.31 6.08 to 61.24 
Collection (°) 
Index ranges 
-14<=h<=14, 
-20<=k<=20, 
-20<=I<=21 
-18≤ h ≤ 18, 
-37 ≤ k ≤ 37, 
-20 ≤ I ≤ 19 
No. of rflns 
collected 
24776 20629 
Refinement 
method 
Full-matrix least-squares 
on F2 
Full-matrix least-squares on 
F2 
GOOF on F2 1.045 0.884 
R1, 
wR2(I>2σ(I)) 
R1= 0.0387, wR2= 0.0932 R1= 0.0381, wR2= 0.0708 
R1, wR2(all 
data) 
R1= 0.0507, wR2= 0.0993 R1= 0.0644, wR2= 0.0755 
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Table 7: Single crystal X-Ray details for complex [Pd(OAc)(C^N)PPh3] (89) and [Pd(N-
Hpap)2(NO2)2] (88). 
 
Compound 
reference 
ijf1042 (89) ijsf1110 (88)  
Formula C40H38NO6PPd·CH2Cl2 C38H42N6O12Pd·2(C2H3N) 
Formula weight 851.01 959.28 
temp (K) 110.15 109.9 
Cryst syst Monoclinic Triclinic 
Space group C2/c P-1 
a(Å) 47.4181(14) 8.4350(6) 
b(Å) 11.0136(3) 10.2678(5) 
c(Å) 17.7382(6) 13.5105(7) 
α(°) 90.00 77.953(4) 
β(°) 107.608 76.502(5) 
γ(°) 90.00 72.666(5) 
V (Å3) 8829.7(5) 1073.86(11) 
Z 8 1 
Dcalcd. (Mg M-3) 1.280 1.483 
F(000) 3488 496 
Μ(mm-1) 0.619 0.503 
Crystal size 
(mm3) 
0.336 × 0.2842 × 0.2773 0.1827 × 0.1176 × 0.042 
θ  range for 
data 
5.84 to 50.22 6.28 to 64.16 
Collection (°) 
Index ranges 
-56 ≤ h ≤ 56, 
-13 ≤ k ≤ 13, 
-21 ≤ I ≤ 21 
-12 ≤ h ≤ 12, 
-15 ≤ k ≤ 15, 
-20 ≤ I ≤ 20 
No. of rflns 
collected 
42881 16535 
Refinement 
method 
Full-matrix least-squares 
on F2 
Full-matrix least-squares on 
F2 
GOOF on F2 1.095 1.060 
R1, 
wR2(I>2σ(I)) 
R1= 0.0373, wR2= 0.1018 R1= 0.0345, wR2= 0.0839 
R1, wR2(all 
data) 
R1= 0.0407, wR2= 0.1038 R1= 0.0377, wR2= 0.0861 
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Table 8: Single crystal X-Ray details for complex 90 and 94. 
 
Compound reference ijf1039 (90) ijf1021 (94)  
Formula C39H37Cl2N2O6PPd C26H22N2O4Pd2 
Formula weight 837.98 639.26 
temp (K) 110.0 110.0 
Cryst syst monoclinic monoclinic 
Space group P21/c P21/c 
a(Å) 10.66940(17) 9.8702(3) 
b(Å) 21.6101(3) 13.0105(5) 
c(Å) 16.3379(3) 17.5786(6) 
α(°) 90.00 90.00 
β(°) 105.5155(17) 94.524(3) 
γ(°) 90.00 90.00 
V (Å3) 3629.69(10) 2250.35(13) 
Z 4 4 
Dcalcd. (Mg M-3) 1.533 1.887 
F(000) 1712 1264 
Μ(mm-1) 0.753 1.636 
Crystal size (mm3) 0.2413 × 0.1145 × 0.114 0.1414 × 0.0734 × 0.0509 
θ  range for data 6.22 to 54.96 2.9041 to 49.9998 
Collection (°) 
Index ranges 
-13 ≤ h ≤ 13, 
-28 ≤ k ≤ 15, 
-21 ≤ I ≤ 21 
-11 ≤ h ≤ 11, 
-15 ≤ k ≤ 15, 
-20 ≤ I ≤ 20 
No. of rflns collected 15420 22605 
Refinement method Full-matrix least-squares on 
F2 
Full-matrix least-squares on 
F2 
GOOF on F2 1.059 1.101 
R1, wR2(I>2σ(I)) R1 = 0.0315, wR2 = 0.0725 R1 = 0.0357, wR2 = 0.0575 
R1, wR2(all data) R1 = 0.0378, wR2 = 0.0769 R1 = 0.0466, wR2 = 0.0606 
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Chapter 6: Conclusions 
 
The principal aim of this project was to synthesise novel bidentate alkene phosphine 
ligands and phosphine sulfide ligands, based on a ferrocenyl-chalcone ligand 
framework, which would allow their metal coordination study and use in homogenous 
catalysis. Previously, considerable work has been done individually on alkene and 
phosphine ligands; very little is known about ligands involving both alkene and 
phosphine moiety within the same ligand, especially in coordination chemistry studies.  
 
 
The project detailed in this thesis involved the synthesis of bidentate phosphino-alkene 
and phosphine sulfide ligand with a chalcone backbone, which contains one enone 
moiety (unlike dba which is a 1,4-dien-3-one). The synthesis of β-biaryl acryl ferrocene 
is relatively straight-forward and was accomplished by a Claisen-Schmidt condensation 
reaction. The target ligands, ferrochalcone 32 and thio-ferrochalcone 33, were 
synthesised from acetyl ferrocene 35 and 2-(diphenylphosphino)benzaldehyde 39 or 2-
(diphenylthiophosphino)-benzaldehyde 40 in good yield. The thio-variant of the Lei 
ligand (17) has been reported previously. The structure of both 32 and thio-Lei ligand 
46 was confirmed by XRD studies.  
 
Following the successful synthesis of these novel ligands, in the next step the metal 
coordination studies of these ligands were conducted using transition metals such as Pt, 
Pd, Rh, Cu and Au. A comparison of the metal complexes of the chalcone ferrocene 
ligand 32 with metal complexes of Lei ligand 17 was also performed. The plan was to 
use these ligands for catalysis so a detailed study of the metal coordination behaviour of 
these ligands was deemed necessary. We were encouraged by discussions with Prof. 
Aiwen Lei (when he visited York in 2009), who was keen to see further coordination 
studies on his and related ligands pursued. 
 
The PdII complex for the ferrochalcone ligand 32 was first synthesised. The NMR 
spectroscopic analysis confirmed that only the phosphine moiety was interacting with 
the metal and that there was no PdII-alkene interaction. The product crashes out of 
solution instantaneously; solubility was a continuing problem for this complex, and is 
best explained by extensive polymerisation. 
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PtII and Pt0 complexes were synthesised for both ferrochalcone 32 and Lei ligand 17. 
For the PtII complexes the NMR spectroscopic analysis showed that the phosphorus was 
interacting with PtII, but as with PdII-there was no evidence of a PtII-alkene interaction. 
However, the XRD analysis showed that the PtII complexes acted as a bidentate ligand 
binding through both alkene and phosphine moieties. It appears in both PdII and PtII 
complexes, that the MIICl2(P)2 complexes are kinetically preferred, whereas the 
MIICl2(P,-η2-alkene) are thermodynamically more stable.  Similarly, Pt0 metal 
complexes were obtained for both the chalcone ferrocene ligand 32 and Lei ligand 17. 
Reaction of Pt0(dba)2 with ferrochalcone 32 in benzene gave a novel Pt0 species, namely 
Pt0(P,-η2-alkene)2. The crystallisation of the solid material in benzene gave light red 
crystals. The XRD studies showed that each of the two molecules of the ligand were 
both P and π-alkene bound to Pt0. Interestingly, the metal coordination by the two P 
atoms and two π-alkenic bonds is intermediate between square-planar and tetrahedral. 
The Pt0 metal complex for the Lei ligand 17 was obtained by reaction with 
Pt0(PPh3)2(η2-C2H4), which gave a product, Pt0(P,-η2-alkene)2, confirmed by NMR 
spectroscopic and mass spectrometric analysis and XRD studies. The crystal structure 
exhibited a geometry which is intermediate between square-planar and tetrahedral.  
 
Coordination studies with rhodium were also conducted. Most of the rhodium 
complexes (all RhI) were found to be air-sensitive, and reactions needed to be conducted 
in the glove box. The RhI complex for the ferrochalcone ligand 32 was obtained by a 
reaction of the ligand with [Rh(cod)Cl]2 in THF in a ligand to metal ratio of 2:1. The 
complex was analysed by NMR spectroscopy. The 31P NMR spectrum exhibited two 
sets of signals which were found as a doublet of doublets.  The coupling constant values 
showed that the RhI was bonded to two different phosphorus atoms giving rise to an AB 
system. Other phosphorous species (downfield) were also observed by 31P NMR 
spectroscopy. An X-ray structure determination revealed [Rh2(ferrochalcone ligand)2] 
57b, where the RhI was bonded to two bridging ligands. The ligand spans two RhI 
centres by P, alkene-coordination to one Rh and then carbonyl O-coordination to the 
other RhI atom. The X-ray structure shows that ferrochalcone 32 acts as a tridentate 
ligand. The RhI complex exhibits a distorted square-planar geometry. A comparative 
study was conducted using Lei ligand 17. Interestingly, the RhI complex is stable in air 
and the reaction was conducted outside the glove box (in the absence of light). The 
successful synthesis of the RhI complex of 17 was confirmed by NMR and IR 
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spectroscopic, and mass spectrometric studies. The singlet peak at δ -13.0 (31P NMR) in 
the ligand had shifted to give a pair of doublet of doublets, akin to the RhI complex of 
ferrochalcone 32. Interestingly, other phosphorus species were minimal for ligand 17. 
The yellow product obtained was crystallised from dichloromethane giving fine yellow 
needles. The RhI metal was found to be coordinated to two ligands of 17. The metal was 
found to be coordinated by two P atoms and two alkenic bonds. 
 
Copper was shown to show interesting coordination behaviour toward the 
thiophosphine ligands. CuI complexes for ferrochalcone 32 were formed by reacting the 
ligand with [Cu(MeCN)4]PF6 and [CuCl]. The structure of the complex was analysed by 
NMR and mass spectrometric techniques. Similarly, the CuI complex for thio-
ferrochalcone 33 was obtained by similar reactions. Comparison of the NMR spectra for 
the free ligand with the complexed ligand revealed the clean formation of a CuI complex 
in both cases. The structure of the CuI complex was analysed by X-ray diffraction 
studies and found to have a trigonal-planar geometry.  The ligand 33 acted as a 
bidentate ligand, binding through both the sulphur and the alkene moiety. The same 
reaction was repeated for the Lei ligand 17, allowing a comparative study of their metal 
coordination behaviour. Reaction of the Lei ligand 17 with [Cu(MeCN)4]PF6 in a ligand 
to metal ratio of 2:1, gave a cationic [CuI(P)2CH3CN]PF6 complex. Whereas, reaction of 
CuCl with 17 in a metal/ligand ratio of 1:1 gave a neutral CuI(P,-η2-alkene)Cl complex. 
The formation of CuI complexes was confirmed by NMR and IR spectroscopic and 
mass spectrometric analysis.  
 
The AuI complexes containing the alkene-phosphine ligands were synthesised and 
characterised. Ferrochalcone gold(I) chloride complex 70 was synthesised. The X-ray 
structure of a single crystal shows that the ferrochalcone 32 acts as a monodentate 
ligand binding through the phosphorus moiety only and there is no evidence for a AuII-
alkene interaction.  The complex showed a linear geometry. The same reaction was 
repeated for the Lei ligand 17. The LIFDI mass spectrum for complex 71 showed a peak 
at m/z 624.05 corresponding to [Au(C27H21PO)Cl]+. The crystals were analysed by XRD 
analysis. Surprisingly a [2+2] cycloaddition product was also found to have formed. A 
70:30 ratio of the dimer:monomer, respectively, was determined.  A AuI complex 
containing monodba-thiophos was also synthesised from the same metal precursor. It is 
worthy of note that the [2+2] cycloaddition reaction occurred on the most hindered 
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alkene. The presence of a mixture of compounds in the crystal suggested that a 
photochemical [π2s+π2s] reaction was occurring in the solid-state.  
 
One of the aims of this project was to design and synthesise a new ligand and to use it in 
catalysis. The reactivity of AuI complexes of these ligands were evaluated as catalysts 
for the cycloisomerisation of 4-phenyl-1-hexen-5-yne, and some interesting results 
obtained. 
 
Cyclic voltammetric studies on both ferrochalcone 32 and ferrochalcone AuI complex 
70 were conducted. The cyclic voltammogram displayed a quasi-reversible ferrocene-
based oxidation, between 0.30 - 0.40 V (i.e. harder to oxidise than ferrocene itself) . 
There was also an irreversible vinyl-ketone based-reduction (chemical). However, the 
AuI complex 70 exhibited a reversible cycle at E1/2 = 0.32 V, corresponding to the redox 
process of the ferrocenyl unit and an anodic peak (Epa) value of -1.12 V. 
 
An important part of this project, although providing a completely different direction, 
was to investigate the purity of palladium(II) acetate, Pd(OAc)2, and its employment in 
stoichiometric cyclopalladation reactions. It goes back to the work reported by 
Nonoyama on the cyclopalladation of papaverine using Pd(OAc)2 where they observed 
a nitro-palladated product on reacting papaverine with Pd(OAc)2 in the presence of 
acetonitrile and air. The cyclopalladation reactions were conducted under various 
conditions. In this project none of the nitro-palladated product was obtained using ultra 
pure Pd(OAc)2. Instead, a novel palladium-dimer 86, with bridging acetate ligands, was 
obtained from CH3CN. When crystallised from DMSO, a PdII-dimer with an oxidised 
methylene was obtained (87). A novel PdII-nitrito complex 90 was also observed 
exhibiting linkage isomerisation (by photoexcitation).  
 
Overall, this project has lead to the successful synthesis of a new class of phosphino-
alkene ligands and their phosphine sulfide variants.  Extensive coordination studies 
show that the ligands act as hemilabile bidentate ligands. The AuI complexes have been 
successfully used in catalysis. A number of findings require further research, especially 
Pd, Pt and Rh mediated reactions. What is clear is that the chalcone phosphine ligands 
exhibit a range of coordination modes to transition metal centres, which could be 
exploited in various catalytic processes (e.g. cross-coupling, hydroformylation, 1,4-
conjugate addition reactions etc.). 
 181
References for Chapter 1 
                                                 
1  Helldorfer, M.; Backhaus, J.; Alt, H. G. Inorg. Chim. Acta 2003, 351, 34.  
 
2  Fischer, C.; Defieber, C.; Carreira, E. M.; Suzuki, T. J. Am. Chem. Soc. 2004, 
126, 1628.  
 
3  Glorius, F. Angew. Chem. Int. Ed. 2004, 43, 3364.  
 
4  Shul’pin, G. B. J. Mol. Catal. A. 2002, 189, 3911. 
 
5  (a) Wender, P. M.; Chem. Rev. 1996, 96, 1.  (b) Trost, B. M.; Science. 1991, 254,  
           1471. 
 
6  Pearson, R. G. J. Am. Chem. Soc. 1963, 85, 3533. 
 
7  Heck, R. F.;Nolley, J. P. J. Am. Chem. Soc. 1968, 90, 5518. 
 
8  Negishi, E. I.; Baba, S. J. Chem. Soc. Chem. Commun. 1976, 596. 
 
9  Milstein, D.; Stille, J. J. Am. Chem. Soc. 1978, 1000, 3636. 
 
10  Miyaura, N.; Suzuki, A. Chem. Rev. 1995, 95, 2457. 
 
11  Sonagashira, K.; Tohda, Y.; Hagihara, N. Tetrahedron Lett. 1975, 4467.  
 
12  Keiji, M. Nippon Kagakkai Koen Yokoshu 1999, 76, 960 
 
13  For a comprehensive review of NHCs: Kantchev, E. A. B.; O’Brien, C. J.; Organ,  
         M. G. Angew. Chem. Int. Ed. 2007, 46, 2768.  
 
14  Hermes, A-R.; Girolami, G. S. Inorg. Chem. 1988, 27, 10. 
 
 182
                                                                                                                                               
15  Pignolet, L. H. Homogenous catalysis with Metal Phosphine Complexes; Plenum:  
         New York, 1983.  
 
16  a) Hofmann, A.W. Ann. Chem. Pharm. 1857, 104, 1. b) Malerbi, B. W. Platinum 
Metal Rev. 1965, 9, 47. 
 
17  Tolman, C. A.; Seidel, W. C.; Gosser, L. W. J. Am. Chem. Soc. 1996, 1, 53. 
 
18  a) Lever, A. B. P. Inorg. Chem. 1990, 29, 1271. (b) Perrin, L.; Clot, E.;     
           Eisenstein, O.; Loch, J.; Crabtree, R. H. Inorg. Chem. 2001, 40, 5806.  
 
19  Tolman, C. A. Chem. Rev. 1997, 77, 313. 
 
20  Astruc, D. Organometallic Chemistry and Catalysis, Springer, 2007, 608. 
 
21  Schlummer, B.; Scholz, U. Adv. Synth. Catal. 2004, 346, 1599.  
 
22  Barder, T. E.; Walker, S. D.; Martinelli, J. R.; Buchwald, S. L. J. Am. Chem. Soc.  
        2005, 127, 4685. 
 
23  Hamze, A.; Provot, O.; Alami, M.; Brion, J. D. J. Organomet. Chem. 2008, 693,  
        2789.  
 
24  Kranenburg, M.; van der Burgt, Y. E. M.; Kamer, P. C. J.; van Leeuwen, P. W. N.  
         M. Organometallics 1995, 14, 3081. 
 
25  Rovis, T.; Johnson, J. B. Angew. Chem. Int. Ed. 2008, 47, 840. 
 
26  Fairlamb, I. J. S.; Kapdi, A. R.; Lee, A. F. Org. Lett. 2004, 6. 4435. 
 
27  Fairlamb, I. J. S. Org. Biomol. Chem. 2008, 6, 3645. 
 
 183
                                                                                                                                               
28  Kurosawa, H.; Kajimaru, H.; Ogoshi, S.; Yoneda, H.; Ikeda, I. J. Am. Chem. Soc.  
         1971, 93, 3350.  
 
29  Zenkina, O. V.; Karton, A.; Shimon, L. J. W.; Martin, J. M. L.; van der Boom, M. 
E. Chem. Eur. J. 2009, 15, 10025. 
 
30  Tromp, D. S.; Tooke, D. M.; Spek, A. L.; Deelman, B-J.; Elsevier, C. J. 
Organometallics 2005, 24, 6411. 
 
31  Johnson, J. B.; Rovis, T. Angew. Chem., Int. Ed. 2008, 47, 840. 
 
32  Firmansjah, L.; Fu, G.  J. Am. Chem. Soc. 2007, 129, 11340. 
 
33  Zeise, W. C. Mag. Pharm. 1830, 35, 105. 
 
34   For general introductions and leading references, see:(a) Hartley, F. R. Chem. 
Rev. 1969, 69, 799. (b) Tsipis, C. A. Coord. Chem. Rev. 1991, 08, 63. (c) 
Crabtree, R. H. The Organometallic Chemistry of the Transition  Metals, Wiley, 
New York, 2003. 
 
35  Hunt, L. B. Platinum Metals Rev. 1984, 28, 76. 
  
36  a) Wunderlich, J. A.; Mellor, D. P.; Acta Crystallogr. 1954, 7, 130. (b) 
Wunderlich, J. A.; Mellor, D. P.; Acta Crystallogr. 1955, 8, 57. 
 
37  a) Dewar, M. J. S. Bull. Soc. Chim. Fr. 1951, 18, 79. (b) Chatt, J.; Duncanson, L.  
         A. J. Chem. Soc. 1953, 2929. 
 
38  Ozawa, F.; Ito, T.; Nakamura, Y.; Tamamoto, A. J. Organomet. Chem. 1979, 168,  
          375.  
 
39  Nakamoto, K. Infrared and Raman Spectra of Inorganic and Coordination  
 184
                                                                                                                                               
         Compounds, Part B: Applications in Coordination, Organometallic, and 
Bioinorganic Chemistry; Wiley-Blackwell: Chicester, 2009. 
 
40  Jeffrey, J. C.; Rauchfuss, T. B. Inorg. Chem. 1979, 18, 2658. 
 
41  Slone, C. S.; Weinberger, D. A.; Mirkin, C. A. Inorg. Chem. 1999, 48, 233. 
 
42  Bennett, M. A.; Kouwenhoven, H. W.; Lewis, J.; Nyholm, R. S. J. Chem. Soc.  
        1964, 4570. 
 
43  a) Maire, P.; Deblon, S.; Breher, F.; Geier, J.; Bohler, C.; Ruegger, H.; Schonberg,  
         H.; Grutzmacher, H. Chem. Eur. J. 2004, 10, 4198. b) Fischbach, U.; Ruegger, H.;  
       Grutzmacher, H. Eur. J. Inorg. Chem. 2007, 2654. 
 
44  Defieber, C.; Ariger, M. A.; Moriel, P.; Carreira, E. M. Angew. Chem. Int. Ed.  
        2007, 46, 3139. 
 
45  Tokunaga, N.; Otomaru, Y.; Okamoto, K.; Ueyama, K.; Shintani, R.; Hayashi, T. 
J. Am. Chem. Soc. 2004, 126, 13584. 
 
46  Kasak, P.; Arion, V. B.; Widhalm, M. Tetrahedron:Asymmetry 2006, 17, 3084. 
 
47  Lewis, J. C.; Berman, A. M.; Bergman, R. G.; Ellman, J. A. J. Am. Chem. Soc.  
         2008, 130, 2493. 
 
48   Luo, X.; Zhang, H.; Duan, H.; Liu, Q.; Zhu, L.; Zhang, T.; Lei, A. Org. Lett. 
2007, 6, 4571. 
 
49  Williams, D. B. G.; Shaw, M. L. Tetrahedron 2007, 63, 1624. 
 
50  a) Luo, X.; Zhang, H.; Duan, H.; Liu, Q.; Zhang, T.; Lei, A. Org. Lett. 2007, 9, 4571. 
b) Zhang, H.; Luo, X.; Wongkhan, K.; Duan, H.; Li, Q.; Zhu, L.; Wang, J.;       
 185
                                                                                                                                               
         Batsanov, A. S.; Howard, J. A. K.; Marder, T. B.; Lei, A. Chem. Eur. J. 2009, 15,  
         3823. 
 
51  Cao, Z.; Liu, Z.; Liu, Y.; Du, H. J. Org. Chem. 2011, 76, 6401. 
 
52  Du, H.; Cao, Z.; Liu, Z.; Feng, X.; Zhuang, M. Org. Lett. 2011, 13, 2164. 
 
53  Shintani, R.; Duan, W-L.; Okamoto, K.; Hayashi, T. Tetrahedron: Asymmetry  
          2005, 16, 3400. 
 
54  a) Hashmi, A. S. K. Angew. Chem. Int. Ed. 2005, 44, 6990. b) Zhang, L. et al. 
Adv. Synth. Catal. 2006, 348, 2271. 
 
55  a) Bruneau, C. Angew. Chem. Int. Ed. 2005, 44, 2328. b) Gorin, D. J.; Toste, F. D.  
         Nature 2007, 446, 395. 
 
56  a) Li, Z.; Brouwer, C.; He, C. Chem. Rev. 2008, 108, 3239. b) Hashmi, A. S. K.;  
          Hutchings, G. J. Angew. Chem. Int. Ed. 2006, 45, 7896. 
 
57  Yamamoto, Y.; Nishina, N. Synlett. 2007, 11, 1767. 
 
58  Shibata, T.; Ueno, Y.; Kanda, K. Synlett. 2006, 411. 
 
59  Echavarren, A. M.; Wang, Y.; Alvarado, C. R. S. J. Am. Chem. Soc. 2011, 133,  
         11952.  
 
60  a) Alexakis, A.; Albrow, V.; Biswas, K.; d’Augustin, M.; Prieto, O.; Woodward, 
S. Chem. Commun. 2005, 2843-2845. b) Alexakis, A.; Benhaim, C. Eur. J. Org.  
         Chem. 2002, 3221. 
 
61  Zhu, L.; Li, G.; Luo, L.; Guo, P.; Lan, J.; You, J. J. Org. Chem. 2009, 74, 2200. 
  
 186
                                                                                                                                               
62  Noh, D.; Chea, H.; Ju, J.; Yun, J. Angew. Chem., Int. Ed. 2009, 48, 6062. 
 
63  a) Burke, A. J.; Carreiro, E. d. P.; Chercheja, S.; Moura, N. M. M.; Ramalho, J. P.  
         P.; Rodrigues, A. I.; dos Santos, C. I. M. J. Organomet. Chem. 2007, 692, 4863. b)  
         Eggers, F.; Luning, U. Eur. J. Org. Chem. 2009, 2328. 
 
64  De Ornellas, S.; Storr, T. E.; Williams, T. J.; Baumann, C. G.; Fairlamb, I. J. S.  
         Curr. Org. Synth. 2011, 8, 79. 
 
65  Kaddouri, H.; Vicente, V.; Ouali, A.; Ouazzani, F,; Taillefer, M. Angew. Chem.,  
         Int. Ed. 2009, 48, 333. 
 
66  Drinkel, E.; Briceño, A.; Dorta, R.; Dorta, R. Organometallics 2010, 29, 2503. 
 
67  Fairlamb, I. J. S.; Jarvis, A. G.; Whitwood, A. C. Dalton Trans. 2011, 40, 3695. 
 
68  Ferrer, C.; Benet-Buchholz, J.; Riera, A.; Verdaguer, X. Chem. Eur. J. 2010, 16, 
8340. 
 
69  Hayashi, T.; Togni, A. Ferrocenes, Homogenous Catalysis, Organic 
Synthesis and  Materials Science, ed. VCH, Weinheim, Germany, 1995. 
 
70  Halterman, R. L.; Togni, A. Metallocenes, ed. VCH, Weinheim, Germany, 1998. 
 
71  Long, N. J. Metallocenes, An introduction to Sandwich Complexes, Blackwell  
         Science, Oxford, UK, 1998. 
 
72  Pauson, P. L. Organomet. Chem. 2001, 3, 637. 
 
73  Dombrowski, K. E.; Baldwin, W.; Sheats, J. E. J. Organomet. Chem. 1986, 302,  
         281. 
 
 187
                                                                                                                                               
74  Connelly, N. G.; Geiger, W. E. Chemical Redox Agents for Organometallic  
     Chemistry. Chemical  Reviews. 1996, 96, 877. 
 
75  Hembre, R. T.; McQueen, J. S. Angew. Chem., Int. Ed. 1997, 109, 79. 
 
76  Dyson, P. J.; Sava, G. Dalton Trans. 2006, 1929. 
 
77  Huxham, L. A.; Cheu, E. L. S.; Patrick, B. O. Inorg. Chim. Acta. 2003, 352, 238. 
 
78  Prokop, A.; Jesse, P.; Kater, L.; Hunlod, A.; Kater, B. J. Cancer. Res. Clin. Oncol.  
         2011, 137, 639. 
 
79  Meunier, P.; Ouattara, I.; Gautheron, B.; Tirouflet, J.; Camboli, D.; Besancon,  
         J.  Eur. J. Med. Chem. 1991, 26, 351. 
 
80  Top, S.; Tang, J.; Vessieres, A.; Carrez, D.; Provot, C.; Jaouen, G. 
Chem. Commun. 1996, 955. 
 
81  Dori, Z.; Gershon, D.; Scharf. Y. Demande FR, 2, 598, 616 (Cl. A61K31/12), 20  
         Nov. 1987, US Appl. 862, 804, 13 May 1986, p. 13. 
 
82  Koepf-Maier, P.; Koepf, H. Neuse EW. Angew. Chem., Int. Ed. 1984, 23,  
         456. 
 
83  Koepf-Maier, P.; Koepf, H. Drugs Future 1986, 11, 297. 
 
84  Biot, C.; Francois, N.; Maciejewski, L.; Brocard, J.; Poulain, D. Med. Chem.  
Lett.  2000, 10, 839. 
 
85  Itoh, T.; Shirakami, S.; Ishida, N.; Yamashita, Y.; Yoshida, T.; Kim, H-S.; 
Wataya, Y. Bioorg. Med. Chem. Lett. 2000, 10, 839. 
 
 188
                                                                                                                                               
86  Baldoli, C.; Maiorana, S.; Licandro. E.; Zinzalla, G.; Perdicchia. D. Org. 
Lett. 2002, 4, 4341. 
 
87  Haque, M. E.; Hossen, M. F.; Pervin, M. M.; Hassan, P.; Khalekuzzaman, M.  
          J. App. Sci. 2006, 6, 988. 
 
88  Hayashi, T in Ferrcenes. Homogenous Catalysis, Organic Synthesis, Materials  
         Science (Eds.: Togni, A.; Hayashi, T), VCH, Weinheim. 1995, 105. 
 
89  Kagan, H. B.; Riant, O. Adv. Asymmetric. Synth. 1997, 2, 189.  
 
90  Richards, C. F.; Lock, A. J. Tetrahedron: Asymmetry 1998, 9, 2377.  
 
91  Togni, A in Metallocenes (Eds.: Togni, A.; Halterman, R, L) Wiley, New York.  
         1998, 685.  
 
92  Santelli, M.; Laurenti, D. Org. Prep. Proced. Int. 1999, 31, 245.  
 
93  Dai, L. X.; Tu, T.; Deng, W. P.; Hou, X. L. Acc. Chem. Res. 2003, 36, 659. 
 
94  Fache, F.; Schulz, E.; Tommasino, M. L.; Lemaire, M. Chem. Rev. 2000, 100, 
2159.  
 
95  McManus, H. A.; Guiry, P. J. Chem. Rev. 2004, 104, 4151. 
 
96  Breuer, M.; Ditrich, K.; Habicher, T.; Kebeler, M.; Zelinski, T. Angew. Chem.  
         2004, 43, 788. 
 
97  Hansen, K. B.; Rosner, T.; Kubryk, M.; Domer, P. G. Org. Lett. 2005, 7, 4935.  
 
98   Lu, S. M.; Han, X. W.; Zhou, Y. G. Adv. Synth. Catal. 2004, 346, 909. 
 
 189
                                                                                                                                               
99  Dyson, P.; Hartinger, C. G. J. Chem. Soc. Rev. 2009, 38, 391. 
 
100  Metzler-Nolte, N.; Salmain, T. In Ferrocenes Ligand, Materials and Biomolcules;  
          Ed.; Wiley: West Sussex. 2008, 499. 
 
101  Wu, X.; Wilairat, P.; Go, M. L. Bioorg. Med. Chem. Lett. 2002, 12, 2299. 
 
102  Zhao, B.; Lu, W. Q.; Wu, Y. J. Mater. Chem. 2000, 10, 1513. 
 
103  Belavaux-Nicot, B.; Fery-Forgues, S. Eur. J. Inorg. Chem. 1999, 1821.  
 
104  McMurry, J. Organic Chemistry, 6th Ed. Thomson-Brooks/cole, NY, 2007. 
 
105  Fairlamb, I. J. S.; Moulton, B. E.; Sawle, P.; Green, C. J.; Motterlini, R. Chem. 
Res.  Toxicol. 2008, 21, 1484.   
 
106   a) Sun, M.; Shi, Q.; Huang, G.; Liang, Y.; Ma, Y. Synthesis 2005, 15, 2482. b)  
          Zhou, W. J.; Ji, S. J.; Shen, Z. L. J. Organomet. Chem. 2006, 691, 1356. 
 
107  Wu, X.; Tieking, E, R. T.; Kostetski, I.; Go, M. L. Eur. J. Pharm. Sci. 2006, 27,  
          175. 
 
108  Wolfe, H.; Kopacka, H.; Ongania, K-H.; Bildstein, B. J. Org. Chem. 2006, 691,  
          1197. 
 
109  Miyaura, N.; Buchwald, S. L. Cross coupling reactions. Springer. 2002, 248.  
 
110  Zhang, H.; Luo, X.; Zhu, L.;Marder, T. B.; Lei, A. Chem. Eur. J. 2009, 0, 0. 
 
 
 
 
 190
                                                                                                                                               
 
References for Chapter 2 
 
111  Mitoraj, M. P.; Michalak, A. Inorg. Chem. 2010, 49, 578. 
 
112  a) Maire, P.; Deblon, S.; Breher, F.; Geier, J.; Bohler, C.; Ruegger, H.;    
            Schonberg, H.; Grutzmacher, H. Chem. Eur. J. 2004, 10, 4198. b) Mariz, R.;    
            Briceno, A.; Dorta, R.; Dorta, R. Organometallics  2008, 27, 6605. c) Stepnicka,  
            P.; Lamac, M.; Cisarova, I. J. Organometallic. Chem. 2008, 693, 446. d)  
            Shintani, R.; Duan, W.-L.; Okamoto, K.; Hayashi, T. Tetrahedron Asymmetry  
            2005, 16, 3400. e) Hennessy, E. J.; Buchwald, S. L. Org. Lett. 2002, 4, 269. 
 
113  a) Fairlamb, I. J. S.; Kapdi, A. R.; Lee, A. F.; McGlacken, G. P.; Weissburger,   
            F.; de Vries, A. H. M.; Schmieder-van de Vondervoort, L. Chem. Eur. J. 2006,  
            12, 8750. b) Fairlamb, I. J. S.; Kapdi, A. R.; Lee, A. F. Org. Lett. 2004, 6, 4435. 
 
114  Luo, X.; Zhang, H.; Duan, H.; Liu, Q.; Zhu, L.; Lei, A. Org. Lett. 2007, 9, 4571. 
 
115  Kudar, V.; Zsoldos-Mady, V.; Simon, K.; Csampai, A.; Sohar, A. J.  
           Organometallic. Chem. 2005, 690, 4018. 
 
116  a) Lopez, E. A. V.; Klimova, T.; Klimova, E. I.; Toledano, A.; Garcia, M. M.  
            Synthesis. 2004, 15, 2471.  b) Nagy, A. G.; Marton, J.; Sohar, P. Acta. Chim.    
           Hung. 1991, 128, 961.  
 
117   Kudar, V.; Zsoldos-Mady, V.; Simon, K.; Csampai, A.; Sohar, P.    
           Organometallic. Chem. 2005, 690, 4018. 
 
118  a) Tolman, C. A. J. Am. Chem. Soc. 1970, 92, 2656. b) Tolman, C. A. J. Am.  
           Chem.  Soc. 1970, 92, 2953. 
 
119  Bandgar, B. P.; Patil, S. A.; Gacche, R. N.; Korbad, B. L.; Kinkar, S. N.; Jalde,    
            S. S. Bioorg. Chem. Lett. 2010, 20, 730. 
 
120  McMurry, M. Organic Chemisty. 6th ed, Thomson-Brooks/Cole, NY, 2007. 
 
 191
                                                                                                                                               
121  a) Tarraga, A.; Molina, P.; Lopez, J. L. Tetrahedron Lett. 2000, 41, 2479. b)  
            Tarraga, A.; Molina, P.; Curiel, D.; Lopez, J. L.; Velasco, M. D. Tetrahedron.  
              1999, 55, 14701. 
 
122
  a) Tanaka, K.; Tada, F. Chem. Rev. 2000, 100, 1025. b) Rothenberg, G.;     
            Downie, A. P.; Raston, C. L.; Scott, J. L. J. Am. Chem. Soc. 2001, 123, 8701. c)    
             Liu, W.; Xu, Q.; Chen, B.; Liang, Y.; Ma, Y.; Liu, W. J. Organometallic.  
             Chem. 2001, 782, 637. d) Liu, W.; Xu, Q.; Chen, B.; Ma, Y. Synth. Commun.  
              2002, 32, 171. 
 
123  Ji, S. J.; Shen, Z. L.; Wang, S. Y. Chin. Chem. Lett. 2003, 14, 663. 
 
124  Villemin, D.; Martin, B.; Puciova, M.; Toma, S. J. Organometallic. Chem. 1994,  
             27, 484. 
 
125  http://chemistry.uah.edu/faculty/vogler/LectureNotes332/CH332Chapter18.pdf 
 
126  Song, Q-B.; Lin, R-X.; Yang, Z-P.; Qi, C-Z. Molecules. 2005, 10, 634.  
 
127  Fang, J.; Jin, Z.; Li, Z.; Liu, W. J. Organometal. Chem. 2003, 674, 1. and  
            references therein. 
 
128  
http://www.as.utexas.edu/astronomy/education/spring07/scalo/secure/Loud
onCh4 Alkenes.pdf 
  
129   http://www.chem.mun.ca/homes/fmkhome/Schlenks.htm 
 
130  Wade, L. G. J. Chem. Educ. 1978, 55, 208. 
 
131  Luo, X.; Zhang, H.; Duan, H.; Liu, Q.; Zhu, L.; Zhang, T.; Lei, A. Org. Lett. 2007, 6, 4571. 
 
132
  "SHELXS-97" - program for structure solution. Sheldrick, G. M. University of  
            Göttingen, Göttingen, Germany, 1997. 
 
 192
                                                                                                                                               
133  "SHELXL-97" - program for the Refinement of Crystal Structures. Sheldrick, G. M.  University of 
Göttingen, Göttingen, Germany, 1997. 
 
134  "SHELXS-97" - program for structure solution. Sheldrick, G. M. University of  
          Göttingen, Göttingen, Germany, 1997. 
 
135  "SHELXL-97" - program for the Refinement of Crystal Structures. Sheldrick, G. M. University of 
Göttingen, Göttingen, Germany, 1997. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 193
                                                                                                                                               
References for Chapter 3 
 
136  Bennett, M. A.; Knrrn, W. R.; Nyholm, R. S. Inorg. Chem. 1968, 7, 552. 
 
137  a) Platinum Metal Rev., 2005, 49, 77. b) Cao, Z.; Liu, Z.; Du, H. J. Org. Chem.  
          2011, 76, 6401. c) Bruye`re, D.; Monteiro, N.; Bouyssi, D.; Balme, G.  
         Organometallic 2003. 687, 466. d) Dias, H. V. R.; Lu, H-L.; Kim, H-J.; Polach, S.  
          A.; Goh, T. K. H. H.; Browning, R. G.; Lovely, C. J. Organometallics 2002, 21,  
          1466. e) Perez, P. J.; Brookhart, M.; Templeton, J. L. Organometallics, 1993, 12,    
          261. f) Lang. F.; Chen, G.; Li, L.; Xing, J.; Han, F.; Liao, J. Chem.Eur. J. 2011,   
          17, 5242.g) Nishimura, T.; Kawamoto, T.; Nagaosa, M.; Kumamoto, H.;   
          Hayashi, T. Angew. Chem. Int. Ed. 2010, 49, 1638.  
 
138  Luo, X.; Zhang, H.; Duan, H.; Liu, Q.; Zhu, L.; Lei, A. Org. Lett. 2007, 9, 4571. 
 
139  a) Slone, C. S.; Weinburger, D. A.; Mirkin, C. A. Prog. Inorg. Chem. 1999, 48,  
            233. b) Braunstein, P.; Naud, F. Angew. Chem., Int. Ed. 2001, 40, 680. 
 
140
  Rovis, T.; Johnson, J. B. Angew. Chem. Int. Ed. 2008, 47, 840. 
 
141  a) Cotton, F. A.; Wilkinson, G. Advanced Inorganic Chemistry: A    
            Comprehensive Text, 2nd Ed.; Interscience: New York, 1966. b) Five-coordinate   
             compounds have been observed for alkene complexes with N,N-donor ligands:            
             Albano, V. G.; Natile, G.; Panunzi, A. Coord. Chem. Rev. 1994, 133, 67. 
 
142  Gray, G. M.; George, J. M.; Jan, M. Inorganica Chimica Acta 2001, 314, 133.  
 
143  Jarvis, A. G. Phd Thesis University of York 2011.  
 
144  Pongracz, P.; Petocz, G.; Shaw, M.; Williams, D. B. G.; Kollar, L. J. Org.      
           Chem. 2010, 29, 2503. 
 
145  Al-Najjar, I. M. Inorg. Chim. Acta 1987, 128, 93. 
 
 194
                                                                                                                                               
146  
http://www.as.utexas.edu/astronomy/education/spring07/scalo/secure/LoudonCh4Alken
es.pdf 
  
147  Metallinos, C.; Zaifman, J.; Belle, L. V.; Dodge, L.; Pilkington, M.  
           Organometallic  2009, 28, 4534. 
 
 
150  Head, R. A. Inorg. Synth. 1990, 28, 132. 
 
151  Tromp, D. S.; Duin, M. A.; Elsevier, C. J. Inorg. Chim. Acta 2002, 327, 90.  
 
152
  March, F. C.; Mason, R.; Scollary, G. R. Aust. J. Chem. 1977, 30, 2407. 
 
153  a) Shintani, R.; Narui, R.; Hayashi, S.; Hayashi, T. Chem. Comm. 2011, 47,    
            6123. b) Gladiali, S.; Grepioni, F.; Medici, S.; Zucca, A.; Kollar, L. Eur. J.   
            Inorg. Chem. 2003, 556. 
 
154  a) Faraonc, F.; Arena, C. G.; Rccondo, E. J. Organomet. Chem. 1991, 419, 399.   
            b) Colquhoun, I. J.; McFarlane, W. J. Magnetic Resonance 1982, 46, 525. c)   
            Gambaro, J. J.; Hohman, W. H.; Meck, D. W. Inorg. Chem. 1989, 28, 4154. d)  
            Pandey, K. K.; Nehete, D. T.; Sharma, R. B. Polyhedron 1990, 9, 2013. 
 
155
  a) Steel, P. J. Coord. Chem. Rev. 1990, 106, 227. b) Panthi, B.; Gipson, S. L.;  
            Franken, A. Acta. Cryst. 2008, E64, m1330. 
 
156  Benech, J-M.; Piguet, C.; Bernardinelli, G.; Hopfgartner, G. J. Chem. Soc.   
           Dalton Trans. 2001, 684.  
 
157  Pearson, R. G. J. Am. Chem. Soc. 1963, 85, 3533. 
 
158  "SHELXS-97" - program for structure solution. Sheldrick, G. M. University of  
          Göttingen, Göttingen, Germany, 1997. 
 
159  "SHELXL-97" - program for the Refinement of Crystal Structures. Sheldrick, G. M. University of 
Göttingen, Göttingen, Germany, 1997. 
 195
                                                                                                                                               
 
160  Dolomanov, O.V.; Bourhis, L. J.; Gildea, R. J.; Howard, J. A. K.; Puschmann, H.  
         OLEX2: a complete structure solution, refinement and analysis program. J. Appl.  
          Cryst. 2009, 42, 339, using "SHELXS-97" - program for structure solution.  
           Sheldrick, G. M.  University of Göttingen, Göttingen, Germany, 1997. 
 
161
  "SHELXL-97" - program for the Refinement of Crystal Structures. Sheldrick, G.   M.  University 
of Göttingen, Göttingen, Germany, 1997. 
 
162  “smtbx-flip” plug-in module to “Olex2” crystallography software, J. Appl. Cryst. 2009, 42, 339. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 196
                                                                                                                                               
References for Chapter 4 
 
 
163  a) Lightman, A. Chemical & Engineering news. American Chemical Society    
            2003, 81, 150. b) Al’brekht, V. G.; Zhurnal, G. Izvestiya Vysshikh Uchebnukh    
            Zavedenii  2001, 6, 33. 
 
164  a) Niinistoe, L. Kemia 2002, 29, 15. b) Elisabeth, L. Praxis der              
            Naturwissenschaften Chemie in der Schule 2007, 56, 31.  
 
165
   Casini, A.; Hartinger, C.; Gabbiani, C.; Mini, E.; Dyson, P. J.; Keppler, B. K.;  
             Messori, L. J. Inorg. Biochem. 2008, 102, 564. 
 
166   Messori, L.; Marcon, G. In Metal ions and their complexes in medication; Sigel,          
            A., Ed.; CRC Press: 2004, 280. 
 
167  Food Standards Agency's web site. Current EU approved additives and their E    
            Numbers.     
            http://www.food.gov.uk/safereating/chemsafe/additivesbranch/enumberlist  
            (accessed on July 1st,  2009) 
 
168  a) Nolan, S. P. Nature. 2007, 445, 496. b) Hashmi, A. S.K. Chem. Rev. 2007,            
             107, 3180. c) Furstner, A. Chem. Soc. Rev. 2009, 38, 3208. 
 
169  a) Skouta, R.; Li, C.J. Tetrahedron. 2008. 64, 4917. b) Gorin, D. J.; Toste, F. D.    
            Nature 2007, 446, 395. c) Hashmi, A.S. K.; Hutchings, G, J. Angew. Chem., Int.   
            Ed. 2006, 45, 7896. d) Hashmi, A. S. K.; Salathe, R.; Frost, T. M. Appl. Catal.           
            A. 2005, 291, 238. 
 
170  Pradal, A.; Toullec, P, Y.; Michelet, V. Synthesis 2011, 10, 1501. 
 
171  Bone, W. A.; Wheeler, R. V. Philos. Trans. R. Soc. London, Ser. A 1906, 206, 1-  
            67. 
 
172  a) Gorin, D. J.; Toste, F. D. Nature  2007, 446, 395. b) Hutchings, G. J. Catal.       
            Today. 2007, 122, 196. c) Hashmi, A. S. K.; Hutchings, G. J. Angew. Chem., Int.  
 197
                                                                                                                                               
            Ed. 2006, 45, 7898. d) Hashmi, A. S. K. Angew. Chem.,  Int. Ed. 2005, 44, 6990.  
           e) Dyker, G. Angew. Chem., Int.Ed. 2000, 39, 4237. 
 
173  a) Furstner, A.; Davies, P. W. Angew. Chem., Int. Ed. 2007, 46, 3410. b) Gorin,  
            D. J.; Sherry, B. D. Toste, F. D. Chem. Rev. 2008, 108, 3351.  
 
174  a) Haug, T. T.; Harschneck, T.; Duschek, A.; Binder, J. T.; Kirsch, S. F. J.  
            Organomet.Chem. 2009, 694, 510. b) Blanc, A.; Alix, A.; Weibel, J.-M.; Pale, P.    
            Eur. J. Org. Chem. 2010, 1644. 
 
175
  a) Sanz, S.; Jones, L. A.; Mohr, F.; Laguna, M. Organometallics 2007, 26, 952.   
 
176  Nieto-Oberhuber, C.; Perez-Galam, P.; Herrero-Gomez, E.; Lauterbach, T.;  
            Rodriguez, C.; Lopez, S.; Echavarren, A. M. J. Am. Chem. Soc. 2008, 130, 269.  
 
177  a) Marion, N.; Gealageas, R.; Nolan, S. P. Org. Lett. 2007, 9, 2653. b) Witham,  
           C. A.; Mauleon, P.; Shapiro, N. D.; Sherry, B. D.; Toste, F. D. J. Am. Chem. Soc.  
            2007, 129, 5838.  
 
178  Diez-Gonzalez, S.; Nolan, S. P. Acc. Chem. Res. 2008, 41, 349. 
 
179  Guan, B. T.; Xing, D.; Cai, G. X.; Yu, N.; Fang, Z.; Shi, Z. J. J. Am. Chem. Soc.  
            2005, 127, 18004.  
 
180   Hashmi, A. S. K.; Schafer, S.; Wolfle, M.; Gil, C, D.; Fischer, P.; Gimeno, M,   
            C. Angew.Chem. Int. Ed. 2007, 46, 6184.  
 
181  Li, X. Q.; Li, C.; Song, F. B. J. Chem. Res. 2007, 722.  
 
182  Brouwer, C.; He, C. Angew. Chem. Int. Ed. 2006, 45, 1744. 
 
183  a) Zhang, L. M.; Sun, J. W.; Kozmin, S. A. Adv. Synth. Catal. 2006, 348, 2271.   
            b) Bruneau, C. Angew. Chem., Int. Ed. 2005, 44, 2328. 
 
184  a) Haruta, M.; Kobayashi, T.; Sano, H.; Yamada, N. Chem. Lett. 1987, 405. b)  
          Haruta, M.; Yamada, N.; Kobayashi, T.; Iijima, S.; J. Catal. 1989, 115, 301. c)  
          Guzman, J.; Gates, B. C. J.Am. Chem. Soc. 2004, 126, 2672. d)    
 198
                                                                                                                                               
          Luengnaruemitchai, A.; Thoa, D. T. K.; Osuwan, S. Int.J. Hydrogen. Energy.  
          2005, 30, 981. 
 
185
  Hua, J.; Zheng, Q.; Zheng, Y.; Wei, K.; Lin, X. Catal. Lett. 2005, 102, 99.  
 
186  Corma, A.; Abad, A.; Garcia, H. Angew. Chem. Int. Ed. 2005, 44, 4066.  
 
187  a) Carrettin, s.; Guzman, J.; Corma, A. Angew. Chem. Int. ed. 2005, 44, 2242. b)  
            Hashmi, A. S. K.; Schwarz, L.; Choi, J.-H, Frost, T. M. Angew. Chem. Int. Ed.  
            2000, 39, 2285. 
 
188  Toste. F. D. Gold catalysis for organic synthesis. Thematic series in the Open     
            access Beilstein Journal of Organic Chemistry. 
 
189   a) Gorin, D. J.; Toste, F. D. Nature 2007, 446, 395. b) Chianese, A. R.; Lee, S.   
            J.; Gagne´, M. R. Angew. Chem., Int. Ed. 2007, 46, 4042. c) Ma, S.; Yu, S.; Gu,   
            Z. Angew. Chem., Int. Ed. 2006, 45, 200. d) Bruneau, C. Angew. Chem., Int. Ed.  
           2005, 44, 2328. 
 
190   a) Li, Z.; Brouwer, C.; He, C. Chem. Rev. 2008, 108, 3239. b) Jime´nez-    
            Nu´n˜ez, E.; Echavarren, A. M. Chem. Rev. 2008, 108, 3326. c) Bongers, N.;  
            Krause, N. Angew.Chem., Int. Ed. 2008, 47, 2178. d) Fu¨rstner, A.; Davies, P.  
            W. Angew. Chem., Int.Ed.  2007, 46, 3410. e) Zhang, L.; Sun, J.; Kozmin, S. A.  
            AdV. Synth. Catal. 2006, 348, 2271. f) Hashmi, A. S. K.; Hutchings, G. J.  
            Angew. Chem., Int. Ed. 2006, 45, 7896. 
 
191  a) Hashmi, A. S. K.; Salathe, R.; Frey, W. Chem. Eur. J. 2006, 12, 6991. b)    
            Harkat, H.; Dembele, A. Y.; Weibel, J.-M.; Blanc, A.; Pale, P. Tetrahedron.  
             2009, 65, 1871.  
 
192  Hashmi, A. S. K. Angew. Chem., Int. Ed. 2008, 47, 6754. 
 
193  Lee. Y. T.; Kang, Y. K.; Chung, Y. K. J. Org. Chem. 2009, 74, 7922. 
 
194  a) Lloyd-Jones, G. C. Org. Biomol. Chem. 2003, 1, 215. b) Echavarren, A. M.;  
            Nevado, C. Chem. Soc. Rev. 2004, 33, 431. c) Diver, S. T.; Giessert, A. J. Chem.  
            Rev. 2004, 104, 1317. 
 
 199
                                                                                                                                               
195  Park, Y.; Kim, S. Y.; Park, J. H.; Cho, J.; Kang, Y. K.; Chung, Y. K. Chem.      
           Comm. 2011, 47, 5190. 
 
196  a) Soriano, E.; Macro-Contelles, J. Acc. Chem. Res. 2009, 42, 1026. b) Hashmi,  
            A. S. K.; Rudolp, M. Chem. Soc. Rev. 2008, 37, 1766. c) Lee, Y. T.; Kang, Y.   
            K.; Chung, Y. K. J. Org.Chem. 2009, 74, 7922. 
 
197  a) Trost, B. M.; Toste, F. D. J. Am. Chem. Soc. 2000, 122, 714. b) Trost, B. M.;  
            Toste, F. D. J. Am. Chem. Soc. 2004, 126, 15592. 
  
198  Trost, B. M.; Lautens, M.; Hung, M. H. J. Am. Chem. Soc. 1984, 106, 7641. 
 
199  a) Trost, B. M.; Chand, V. K. Synthesis 1993, 824. b) Chatani, N.; Morimoto, T.;  
            Muto, T.; Murai, S. Organometallics 2001, 20, 3704. 
 
200  Shibtata, T.; Kobayashi, Y.; Maekawa, S.; Toshida, N.; Takagi, K. Tetrahedron  
            2005, 61, 9018.  
 
201  a) Grigg, R.; Stevenson, P.; Worakun, T. Tetrahedron 1988, 44, 4967. b) Cao,    
            P.; Wang, B.; Zhang, X. J. Am. Chem. Soc. 2000, 122, 6490. 
 
202  Fehr, C.; Farris, I.; Sommer, H. Org. Lett. 2006, 8, 1839. 
 
203  Michelet, V.; Toullec, P, Y.; Genet, J. P. Angew. Chem. Int. Ed. 2008, 47, 4268. 
 
204  Marion, N.; De-Fremont, P.; Lemiere, G.; Stevens, E. D.; Nolan, S. P. Chem.  
           Commun. 2006, 2048. 
 
205
  Luzung, M. R.; Markham, J. P.; Toste, F. D. J. Am. Chem. Soc. 2004, 126,       
            10858. 
 
206  Axen, U.; Lincoln, F. H.; Thompson, J. L. J. Chem. Soc. D. Chem. Commun.      
            1969, 303. 
  
207  Furstner, A.; Hannen, P. Chem. Eur. J. 2006, 12, 3006. 
  
 200
                                                                                                                                               
208  Staben, S. T.; Kennedy-Smith, J. J.; Huang, D.; Corkey, B. K.; Toste, F. D.     
            Angew.Chem. Int. Ed. 2006, 45, 5991. 
 
209  Ishiuchi, K.; Kubota, T.; Morita, H.; Kobayashi, J. Tetrahedron Lett. 2006, 47,  
            3287.  
 
210  Marion, N.; Fremont, P-D.; Lemiere, G.; Stevens, E. D.; Fensterbank, L.; Nolan,     
            S. P. Chem.Commun. 2006, 2048 
 
211
  Montaudo, G.; Caccamese, S. J. Org. Chem. 1973, 38, 710.  
 
212  Karpuk, E.; Schollmeyer, D.;Meier, H. Eur. J. Org. Chem. 2007, 1983.  
 
213  Garvis, A. J. PhD Thesis. University of York 2011. 
 
214  Schmidt, G. M. J. Pure Appl. Chem., 1971, 27, 647. 
 
215  Alcock, N. W.; de Meester, P.; Kemp, T. J. J. Chem. Soc., Perkin Trans. II 1979,  
           921. 
 
216 http://www.as.utexas.edu/astronomy/education/spring07/scalo/secure/LoudonCh4Alkenes.pdf 
 
217  Luzung, M. R.; Markham, J. P.; Toste, F. D. J. Am. Chem. Soc. 2004, 126,      
            10858.  
 
218  a) Cunningham, A. J.; Underwood, A. L. Cyclic voltammetry of the pyridine  
            nucleotides and a series of nicotinamide model compounds. Biochem. 1967, 6,  
            266. b) Ti-Tien, H. Cyclic voltammetry of bilayer lipid membranes. J. Phys.    
            Chem. 1984, 88, 3172. 
 
219  Ito, N.; Saji, T.; Aoyagui, S. J. Organomet. Chem. 1983, 247, 301. 
 
220  a) Sharp, M.; Petersson, M.; Edstrom, K. J. Electroanal. Chem. 1980, 109, 271.  
            b) Montenegro, M. I.; Pletcher, D. J. Electroanal. Chem. 1986, 200. 371. 
 
221   http://www.chem.mun.ca/homes/fmkhome/Schlenks.htm 
 201
                                                                                                                                               
 
222  Faggiani, R.; Howard-Lock. H. E.; Lock. C. J. L.; Turner. M. A. Can. J. Chem.  
            1987, 65, 1568. 
 
223  Schwier, T.; Rubin, M.; Gevorgyan, V. Org. Lett. 2004, 6, 1999. 
 
224  Luzung, M. R.; Markham, J. P.; Toste, F. D. J. Am. Chem. Soc. 2004, 126,  
           10858. 
 
225  "SMART" - control software Bruker SMART Apex X-ray Diffractometer.  
            v5.625, Bruker-AXS GMBH, Karlsruhe, Germany. 
 
226  "SAINT+" - integration software for Bruker SMART detectors. v6.45, Bruker- 
            AXS GMBH, Karlsruhe, Germany. 
 
227  "SADABS" - program for absorption correction. v2.10. Sheldrick, G. M.  Bruker  
             AXS Inc., Madison, Wisconsin, USA, 2007. 
 
228  "SHELXS-97" - program for structure solution. Sheldrick, G. M. University of  
            Göttingen, Göttingen, Germany, 1997. 
 
229  "SHELXL-97" - program for the Refinement of Crystal Structures. Sheldrick, G.  
             M. University of Göttingen, Göttingen, Germany, 1997. 
 
230  CrysAlisPro, Oxford Diffraction Ltd. Version 1.171.34.40. 
 
231  Empirical absorption correction using spherical harmonics, implemented in   
            SCALE3 ABSPACK scaling algorithm within CrysAlisPro software, Oxford  
            Diffraction Ltd. Version 1.171.34.40. 
 
232  Dolomanov, O.V.; Bourhis, L. J.; Gildea, R. J.; Howard, J. A. K.; Puschmann,  
            H. OLEX2: a complete structure solution, refinement and analysis program. J.   
            Appl.Cryst. 2009, 42, 339, using "SHELXS-97" - program for structure  
             solution. Sheldrick, G. M.  University of Göttingen, Göttingen, Germany, 1997. 
 
 
 
 
 202
                                                                                                                                               
References for Chapter 5 
 
233  http://en.wikipedia.org/wiki/Palladium  
 
234  Palladium. International Platinum Group Metals Association.  
            http://www.ipa-news.com/pgm/index.htm. 
 
235  a) Stille, J. K. Angew. Chem. 1986, 98, 504. b) Heck, R. F. Comprehensive    
           Organic Synthesis. Pergamon. Oxford. 1991, 4, 833. c) Miyaura, N.; Suzuki, A.   
           Chem. Rev. 1995, 95, 2457. d) Luh, T. Y.; Leung, M. K.; Wong, K. T. Chem.  
           Rev. 2000, 100, 3187. e) Hiyama, T. J. Organomet. Chem. 2002, 653, 58. f)  
           Negishi, E. –i.; Hu, Q.; Wang, G. Aldrichimica. Acta. 2005, 38, 71. g) Trost, B.  
           M.; Crawley, M. L. Chem. Rev. 2003, 103, 2921. h) Surry, D. S.; Buchwald, S.  
           L. Angew. Chem. 2008, 120, 6438. i) Hartwig, J. F. Nature. 2008, 455, 314. j)  
           Denmark, S. E.; Regens, C. S. Acc. Chem. Res. 2008, 41, 1486. 
 
236  Chen, X.; Engle, K. M.; Yu, J-Q. Angew. Chem. Int. Ed. 2009, 48, 5094. 
 
237  Cope, A. C.; Siekman, R. W. J. Am. Chem. Soc. 1965, 87, 3272.  
 
238  Cope, A. C.; Friedrich, E. C. J. Am. Chem. Soc. 1968, 90, 909. 
 
239  Iyer, S.; Ramesh, C. Tetrahedron Lett. 2000, 41, 8981. 
 
240  Weissmann, H.; Milstein, D. Chem. Commun. 1999, 1901.  
 
241  Nonoyama, M. Synth. React. Inorg. Met.-Org. Chem. 1999, 29, 119. 
 
242  Nonoyama, M.; Nakajima, K. Polyhedron. 1999, 18, 533.  
 
243   Stephenson, T. A.; Morehouse, S. M.; Powell, A. R. J. Chem. Soc. 1965, 667. 
 
244  Cheng, C. D.; Gonela, R. K.; Gu, Q.; Haynie, D. T. Nano Lett. 2005, 5, 175. 
 
245  a) Skapski, A. C.; Smart, M. L. J. Chem. Soc. 1970, 658. b) Cotton, F. A.; Han,  
            S. Rev. Chim. Miner. 1985, 22, 277.   
 203
                                                                                                                                               
 
246  a) Romm, I. P.; Buslaeva, T. M.; Lyalina, N. N.; Simitsyn, N. M. Koord. Khim.  
            1992, 18, 165. b) Stoyanov, E. S. J. Struct. Chem. 2000, 41, 440.  
 
247  Marson, A.; VanOort, A. B.; Mul, W. P. Eur. J. Inorg. Chem. 2002, 3028. 
 
248  Zhang, R.; Ma, C.; Yin, H. Huaxue Shiji. 1994, 16, 383. 
 
249    M. Walter, and L. Ramaley.  Anal. Chem. 1973, 45, 165.  
  
250  Bakhmutov, V. I.; Berry, J. F.; Cotton, F. A.; Murillo, C. A. Dalton Trans. 2005,    
            1989. 
 
251  The fully balanced equation is: 3Pd0+6HNO3+6HOAc→  
            Pd3(OAc)6+6NO2+6H2O. 
 
252  Pd3(OAc)5NO2 can only be isolated by manual picking of the crystals from     
            Pd3(OAc)6  
 
253  In the original paper (ref. 14a), crystalline material precipitated within a day. 
 
254  Walter, M.; Ramaley, L. Analytical Chemistry 1973, 45, 165. 
 
255  Kukushkin, Yu. N.; Vyazmenskii, Yu. E.; Zorina, L. I. Neorg. Khim. 1968, 13,    
            1595. 
  
256  Kukushkin, Yu. N. Coord. Chem. Rev. 1995, 139, 375.  
 
257  Santoro, A.; Wegrzyn, M.; Whitwood, A. C.; Bruce, D. W. J. Am. Chem. Soc.  
            2010, 132, 10689.  
 
258
     M. Nonoyama, Synth. React. Inorg. Met. -Org. Chem., 1999, 29, 119. 
 
259  Warren, M. R.; Brayshaw, S. K.; George, M. W.; Warren, J. E.; Teat, S. J.  
           Angew.Chem. Int. Ed. 2009, 48, 5711.   
 204
                                                                                                                                               
 
260   a) Pressprich, M. R.; White, M. A.; Coppens, P. J. Am. Chem. Soc. 1994, 116,  
            5233. b) Fomitechev, D. V.; Coppens, P. Inorg. Chem. 1996, 35, 7021. 
 
261  a) Kubota, M.; Ohba, S. Acta Crystallogr. Sect. B. 1992, 48, 627. b)  
            Kovalevsky, A. Yu.; Bagley, K. A.; Coppens, P. Chem. Eur. J. 2005, 11, 7254.  
 
262  Kovalevsky, A. Yu.; Coppen, P. J. Am. Chem. Soc. 2002, 124, 9241. 
 
263  S. K. Brayshaw, J. W. Knight, P. R. Raithby, T. L. Savarese, S. Schiffers, S. J.  
            Teat, J. E. Warren, and M. R. Warren, J. App. Cryst., 2010, 43, 337. 
 
264  L. E. Hatcher, M. R. Warren, D. R. Allan, S. K. Brayshaw, A. L. Johnson, S.  
           Fuertes, S. Schiffers, A. J. Stevenson, S. J. Teat, C. H. Woodall, and P. R.  
           Raithby, Angew. Chem. Int. Ed., 2011, 50, 8371. 
 
265  Anderson, C. E.; Kirsch, S. F.; Overman, L. E.; Richards, C. J.; Watson, M. P.  
            Organic syntheses 2007, 84, 148. 
 
266  M. Walter, and L. Ramaley, Anal. Chem., 1973, 45, 165.   
 
267  Anderson, C. E.; Kirsch, S. F.; Overman, L. E.; Richards, C. J.; Watson, M. P.  
            Organic syntheses 2007, 84, 148. 
 
268  G. M. Sheldrick, Acta Crystallogr., Sect. A, 1990, 46, 467. 
 
269  G. M. Sheldrick, Acta Crystallogr., Sect. A, 2008, 64, 112. 
 
